Fluororesin composition and molded article

By combining fluororesin A with high temperature melting point and fluororesin B with no high temperature melting point in the fluororesin composition and adding a filler material, the problem of limited application of PTFE at high temperature is solved, and excellent tensile characteristics are achieved. Operateness, and improve electrical and thermal conductivity.

CN118922493APending Publication Date: 2024-11-08DAIKIN INDUSTRIES LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202380029813.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-09-30
Filing Date
2023-03-31
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the prior art, polytetrafluoroethylene (PTFE) cannot fully utilize its physical properties after forming, resulting in limited regeneration applications and difficulty in displaying excellent tensile characteristics and operability at high temperatures.

Method used

A fluororesin composition that does not show melt flowability, comprising fluororesin A having a temperature above the melting point and fluororesin B having a temperature above the melting point, combined with a filler material such as glass fibers, charcoal. Black, etc., copolymerizes the modified monomer with TFE to form a fluororesin composition with excellent tensile properties and operability.

Benefits of technology

It is achieved to maintain excellent tensile characteristics and operability at high temperatures, improve the conductivity and thermal conductivity of the fluororesin composition, and reduce the porosity and cost of the molded body.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005056503960000061
    Figure BDA0005056503960000061
  • Figure BDA0005056503960000062
    Figure BDA0005056503960000062
  • Figure BDA0005056503960000261
    Figure BDA0005056503960000261
Patent Text Reader

Abstract

The purpose of the present invention is to provide: a fluororesin composition having excellent tensile properties and workability despite containing a fluororesin having a history of heating to a temperature equal to or higher than the melting point; and a molded article obtained from the fluororesin composition. The present disclosure relates to a fluororesin composition that does not exhibit melt fluidity, comprising: a fluororesin A that does not exhibit melt fluidity and has a history of heating to a temperature above a melting point; at least one type of fluororesin B selected from the group consisting of fluororesins exhibiting melt fluidity and fluororesins not exhibiting melt fluidity having no history of heating to a temperature equal to or higher than the melting point; and a filler material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to a fluororesin composition and a molded article. Background Art

[0002] Polytetrafluoroethylene (PTFE) that has been heated to a temperature higher than its melting point for molding processing or the like cannot obtain sufficient physical properties even if it is directly reused as a molding material, so recycling for molding purposes is limited to a certain extent.

[0003] Patent Documents 1 and 2 describe technologies for recycling PTFE that has been pulverized after firing or PTFE that has been heated.

[0004] Prior art literature

[0005] Patent Literature

[0006] Patent Document 1: International Publication No. 2019 / 244433

[0007] Patent Document 2: Japanese Patent Application Publication No. 2006-70233 Summary of the invention

[0008] Problems to be solved by the invention

[0009] An object of the present disclosure is to provide a fluororesin composition having excellent tensile properties and handleability despite containing a fluororesin having a history of being heated to a temperature not lower than a melting point, and a molded article obtained from the fluororesin composition.

[0010] Means for solving problems

[0011] The present disclosure (1) relates to a fluororesin composition that does not exhibit melt fluidity, comprising:

[0012] A fluororesin A which does not exhibit melt fluidity when heated to a temperature above its melting point;

[0013] at least one fluororesin B selected from the group consisting of fluororesins that exhibit melt fluidity and fluororesins that do not exhibit melt fluidity and do not have a history of being heated to a temperature higher than a melting point; and

[0014] Filling material.

[0015] The present disclosure (2) is the fluororesin composition according to the present disclosure (1), which has one or more melting points in a temperature range of less than 333°C and one or more melting points in a temperature range of 333°C to 360°C.

[0016] The present disclosure (3) is the fluororesin composition according to the present disclosure (1) or (2), wherein the fluororesin composition comprises a tetrafluoroethylene unit and a modified monomer unit based on a modified monomer copolymerizable with tetrafluoroethylene.

[0017] The present disclosure (4) is the fluororesin composition according to the present disclosure (3), wherein the amount of the modified monomer unit is 1.0% by mass or less based on the total polymerized units constituting the fluororesin composition.

[0018] The present disclosure (5) is a fluororesin composition in combination with any one of the present disclosures (1) to (4), wherein the fluororesin A is polytetrafluoroethylene.

[0019] The present disclosure (6) is a fluororesin composition in combination with any one of the present disclosures (1) to (5), wherein the melt flow rate of the fluororesin exhibiting melt fluidity is 0.25 g / 10 min or more.

[0020] The present disclosure (7) is a fluororesin composition in combination with any one of the present disclosures (1) to (6), wherein the fluororesin exhibiting melt fluidity is a fluororesin having a melting point of 320° C. or less.

[0021] The present disclosure (8) is a fluororesin composition in any combination with any one of the present disclosures (1) to (7), wherein the fluororesin B is the above-mentioned fluororesin exhibiting melt fluidity, and the above-mentioned fluororesin composition further contains a fluororesin C that does not exhibit melt fluidity, and the fluororesin C has: a portion that has no history of being heated to a temperature above the melting point.

[0022] The present disclosure (9) is a fluororesin composition in combination with any one of the present disclosures (1) to (8), wherein the apparent density is 0.40 g / ml or more.

[0023] The present disclosure (10) is a fluororesin composition in combination with any one of the present disclosures (1) to (9), wherein the angle of repose is less than 40°.

[0024] The present disclosure (11) is a fluororesin composition in combination with any one of the present disclosures (1) to (10), wherein the average secondary particle size is 5 μm to 700 μm.

[0025] The present disclosure (12) is a fluororesin composition in any combination with any one of the present disclosures (1) to (11), wherein the maximum linear length of particles of the fluororesin A is smaller than the maximum linear length of particles of the fluororesin B.

[0026] The present disclosure (13) is a fluororesin composition in any combination with any one of the present disclosures (1) to (12), wherein the filler is at least one selected from the group consisting of glass fiber, glass beads, carbon fiber, spherical carbon, carbon black, graphite, silica, alumina, mica, silicon carbide, boron nitride, titanium oxide, bismuth oxide, cobalt oxide, molybdenum disulfide, bronze, gold, silver, copper and nickel.

[0027] The present disclosure (14) is a fluororesin composition in combination with any one of the present disclosures (1) to (13), wherein the filler is a conductive filler.

[0028] The present disclosure (15) is the fluororesin composition according to the present disclosure (14), wherein the conductive filler is carbon black.

[0029] The present disclosure (16) is a fluororesin composition in combination with any one of the present disclosures (1) to (15), which is a powder.

[0030] The present disclosure (17) is a fluororesin composition in any combination with any one of the present disclosures (1) to (16), which is a powder for compression molding or a powder for plunger extrusion molding.

[0031] The present disclosure (18) is a fluororesin composition in combination with any one of the present disclosures (1) to (17), wherein the fluororesin composition has a tensile strength at break of 8 MPa or more.

[0032] The present disclosure (19) is a molded article obtained by compression molding and firing a fluororesin composition in any combination with any one of the present disclosures (1) to (18), or by plunger extrusion molding.

[0033] The present disclosure (20) is a fluororesin composition having one or more endothermic peaks in the range of 320°C to 335°C, wherein when thermally decomposed at 600°C in a nitrogen atmosphere, a residue of 15% by mass or less based on the above-mentioned fluororesin composition is generated, and the fluororesin composition exhibits electrical conductivity or a thermal conductivity of 0.3 W / m·K or more.

[0034] The present disclosure (21) is the fluororesin composition of the present disclosure (20), further comprising one or more endothermic peaks in a range exceeding 335°C.

[0035] The present disclosure (22) is the fluororesin composition of the present disclosure (20) or (21), further comprising an electrically conductive filler or a thermally conductive filler.

[0036] The present disclosure (23) is a fluororesin composition in any combination with any one of the present disclosures (20) to (22), wherein the volume resistivity is 10 4 Ω·cm or less.

[0037] The present disclosure (24) is a fluororesin composition in combination with any one of the present disclosures (20) to (23), wherein the apparent density is 0.40 g / ml or more.

[0038] The present disclosure (25) is a fluororesin composition in combination with any one of the present disclosures (20) to (24), wherein the angle of repose is less than 40°.

[0039] The present disclosure (26) is a fluororesin composition in any combination with any one of the present disclosures (20) to (25), which is a powder for plunger extrusion molding.

[0040] The present disclosure (27) is a fluororesin composition in combination with any one of the present disclosures (20) to (26), wherein the fluororesin composition has a tensile strength at break of 8 MPa or more.

[0041] The present disclosure (28) is a fluororesin composition in combination with any one of the present disclosures (1) to (18) and (20) to (27), which is not for porous use.

[0042] Effects of the Invention

[0043] According to the present disclosure, there can be provided a fluororesin composition having excellent tensile properties and handleability despite containing a fluororesin having a history of being heated to a temperature not lower than a melting point, and a molded article obtained from the fluororesin composition. DETAILED DESCRIPTION

[0044] The present disclosure is described in detail below.

[0045] The present disclosure provides a fluororesin composition that does not exhibit melt fluidity (hereinafter also referred to as the first fluororesin composition of the present disclosure), comprising: a fluororesin A that does not exhibit melt fluidity and has a history of being heated to a temperature not less than its melting point; at least one fluororesin B selected from the group consisting of fluororesins that exhibit melt fluidity and fluororesins that do not exhibit melt fluidity and do not have a history of being heated to a temperature not less than their melting point; and a filler.

[0046] Since the first fluororesin composition of the present disclosure has the above-mentioned constitution, it is excellent in tensile properties (eg, tensile breaking strength, tensile breaking strain) and handleability (handleability as a powder) despite containing a fluororesin having a history of heating to a temperature not lower than its melting point.

[0047] The fluororesin A has a history of being heated to a temperature higher than the melting point. Examples of the heating include heating for molding, heat treatment, and the like.

[0048] The melting point of the fluororesin A is preferably 100°C or higher and lower than 333°C, more preferably lower than 332°C, and still more preferably lower than 331°C.

[0049] The lower limit is not limited, but is more preferably 140°C, and further preferably 180°C or higher.

[0050] The fluororesin A preferably has one or more melting points in a temperature range of less than 333° C. The temperature range of less than 333° C. is more preferably less than 332° C., further preferably less than 331° C., and is preferably 100° C. or more, more preferably 140° C. or more, further preferably 180° C. or more.

[0051] The melting point being within the above range means that the material has a history of being heated to a temperature higher than the melting point.

[0052] The fluororesin A may have a melting point in a temperature range of 333° C. or higher.

[0053] In this specification, the melting point of a fluororesin is the temperature corresponding to the minimum point in a melting heat curve obtained by differential scanning calorimetry [DSC] at a heating rate of 10°C / min using X-DSC7000 (manufactured by Hitachi High-tech Science Corporation). When there are two or more minimum points in one melting peak, each of them is regarded as the melting point.

[0054] Fluororesin A does not exhibit melt fluidity.

[0055] In the present specification, "not showing melt fluidity" means that the melt flow rate (MFR) is less than 0.25 g / 10 min, preferably less than 0.10 g / 10 min, and more preferably 0.05 g / 10 min or less.

[0056] In this specification, MFR is a value obtained as the mass (g / 10 minutes) of the polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm per 10 minutes under a measurement temperature (e.g., 372°C in the case of PFA and FEP, 297°C in the case of ETFE) and a load (e.g., 5 kg in the case of PFA, FEP and ETFE) determined according to ASTM D1238 using a melt flow indexer. In the case of PTFE, it is a value measured under the same measurement conditions as for PFA.

[0057] In addition, when a preform (unfired molded body) formed by compression molding a fluororesin is heated above the melting point of the fluororesin for more than 1 hour, the reduction rate of the thickness after heating relative to the thickness before heating is less than 20%, or the thickness after heating is increased compared to the thickness before heating, which also means that the fluororesin does not show melt fluidity.

[0058] Polytetrafluoroethylene [PTFE] is preferred as the fluororesin A. The PTFE may be a high molecular weight PTFE.

[0059] The PTFE as fluororesin A may be a homopolymer of TFE or a modified PTFE comprising 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (hereinafter also referred to as "modified monomer units"). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0060] The content of the modified monomeric unit of the preferred modified PTFE is 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0061] In the present specification, the modified monomer unit refers to a part of the molecular structure of PTFE, and is a part derived from a modified monomer.

[0062] The content of each polymerized unit can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomer.

[0063] As the above-mentioned modifying monomer, there is no particular limitation as long as it can be copolymerized with TFE, and examples thereof include perfluoroolefins such as hexafluoropropylene [HFP]; hydrogen-containing fluoroolefins such as trifluoroethylene and vinylidene fluoride [VDF]; perhaloolefins such as chlorotrifluoroethylene; perfluorovinyl ether: perfluoroallyl ether; (perfluoroalkyl)ethylene, ethylene, etc. In addition, the modifying monomer used may be one or more.

[0064] The perfluorovinyl ether is not particularly limited, and examples thereof include perfluorounsaturated compounds represented by the following general formula (A):

[0065] CF2=CF-ORf(A)

[0066] (wherein Rf represents a perfluoroorganic group). In the present specification, the "perfluoroorganic group" refers to an organic group in which all hydrogen atoms bonded to carbon atoms are replaced by fluorine atoms. The perfluoroorganic group may have an ether oxygen.

[0067] Examples of the perfluorovinyl ether include perfluoro(alkyl vinyl ether) [PAVE] wherein Rf in the general formula (A) is a perfluoroalkyl group having 1 to 10 carbon atoms. The perfluoroalkyl group preferably has 1 to 5 carbon atoms.

[0068] Examples of the perfluoroalkyl group in PAVE include a perfluoromethyl group, a perfluoroethyl group, a perfluoropropyl group, a perfluorobutyl group, a perfluoropentyl group, and a perfluorohexyl group.

[0069] As the perfluorovinyl ether, further examples include those in which Rf in the general formula (A) is a perfluoro(alkoxyalkyl) group having 4 to 9 carbon atoms, and Rf is the following formula:

[0070] [Chemistry 1]

[0071]

[0072] (wherein m represents 0 or an integer of 1 to 4), and Rf is the following formula:

[0073] [Chemistry 2]

[0074]

[0075] (wherein n represents an integer of 1 to 4) and the like.

[0076] The (perfluoroalkyl)ethylene (PFAE) is not particularly limited, and examples thereof include (perfluorobutyl)ethylene (PFBE) and (perfluorohexyl)ethylene.

[0077] Examples of perfluoroallyl ethers include those of general formula (B):

[0078] CF2=CF-CF2-ORf 1 (B)

[0079] (Where Rf 1 represents a perfluorinated organic group).

[0080] The above Rf 1 Preferred are perfluoroalkyl groups having 1 to 10 carbon atoms or perfluoroalkoxyalkyl groups having 1 to 10 carbon atoms. As the perfluoroallyl ether, at least one selected from the group consisting of CF2=CF-CF2-O-CF3, CF2=CF-CF2-O-C2F5, CF2=CF-CF2-O-C3F7, and CF2=CF-CF2-O-C4F9 is preferred, at least one selected from the group consisting of CF2=CF-CF2-O-C2F5, CF2=CF-CF2-O-C3F7, and CF2=CF-CF2-O-C4F9 is more preferred, and CF2=CF-CF2-O-CF2CF3 is further preferred.

[0081] The standard specific gravity (SSG) of the PTFE as the fluororesin A is preferably 2.280 or less, more preferably 2.10 or less, and preferably 1.50 or more, more preferably 1.60 or more. The SSG is measured by a water displacement method according to ASTM D-792 using a sample molded according to ASTM D 4895-89.

[0082] The PTFE as the fluororesin A generally has non-melt secondary processability. The non-melt secondary processability refers to the property that the melt flow rate cannot be measured at a temperature higher than the melting point according to ASTM D-1238 and D-2116, in other words, the property that it is not easy to flow even in the melting temperature range.

[0083] One of the melting points of the PTFE (high molecular weight PTFE) as the fluororesin A is preferably 310° C. or higher, more preferably 320° C. or higher, and preferably lower than 333° C. The melting point may be in a temperature range of 333° C. or higher.

[0084] The first fluororesin composition of the present disclosure may contain particles of fluororesin A. The particles of fluororesin A may be secondary particles of fluororesin A.

[0085] The average secondary particle size of the particles of the fluororesin A is preferably 1 μm to 200 μm. The average secondary particle size is more preferably 5 μm or more, further preferably 10 μm or more, more preferably 150 μm or less, further preferably 100 μm or less, further preferably 70 μm or less, particularly preferably 50 μm or less, and most preferably 30 μm or less.

[0086] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0087] The particle D90 of the fluororesin A is preferably 10 μm or more, more preferably 30 μm or more, and even more preferably 50 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, and even more preferably 400 μm or less.

[0088] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0089] The particles of the fluororesin A can be obtained, for example, by compression molding a fluororesin that does not have a history of being heated to a temperature above the melting point and does not show melt fluidity, and firing it, and crushing the cuttings of the resulting molded product. The above-mentioned crushing can be carried out using a pulverizer, etc. After coarse crushing, it can be micronized. The shape of the compression molding is not particularly limited. The firing temperature is above the melting point of the fluororesin. The pulverizer is not particularly limited, as long as it can crush the cuttings (preferably micronized). For example, a jet mill, a hammer mill, a power mill, a stone mill type pulverizer, a freezing pulverizer, etc. can be cited.

[0090] The particles of the fluororesin A can also be obtained by heating a powder of a fluororesin that does not have a history of being heated to a temperature above the melting point and does not exhibit melt fluidity without compression molding to a temperature above the melting point and then pulverizing it using a pulverizer. The pulverizer is the same as that described above.

[0091] The first fluororesin composition of the present disclosure further contains a filler, thereby improving mechanical properties such as wear resistance and compression creep resistance.

[0092] Examples of the above-mentioned filler materials include glass fiber, glass beads, carbon fiber, spherical carbon, carbon black, graphite, silica, alumina, mica, silicon carbide, boron nitride, titanium oxide, bismuth oxide, cobalt oxide, molybdenum disulfide, bronze, gold, silver, copper, nickel, aromatic polyester, polyimide, polyphenylene sulfide, etc., and one or more kinds thereof can be used.

[0093] Among them, at least one selected from the group consisting of glass fiber, carbon fiber, graphite, and bronze is preferred.

[0094] The content of the filler is preferably 0 to 80% by mass relative to the fluororesin composition. The content is more preferably 1% by mass or more, further preferably 5% by mass or more, still more preferably 10% by mass or more, particularly preferably 12% by mass or more, and more preferably 70% by mass or less, further preferably 60% by mass or less, still more preferably 50% by mass or less, particularly preferably 40% by mass or less, particularly preferably 30% by mass or less, and most preferably 25% by mass or less.

[0095] For the purpose of imparting conductivity to the molded body, it is also preferred to use a conductive filler as the above-mentioned filling material. When a conductive filler is used as the above-mentioned filling material, it was surprisingly found that by using the above-mentioned fluororesin A and fluororesin B together as the fluororesin, the conductivity is improved compared with the case of using only fluororesin B. It is believed that when fluororesin A is used, gaps are easily generated in the molded body, and the conductive filler is filled in a manner of filling the gaps, thereby forming a good conductive path and improving the conductivity.

[0096] Examples of the conductive filler include carbon fillers and metal fillers.

[0097] Examples of the carbon filler include carbon black, graphite, graphene sheets, carbon nanotubes (CNTs), PAN-based carbon fibers, and pitch-based carbon fibers, and one or more of these may be used.

[0098] Examples of the metal filler include metal powders such as iron, silver, copper, stainless steel, aluminum, and nickel, conductive metal oxide powders such as zirconium oxide, metal fibers thereof, conductive metal oxide fibers, and metal-coated synthetic fibers.

[0099] Carbon fillers and metal fillers may also be used in combination.

[0100] As the conductive filler, a carbon filler is preferred, and carbon black is more preferred. In the first fluororesin composition of the present disclosure, good conductivity can be imparted even when carbon black, which is relatively inexpensive and has excellent handleability, is used.

[0101] The carbon black is preferably conductive carbon black, more preferably at least one selected from the group consisting of acetylene black, Ketjen black, channel black, furnace black, lamp black and thermal black, and further preferably at least one selected from the group consisting of acetylene black, Ketjen black and furnace black.

[0102] The carbon black can provide a molded body having higher conductivity, and therefore the oil absorption is preferably 100 ml / 100 g or more, more preferably 120 ml / 100 g or more, and particularly preferably 150 ml / 100 g or more.

[0103] In the first fluororesin composition of the present disclosure, the content of the conductive filler (preferably carbon black) is preferably 20% by mass or less, more preferably 15% by mass or less, further preferably 10% by mass or less, particularly preferably 8.0% by mass, and is preferably 1.0% by mass or more, more preferably 2.0% by mass or more, based on the fluororesin composition.

[0104] As described above, even if the amount of the conductive filler is relatively small, good conductivity can be imparted, and thus conductivity can be imparted without impairing molding processability or the mechanical strength of the molded body.

[0105] By setting the aspect ratio of the conductive filler such as CNT to 1000 or more, a good conductive network is easily formed, so the compounding amount can be further reduced. The content of the conductive filler having an aspect ratio of 1000 or more is preferably 10% by mass or less, more preferably 5% by mass or less, further preferably 3% by mass or less, particularly preferably 1% by mass, and preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, and further preferably 0.01% by mass or more, relative to the fluororesin composition.

[0106] In addition to the above-mentioned conductive fillers, non-conductive fillers may also be used in combination within the range that does not hinder the performance. Examples of non-conductive fillers include non-conductive inorganic oxide fillers such as silicon dioxide, silicates, clay, diatomaceous earth, montmorillonite, talc, calcium carbonate, calcium silicate, barium sulfate, fatty acid calcium, titanium oxide, red iron, boron nitride, aluminum nitride, magnesium oxide, aluminum oxide, and non-conductive resin fillers such as polyimide.

[0107] For the purpose of imparting thermal conductivity to the molded body, it is also preferable to use a thermally conductive filler as the above-mentioned filling material. When a thermally conductive filler is used as the above-mentioned filling material, it was surprisingly found that by using the above-mentioned fluororesin A and fluororesin B together as the fluororesin, the thermal conductivity is improved compared with the case of using only fluororesin B. It is believed that when fluororesin A is used, since the filler does not enter fluororesin A, the thermally conductive filler is filled around fluororesin A, thereby forming a good thermal conductive path and improving thermal conductivity.

[0108] Examples of the thermally conductive filler include boron nitride, aluminum nitride, magnesium oxide, and aluminum oxide, and one or more of the fillers may be used.

[0109] The thermally conductive filler is preferably boron nitride. The first fluororesin composition of the present disclosure can be provided with good thermal conductivity.

[0110] In the first fluororesin composition of the present disclosure, the content of the thermally conductive filler (preferably boron nitride) is preferably 20% by mass or less, more preferably 15% by mass or less, further preferably 10% by mass or less, particularly preferably 8.0% by mass, and is preferably 1.0% by mass or more, more preferably 2.0% by mass or more, based on the fluororesin composition.

[0111] As described above, even if the amount of the thermally conductive filler is relatively small, good thermal conductivity can be imparted, and therefore thermal conductivity can be imparted without impairing molding processability or the mechanical strength of the molded body.

[0112] The first fluororesin composition of the present disclosure further comprises at least one fluororesin B selected from the group consisting of a fluororesin exhibiting melt fluidity and a fluororesin not exhibiting melt fluidity that has no history of being heated to a temperature higher than a melting point. By including the fluororesin B, the tensile properties are improved compared to the case of using only the fluororesin A and the filler.

[0113] It is one of the preferred embodiments that the fluororesin B is a fluororesin having melt fluidity.

[0114] The MFR of the fluororesin exhibiting melt fluidity may be 0.25 g / 10 min or more, preferably 0.50 g / 10 min or more, more preferably 1.00 g / 10 min or more, and the MFR may be 100 g / 10 min or less, preferably 80 g / 10 min or less.

[0115] The fluororesin exhibiting melt fluidity is preferably at least one selected from the group consisting of fluororesins having a melting point of 320° C. or lower and low molecular weight polytetrafluoroethylene (low molecular weight PTFE), and more preferably a fluororesin having a melting point of 320° C. or lower.

[0116] The details of the above-mentioned fluororesin showing melt fluidity will be described later.

[0117] When the fluororesin B is a fluororesin exhibiting melt fluidity, the first fluororesin composition of the present disclosure preferably further comprises a fluororesin C that does not exhibit melt fluidity, and the fluororesin C has a portion that does not have a history of being heated to a temperature higher than the melting point. By further comprising the fluororesin C, the tensile properties are further improved.

[0118] The details of the fluororesin C are described later.

[0119] It is also a preferred embodiment that the fluororesin B is a fluororesin that does not exhibit melt fluidity and does not have a history of being heated to a temperature higher than its melting point. The fluororesin that does not exhibit melt fluidity and does not have a history of being heated to a temperature higher than its melting point can be polymerized by suspension polymerization or emulsion polymerization.

[0120] As the fluororesin that does not have a history of being heated to a temperature above the melting point and does not show melt fluidity, PTFE is preferred. The PTFE may be a homopolymer of TFE or a modified PTFE comprising more than 99.0% by mass of polymerized units based on TFE and less than 1.0% by mass of polymerized units based on modified monomers (modified monomer units).

[0121] The details of the fluororesin that does not have a history of being heated to a temperature higher than the melting point and does not exhibit melt fluidity will be described later.

[0122] From the viewpoint of further improving tensile properties, the content of the fluororesin A in the first fluororesin composition of the present disclosure is preferably 10% by mass to 99.5% by mass relative to the above fluororesin composition. The above content is more preferably 30% by mass or more, further preferably 40% by mass or more, particularly preferably 50% by mass or more, and more preferably 99% by mass or less, further preferably 95% by mass or less, still more preferably 90% by mass or less, particularly preferably 85% by mass or less, and particularly preferably 80% by mass or less.

[0123] From the viewpoint of further improving tensile properties, when the fluororesin B in the first fluororesin composition of the present disclosure is a fluororesin exhibiting melt fluidity, the content is preferably 0.5 to 30% by mass relative to the above fluororesin composition. The above content is more preferably 1.0% by mass or more, further preferably 3% by mass or more, still more preferably 5% by mass or more, particularly preferably 7% by mass or more, and more preferably 25% by mass or less, further preferably 20% by mass or less, still more preferably 15% by mass or less, particularly preferably 10% by mass or less.

[0124] From the viewpoint of further improving tensile properties, when the fluororesin B in the first fluororesin composition of the present disclosure is a fluororesin that does not have a history of being heated to a temperature higher than the melting point and does not exhibit melt fluidity, the content is preferably 10 to 90% by mass relative to the above fluororesin composition. The above content is more preferably 15% by mass or more, further preferably 20% by mass or more, still more preferably more than 20% by mass, particularly preferably 25% by mass or more, and particularly preferably 30% by mass or more, and more preferably 80% by mass or less, further preferably 70% by mass or less, still more preferably 60% by mass or less, and particularly preferably 50% by mass or less.

[0125] From the viewpoint of further improving tensile properties, the content of the fluororesin C in the first fluororesin composition of the present disclosure is preferably 0 to 80% by mass relative to the above fluororesin composition. The above content is more preferably 1% by mass or more, further preferably 10% by mass or more, still more preferably 20% by mass or more, particularly preferably 30% by mass or more, and particularly preferably 40% by mass or more, and is more preferably 75% by mass or less, further preferably 70% by mass or less, still more preferably 65% ​​by mass or less, particularly preferably 60% by mass or less, and particularly preferably 50% by mass or less.

[0126] The total amount of the fluororesins A to C in the first fluororesin composition of the present disclosure is preferably 80 mass % or more, more preferably 85 mass % or more, further preferably 90 mass % or more, still more preferably 95 mass % or more, particularly preferably 98 mass % or more, based on the above fluororesin composition.

[0127] The first fluororesin composition of the present disclosure does not exhibit melt fluidity.

[0128] The MFR of the first fluororesin composition of the present disclosure may be less than 0.25 g / 10 min, preferably less than 0.10 g / 10 min, more preferably not more than 0.05 g / 10 min.

[0129] In addition, when a preform (unfired molded body) obtained by compression molding the first fluororesin composition of the present disclosure is heated at a temperature above the melting point of the fluororesin composition for more than 1 hour, the reduction rate of the thickness after heating relative to the thickness before heating is less than 20%, or the thickness after heating is increased compared to the thickness before heating, which also means that the fluororesin composition does not show melt fluidity.

[0130] The first fluororesin composition of the present disclosure preferably has one or more melting points in a temperature range of less than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0131] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0132] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0133] Having melting points in the above two temperature ranges means that the fluororesin composition contains a fluororesin that does not exhibit melt fluidity when heated to a temperature not less than the melting point, and a fluororesin that does not exhibit melt fluidity when heated to no less than the melting point.

[0134] The first fluororesin composition of the present disclosure preferably comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE. The fluororesin composition may comprise only TFE units and modified monomer units as polymerized units.

[0135] From the perspective of further improving operability and tensile properties, the content of the modified monomer unit is preferably 1.0% by mass or less relative to all polymerized units constituting the fluororesin composition. As the lower limit of the content of the modified monomer unit, it is preferably 0.00001% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, further more preferably 0.005% by mass, and particularly preferably 0.010% by mass. As the upper limit of the content of the modified monomer unit, it is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0136] The first fluororesin composition of the present disclosure preferably contains 99.0 mass % or more of TFE units based on all polymerized units.

[0137] The content of the polymerized units constituting the first fluororesin composition of the present disclosure can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomers. Alternatively, when the raw material composition is known, the content can be calculated from the raw material composition.

[0138] From the viewpoint of better workability, the apparent density of the first fluororesin composition of the present disclosure is preferably 0.40 g / ml or more, more preferably 0.42 g / ml or more, further preferably 0.45 g / ml or more, and particularly preferably 0.47 g / ml or more. The upper limit is not particularly limited and may be 1.00 g / ml.

[0139] The above apparent density is measured in accordance with JIS K6891.

[0140] The angle of repose of the first fluororesin composition of the present disclosure is preferably less than 40°, more preferably less than 38°, and even more preferably less than 35°, from the viewpoint of excellent fluidity and further excellent handleability.

[0141] The above repose angle is the value measured as follows: the total height is 115mm, the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake portion is set so that the height from the bottom of the funnel to the sample falling surface is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the dropped sample is measured with a protractor to obtain the value.

[0142] The first fluororesin composition of the present disclosure preferably has an average secondary particle size of 5 to 700 μm, more preferably 10 μm or more, further preferably 20 μm or more, and more preferably 600 μm or less, further preferably 500 μm or less, particularly preferably 400 μm or less.

[0143] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0144] In the first fluororesin composition of the present disclosure, the maximum linear length of the particles of the fluororesin A is preferably smaller than the maximum linear length of the particles of the fluororesin B. If the maximum linear lengths of the particles of the fluororesins A and B are in the above relationship, the apparent density of the fluororesin composition can be increased, and the workability can be further improved. In addition, since there is no need to perform a deformation treatment for increasing the maximum linear length of the particles of the fluororesin A, the production cost of the fluororesin composition can be reduced.

[0145] The form of the first fluororesin composition of the present disclosure is not particularly limited, but is preferably a powder.

[0146] The first fluororesin composition of the present disclosure is preferably a fluororesin composition not exhibiting melt fluidity (also referred to as fluororesin composition (1)), comprising a fluororesin A not exhibiting melt fluidity having a history of being heated to a temperature not less than its melting point, a fluororesin B1 exhibiting melt fluidity, and a filler.

[0147] Since the fluororesin composition (1) contains the fluororesin B1 which exhibits melt fluidity, it has excellent tensile properties (e.g., tensile breaking strength and tensile breaking strain) despite containing the fluororesin A which has a history of being heated to a temperature above the melting point. This effect is believed to be caused by the fluororesin B1 filling the interface between the particles of the fluororesin A during molding.

[0148] In the fluororesin composition (1), as a method for distinguishing between fluororesin A and fluororesin B1, for example, the following method can be cited: the fluororesin composition is placed on a hot stage, and while the temperature is increased at 5°C / min, it is observed under a microscope, and whether the particles are fluororesin A or B1 is determined by whether the shape of the particles is maintained.

[0149] As the fluororesin A and the filler in the fluororesin composition (1), those described above can be used.

[0150] The above-mentioned fluororesin B1 exhibits melt fluidity.

[0151] In this specification, showing melt fluidity means that the MFR is 0.25 g / 10 min or more, preferably 0.50 g / 10 min or more, and more preferably 1.00 g / 10 min or more. The MFR may be 100 g / 10 min or less, and preferably 80 g / 10 min or less.

[0152] Furthermore, when a preform (unfired molded body) obtained by compression molding a fluororesin is heated at a temperature above the melting point of the fluororesin for more than 1 hour, a reduction rate of the thickness after heating relative to the thickness before heating of 20% or more also means that the fluororesin exhibits melt fluidity.

[0153] It is preferred that the fluororesin B1 does not have a history of being heated to a temperature higher than its melting point.

[0154] The melting point of the fluororesin B1 is preferably 100° C. to 340° C. The melting point is more preferably 140° C. or higher, further preferably 160° C. or higher, and more preferably 336° C. or lower, further preferably 333° C. or lower, further preferably 332° C. or lower, particularly preferably 331° C. or lower, and particularly preferably 330° C. or lower.

[0155] The melting point of fluororesin B1 can be measured by the above method. When the amount of fluororesin B1 is as low as, for example, 5% by mass or less relative to the total amount of fluororesin A and fluororesin B1, it is sometimes difficult to detect by the above method. In this case, sometimes, when heating, the temperature is kept lower than the melting point of fluororesin B1 (preferably a temperature lower than the above melting point by 10°C or more) for 10 minutes, and then the temperature is raised again at a rate of 10°C / min, thereby enabling the melting peak of fluororesin B1 to be detected. The temperature can also be raised by this method.

[0156] The fluororesin B1 is preferably at least one selected from the group consisting of fluororesins having a melting point of 320° C. or lower and low molecular weight polytetrafluoroethylene (low molecular weight PTFE), and more preferably a fluororesin having a melting point of 320° C. or lower.

[0157] As the fluororesin B1, a perfluororesin is also preferred.

[0158] Examples of the fluororesin having a melting point of 320° C. or less include tetrafluoroethylene [TFE] / perfluoro(alkyl vinyl ether) [PAVE] or perfluoro(alkyl allyl ether) copolymers [PFA], TFE / hexafluoropropylene [HFP] copolymers [FEP], ethylene [Et] / TFE copolymers [ETFE], Et / TFE / HFP copolymers [EFEP], polytrifluorochloroethylene [PCTFE], chlorotrifluoroethylene [CTFE] / TFE copolymers, CTFE / TFE / PAVE copolymers, Et / CTFE copolymers, The present invention relates to a copolymer of poly(vinyl fluoride) [PVF], poly(vinylidene fluoride) [PVdF], vinylidene fluoride [VdF] / TFE copolymer, VdF / HFP copolymer, VdF / TFE / HFP copolymer, VdF / HFP / (meth)acrylic acid copolymer, VdF / CTFE copolymer, VdF / pentafluoropropylene copolymer, VdF / PAVE / TFE copolymer, etc., preferably at least one selected from the group consisting of PFA, FEP and ETFE, more preferably at least one selected from the group consisting of PFA and FEP, and further preferably PFA.

[0159] The PFA includes TFE units and PAVE units or perfluoro(alkyl allyl ether) units. Examples of the PAVE include monomers in which Rf in the general formula (A) is a perfluoroalkyl group having 1 to 10 carbon atoms. Examples of the perfluoro(alkyl allyl ether) include monomers in which Rf in the general formula (B) is 1 A monomer containing a perfluoroalkyl group having 1 to 10 carbon atoms.

[0160] The above-mentioned PFA is not particularly limited, but preferably is a copolymer in which the molar ratio of TFE units to PAVE units or perfluoro(alkyl allyl ether) units (TFE units / (PAVE units or perfluoro(alkyl allyl ether) units)) is 70 / 30 or more and less than 99 / 1. A more preferred molar ratio is 70 / 30 or more and 98.9 / 1.1 or less, and a further preferred molar ratio is 80 / 20 or more and 98.9 / 1 or less. The above-mentioned PFA is also preferably a copolymer in which the polymerization units derived from monomers copolymerizable with TFE and PAVE or perfluoro(alkyl allyl ether) are 0.1 mol% to 10 mol% (the total of TFE units and PAVE units or perfluoro(alkyl allyl ether) units is 90 mol% to 99.9 mol%), more preferably 0.1 mol% to 5 mol%, and particularly preferably 0.2 mol% to 4 mol%.

[0161] Examples of monomers copolymerizable with TFE and PAVE or perfluoro(alkyl allyl ether) include HFP, formula (I): CZ 1 Z 2 =CZ 3 (CF2) n Z 4 (Where Z 1 , Z 2 and Z 3 are the same or different, representing a hydrogen atom or a fluorine atom, Z 4 represents a hydrogen atom, a fluorine atom or a chlorine atom, and n represents an integer of 2 to 10. ) and a vinyl monomer represented by formula (II): CF2=CF-OCH2-Rf 2 (Where Rf 2 represents a perfluoroalkyl group having 1 to 5 carbon atoms. ) represented by an alkyl perfluorovinyl ether derivative, formula (III): CZ 5 Z 6 =CZ 7 -CZ 8 Z 9 -O-Rf 3 (In the formula, in the formula, Z 5 , Z 6 and Z 7 are the same or different, representing a hydrogen atom, a chlorine atom or a fluorine atom, Z 8 and Z 9 represents a hydrogen atom or a fluorine atom, Rf 3 represents a perfluoroalkyl group having 1 to 5 carbon atoms. ) and the like. As the allyl ether monomer, preferably CH2=CFCF2-O-Rf 3 CF2=CFCH2-O-Rf 3 、CH2=CHCF2-O-Rf 3 (Where Rf 3Same as the above formula (III) etc.

[0162] Examples of monomers copolymerizable with TFE, PAVE or perfluoro(alkyl allyl ether) include unsaturated monocarboxylic acids, unsaturated dicarboxylic acids and anhydrides of unsaturated dicarboxylic acids such as itaconic acid, itaconic anhydride, citraconic anhydride and 5-norbornene-2,3-dicarboxylic anhydride.

[0163] The melting point of the PFA is preferably 180°C to 320°C, more preferably 230°C to 320°C, and even more preferably 280°C to 320°C.

[0164] The MFR of the PFA is preferably 0.25 g / 10 min to 100 g / 10 min, more preferably 0.5 g / 10 min or more, further preferably 1.0 g / 10 min or more, and more preferably 90 g / 10 min or less, further preferably 80 g / 10 min or less.

[0165] The MFR of PFA is a value obtained as the mass (g / 10 minutes) of a polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm at a measurement temperature of 372° C. and a load of 5 kg per 10 minutes using a melt flow indexer in accordance with ASTM D1238.

[0166] The above-mentioned FEP is not particularly limited, but preferably a copolymer in which the molar ratio of TFE unit to HFP unit (TFE unit / HFP unit) is 70 / 30 or more and less than 99 / 1. A more preferred molar ratio is 70 / 30 or more and 98.9 / 1.1 or less, and a further preferred molar ratio is 80 / 20 or more and 98.9 / 1.1 or less. The above-mentioned FEP is also preferably a copolymer in which the polymerized unit derived from a monomer copolymerizable with TFE and HFP is 0.1 mol% to 10 mol% (90 mol% to 99.9 mol% in total of TFE unit and HFP unit), more preferably 0.1 mol% to 5 mol%, and particularly preferably 0.2 mol% to 4 mol%.

[0167] Examples of the monomer copolymerizable with TFE and HFP include PAVE, a monomer represented by formula (III), and an alkyl perfluorovinyl ether derivative represented by formula (II).

[0168] Examples of monomers copolymerizable with TFE and HFP include unsaturated monocarboxylic acids, unsaturated dicarboxylic acids, and anhydrides of unsaturated dicarboxylic acids such as itaconic acid, itaconic anhydride, citraconic anhydride, and 5-norbornene-2,3-dicarboxylic anhydride.

[0169] The melting point of the FEP is preferably 150°C to 320°C, more preferably 200°C to 320°C, and even more preferably 240°C to 320°C.

[0170] The MFR of the FEP is preferably 0.25 g / 10 min to 100 g / 10 min, more preferably 0.5 g / 10 min or more, further preferably 1.0 g / 10 min or more, and more preferably 80 g / 10 min or less, further preferably 60 g / 10 min or less.

[0171] The MFR of FEP is a value obtained as the mass (g / 10 minutes) of the polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm at a measurement temperature of 372° C. and a load of 5 kg per 10 minutes using a melt flow indexer in accordance with ASTM D1238.

[0172] As the above-mentioned ETFE, a copolymer having a molar ratio of TFE units to ethylene units (TFE units / ethylene units) of 20 / 80 or more and 90 / 10 or less is preferred. A more preferred molar ratio is 37 / 63 or more and 85 / 15 or less, and a further preferred molar ratio is 38 / 62 or more and 80 / 20 or less. ETFE can be a copolymer consisting of TFE, ethylene, and a monomer copolymerizable with TFE and ethylene. As a monomer copolymerizable with TFE, the following formula can be cited:

[0173] CH2=CX 1 R 4 CF2=CFRf 4 CF2=CFORf 4 、CH2=C(Rf 4 )2(where X 1 represents a hydrogen atom or a fluorine atom, Rf 4 represents a fluoroalkyl group which may contain an ether bond), a monomer represented by formula (III), wherein CF2=CFRf is preferred. 4 CF2=CFORf 4 and CH2=CX 1 R 4 The fluorine-containing vinyl monomer represented by formula (III), more preferably HFP, CF2=CF-ORf 5 (Where Rf 5 represents a perfluoroalkyl group having 1 to 5 carbon atoms. ) represented by perfluoro(alkyl vinyl ether), CF2=CF-CF2-O-Rf 3 (Where Rf 3 represents a perfluoroalkyl group having 1 to 5 carbon atoms. 4 CH2=CX is a fluoroalkyl group having 1 to 8 carbon atoms 1 R 4The fluorine-containing vinyl monomer shown. In addition, as a monomer copolymerizable with TFE and ethylene, an aliphatic unsaturated carboxylic acid such as itaconic acid and itaconic anhydride may be used. The monomer copolymerizable with TFE and ethylene is preferably 0.1 mol% to 10 mol%, more preferably 0.1 mol% to 5 mol%, and particularly preferably 0.2 mol% to 4 mol% relative to the fluorine-containing polymer.

[0174] The melting point of the ETFE is preferably 140°C to 320°C, more preferably 160°C to 320°C, and even more preferably 195°C to 320°C.

[0175] The MFR of the ETFE is preferably 0.25 g / 10 min to 100 g / 10 min, more preferably 0.5 g / 10 min or more, further preferably 1.0 g / 10 min or more, and more preferably 90 g / 10 min or less, further preferably 80 g / 10 min or less.

[0176] The MFR of ETFE is a value obtained as the mass (g / 10 minutes) of a polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm at a measurement temperature of 297° C. and a load of 5 kg per 10 minutes using a melt flow indexer in accordance with ASTM D1238.

[0177] The melt viscosity (complex viscosity) of the low molecular weight PTFE at 380°C is preferably 1.0×10 1 ~1.0×10 7 Pa·s.

[0178] The melt viscosity is more preferably 1.0×10 2 Pa·s or more, more preferably 1.5×10 3 Pa·s or more, particularly preferably 7.0×10 3 Pa·s or more, and more preferably 7.0×10 5 Pa·s or less, more preferably 3.0×10 5 Pa·s or less, particularly preferably 1.0×10 5 Pa·s or less.

[0179] In this specification, "low molecular weight PTFE" means PTFE having the above-mentioned melt viscosity within the above-mentioned range.

[0180] The melt viscosity is measured according to ASTM D 1238 using a flow tester (manufactured by Shimadzu Corporation) and The value was measured by using a die of 100 mm / s and holding a 2 g sample heated in advance at 380°C for 5 minutes at the above temperature under a load of 0.7 MPa.

[0181] The MFR value of the low molecular weight PTFE obtained as the mass (g / 10 minutes) of the polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm per 10 minutes at 372°C and a load of 5 kg is preferably 0.25 g / 10 minutes or more, more preferably 0.10 g / 10 minutes or more, and further preferably 0.05 g / 10 minutes or more. In addition, the MFR is preferably 50 g / 10 minutes or less, more preferably 30 g / 10 minutes or less, and further preferably 10 g / 10 minutes or less.

[0182] The melting point of the low molecular weight PTFE is preferably 320° C. to 340° C., more preferably 324° C. or higher, more preferably 336° C. or lower, further preferably 333° C. or lower, still more preferably 332° C. or lower, particularly preferably 331° C. or lower, and particularly preferably 330° C. or lower.

[0183] The low molecular weight PTFE may be a homopolymer of TFE, or a modified PTFE comprising 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (hereinafter also referred to as "modified monomer units"). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0184] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0185] Examples of the modifying monomer include the monomers described above for PTFE (high molecular weight PTFE) which is a fluororesin that does not exhibit melt fluidity.

[0186] The content of each polymerized unit of the above polymer can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the types of monomers.

[0187] The fluororesin B1 can be produced by a known polymerization method such as emulsion polymerization, suspension polymerization, solution polymerization, or the like.

[0188] The fluororesin composition (1) may contain particles of the fluororesin B1. The particles of the fluororesin B1 may be primary particles or secondary particles of the fluororesin B1.

[0189] When the particles of the fluororesin B1 are primary particles (in the state of aqueous dispersion), the average primary particle size is preferably 500 nm or less. The average primary particle size is more preferably 400 nm or less, and further preferably 300 nm or less. In addition, the average primary particle size is preferably 10 nm or more, more preferably 25 nm or more, further preferably 50 nm or more, still more preferably 100 nm or more, and particularly preferably 150 nm or more.

[0190] The above average primary particle size is the average value of the diameters of 100 or more particles randomly selected from an aqueous dispersion adjusted to a solid content concentration of 0.5 mass % dropped onto an aluminum foil, dried at 150° C. for 1 hour to remove water, and observed using a scanning electron microscope (SEM).

[0191] When the particles of the fluororesin B1 are secondary particles (in the form of powder), the average secondary particle size is preferably 100 μm or less. The average secondary particle size is more preferably 70 μm or less, further preferably 50 μm or less, and particularly preferably 40 μm or less. In addition, the average secondary particle size is preferably 1 μm or more, more preferably 5 μm or more, further preferably 10 μm or more, and even more preferably 20 μm or more.

[0192] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0193] The fluororesin composition (1) preferably further comprises a fluororesin C which does not exhibit melt fluidity, and the fluororesin C has a portion which does not have a history of being heated to a temperature higher than the melting point. The fluororesin composition (1) is excellent in tensile properties even without comprising the fluororesin C, but by further comprising the fluororesin C, the tensile properties are further improved.

[0194] The fluororesin composition (1) preferably contains fluororesins A and B and optionally fluororesin C.

[0195] Fluororesin C has a portion that has no history of being heated to a temperature higher than its melting point.

[0196] Fluororesin C preferably has one or more melting points in the temperature range of 333° C. to 360° C. The temperature range is more preferably 334° C. or higher, further preferably 335° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0197] The melting point being within the above range means that there is no history of heating to a temperature higher than the melting point.

[0198] In addition to the above-mentioned melting point, the melting point may be in a temperature range lower than 333°C.

[0199] When the fluororesin composition (1) further contains a fluororesin C, it preferably has one or more melting points in a temperature range of less than 333°C and one or more melting points in a temperature range of 333°C to 360°C.

[0200] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0201] The temperature range of 333°C to 360°C is more preferably 334°C or higher, and further preferably 335°C, and is more preferably 355°C or lower, and further preferably 350°C or lower.

[0202] Having melting points in the above two temperature ranges means that the fluororesin composition comprises a fluororesin A which has a history of being heated to a temperature higher than its melting point and does not exhibit melt fluidity, and a fluororesin C which does not exhibit melt fluidity and has a portion which has no history of being heated to a temperature higher than its melting point.

[0203] Fluororesin C does not exhibit melt fluidity. The melt fluidity is as described above.

[0204] PTFE is preferred as the fluororesin C. The PTFE may be high molecular weight PTFE.

[0205] The PTFE (high molecular weight PTFE) as the fluororesin C preferably has at least one endothermic peak in the range of 333°C to 347°C in the heat of fusion curve when the temperature is increased at a rate of 10°C / min using a differential scanning calorimeter [DSC], and the heat of fusion at 290°C to 350°C calculated from the heat of fusion curve is preferably 62 mJ / mg or more.

[0206] The standard specific gravity (SSG) of the PTFE as the fluororesin C is preferably 2.130 to 2.280. The standard specific gravity is measured by a water displacement method according to ASTM D 792 using a sample molded according to ASTM D 4895 89.

[0207] The "high molecular weight" of PTFE that has no history of being heated to a temperature higher than its melting point means that the standard specific gravity is within the above range.

[0208] The PTFE as the fluororesin C generally has non-melt secondary processability. The non-melt secondary processability is as described above.

[0209] The PTFE as the fluororesin C may be a homopolymer of TFE or a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modifying monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0210] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0211] The modifying monomer that can be used in the above-mentioned PTFE as the fluororesin C is the same as the modifying monomer exemplified for the PTFE (high molecular weight PTFE) as the fluororesin A.

[0212] The fluororesin composition (1) may contain particles of fluororesin C. The particles of fluororesin C may be primary particles of fluororesin C or secondary particles.

[0213] When the particles of the fluororesin C are primary particles (in the state of aqueous dispersion), the average primary particle size is preferably 500 nm or less. The average primary particle size is more preferably 400 nm or less, further preferably 350 nm or less, and particularly preferably 300 nm or less. In addition, the average primary particle size is preferably 10 nm or more, more preferably 25 nm or more, further preferably 50 nm or more, still more preferably 100 nm or more, and particularly preferably 150 nm or more.

[0214] The above average primary particle size is the average value of the diameters of 100 or more particles randomly selected from an aqueous dispersion adjusted to a solid content concentration of 0.5 mass % dropped onto an aluminum foil, dried at 150° C. for 1 hour to remove water, and observed using a scanning electron microscope (SEM).

[0215] When the particles of the fluororesin C are secondary particles (in the form of powder), the average secondary particle size is preferably 700 μm or less. The average secondary particle size is more preferably 500 μm or less, further preferably 100 μm or less, still more preferably 60 μm or less, and particularly preferably 50 μm or less. In addition, the average secondary particle size is preferably 1 μm or more, more preferably 5 μm or more, still more preferably 10 μm or more, and still more preferably 20 μm or more.

[0216] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0217] In one embodiment of the fluororesin composition (1), when the particles of the fluororesin C are in the form of primary particles, the average aspect ratio is preferably 2.0 or less, more preferably 1.7 or less, further preferably 1.6 or less, still more preferably 1.5 or less, particularly preferably 1.4 or less, and particularly preferably 1.3 or less. The average aspect ratio may be 1.0 or more.

[0218] The average aspect ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), performing image processing on 100 or more primary particles randomly selected, and averaging the ratio of the major axis to the minor axis.

[0219] In another embodiment of the fluororesin composition (1), when the particles of the fluororesin C are present in the form of primary particles, the proportion of the particles of the fluororesin C having an aspect ratio of 2.5 or more is preferably 0.5% or more, more preferably 1.0% or more, further preferably 1.5% or more, and particularly preferably 2.0% or more relative to the total number of particles of the fluororesin C. The above proportion is preferably 20% or less, more preferably 15% or less, and further preferably 10% or less.

[0220] The above ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), randomly extracting 100 or more primary particles, performing image processing, calculating the aspect ratio of each particle, and determining the ratio to the total number of the extracted particles.

[0221] From the viewpoint of further improving the tensile properties, the content of the fluororesin A in the fluororesin composition (1) is preferably 10% by mass to 99.5% by mass relative to the fluororesin composition. The content is more preferably 30% by mass or more, further preferably 40% by mass or more, particularly preferably 50% by mass or more, and more preferably 99% by mass or less, further preferably 95% by mass or less, still more preferably 90% by mass or less, particularly preferably 85% by mass or less, and particularly preferably 80% by mass or less.

[0222] From the viewpoint of further improving tensile properties, the content of the fluororesin B1 in the fluororesin composition (1) is preferably 0.5% by mass to 30% by mass relative to the above-mentioned fluororesin composition. The above-mentioned content is more preferably 1.0% by mass or more, further preferably 3% by mass or more, still more preferably 5% by mass or more, particularly preferably 7% by mass or more, and more preferably 25% by mass or less, further preferably 20% by mass or less, still more preferably 15% by mass or less, particularly preferably 10% by mass or less.

[0223] From the viewpoint of further improving the tensile properties, the content of the fluororesin C in the fluororesin composition (1) is preferably 0 to 80% by mass relative to the fluororesin composition. The content is more preferably 1% by mass or more, further preferably 10% by mass or more, still more preferably 20% by mass or more, particularly preferably 30% by mass or more, particularly preferably 40% by mass or more, and more preferably 75% by mass or less, further preferably 70% by mass or less, still more preferably 65% ​​by mass or less, particularly preferably 60% by mass or less, particularly preferably 50% by mass or less.

[0224] The total amount of the fluororesins A to C in the fluororesin composition (1) is preferably 80% by mass or more, more preferably 85% by mass or more, further preferably 90% by mass or more, still more preferably 95% by mass or more, particularly preferably 98% by mass or more, based on the above fluororesin composition.

[0225] The fluororesin composition (1) does not exhibit melt fluidity.

[0226] The MFR of the fluororesin composition (1) may be less than 0.25 g / 10 min, preferably less than 0.10 g / 10 min, more preferably not more than 0.05 g / 10 min.

[0227] Furthermore, when a preform (unfired molded body) obtained by compression molding a fluororesin composition (1) is heated at a temperature not lower than the melting point of the fluororesin composition for at least 1 hour, the reduction rate of the thickness after heating relative to the thickness before heating is less than 20%, or the thickness after heating is increased compared to the thickness before heating, which also means that the fluororesin composition does not exhibit melt fluidity, and is therefore preferred.

[0228] The fluororesin composition (1) comprises TFE units and modified monomer units based on a modifying monomer copolymerizable with TFE, wherein the amount of the modified monomer units is preferably 1.0% by mass or less relative to all polymerized units, and the amount of the TFE units is preferably 99.0% by mass or more.

[0229] The lower limit of the content of the modified monomer unit in the fluororesin composition (1) may be 0% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, still more preferably 0.005% by mass, and particularly preferably 0.010% by mass. The upper limit of the content of the modified monomer unit is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0230] The content of the modified monomer unit can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomer. Alternatively, when the raw material composition is known, the content can be calculated from the raw material composition.

[0231] The form of the fluororesin composition (1) is not particularly limited, but is preferably a powder.

[0232] The first fluororesin composition of the present disclosure preferably has an average secondary particle size of 5 to 700 μm, more preferably 10 μm or more, further preferably 20 μm or more, and more preferably 600 μm or less, further preferably 500 μm or less, particularly preferably 400 μm or less.

[0233] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0234] The D90 of the fluororesin composition (1) is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, further preferably 400 μm or less.

[0235] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0236] From the viewpoint of further improving the tensile properties, the content (total amount) of the low molecular weight fluorinated compounds in the fluororesin composition (1) is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the above-mentioned fluororesin composition.

[0237] The content of the low molecular weight fluorine-containing compound is measured by Soxhlet extraction of a sample with methanol and then by liquid chromatography-mass spectrometry (LC / MS / MS).

[0238] Examples of the low molecular weight fluorine-containing compound include fluorine-containing carboxylic acids having 4 or more carbon atoms and salts thereof, fluorine-containing sulfonic acids having 4 or more carbon atoms and salts thereof, and the like, all of which may have an ether bond (—O—).

[0239] Examples of the low molecular weight fluorine-containing compound include anionic fluorine-containing surfactants, etc. The anionic fluorine-containing surfactant may be, for example, a surfactant containing fluorine atoms and having a total carbon number of 20 or less in the portion excluding the anionic group.

[0240] The anionic fluorine-containing surfactant may be a fluorine-containing surfactant having an anionic moiety with a molecular weight of 1,000 or less, or may be a fluorine-containing surfactant having an anionic moiety with a molecular weight of 800 or less.

[0241] It should be noted that the above-mentioned "anionic part" refers to the part of the above-mentioned fluorinated surfactant other than the cation. For example, in F(CF2) represented by the formula (I) described below n1 In the case of COOM, it is "F(CF2) n1 COO” part.

[0242] In addition, as the above-mentioned low molecular weight fluorinated compound, a fluorinated surfactant having a LogPOW of 3.5 or less can be cited. The above-mentioned LogPOW is the partition coefficient between 1-octanol and water, and is represented by LogP [wherein P represents the ratio of the fluorinated surfactant concentration in octanol to the fluorinated surfactant concentration in water when an octanol / water (1:1) mixed solution containing a fluorinated surfactant undergoes phase separation].

[0243] The above LogPOW is calculated as follows: On column: TOSOH ODS-120T column ( HPLC was performed on standard substances (heptanoic acid, octanoic acid, nonanoic acid and decanoic acid) with known octanol / water partition coefficients under the following conditions: (a) elution solvent: acetonitrile / 0.6 mass% HClO4 water = 1 / 1 (vol / vol%), flow rate: 1.0 ml / min, sample amount: 300 μL, column temperature: 40°C, detection light: UV210 nm, and a calibration curve of each elution time and the known octanol / water partition coefficient was prepared. Based on the calibration curve, the elution time of HPLC in the sample solution was calculated.

[0244] Specific examples of the fluorinated surfactant include U.S. Patent Application Publication No. 2007 / 0015864, U.S. Patent Application Publication No. 2007 / 0015865, U.S. Patent Application Publication No. 2007 / 0015866, U.S. Patent Application Publication No. 2007 / 0276103, U.S. Patent Application Publication No. 2007 / 0117914, U.S. Patent Application Publication No. 2007 / 142541, U.S. Patent Application Publication No. 2008 / 0015319, U.S. Patent No. 3250808, Fluorinated surfactants described in U.S. Patent No. 3271341, Japanese Patent Application Publication No. 2003-119204, International Publication No. 2005 / 042593, International Publication No. 2008 / 060461, International Publication No. 2007 / 046377, Japanese Patent Application Publication No. 2007-119526, International Publication No. 2007 / 046482, International Publication No. 2007 / 046345, U.S. Patent Application Publication No. 2014 / 0228531, International Publication No. 2013 / 189824, and International Publication No. 2013 / 189826.

[0245] Examples of the anionic fluorinated surfactant include the following general formula (N 0 ):

[0246] X n0 -Rf n0 -Y 0 (N 0 )

[0247] (Where X n0 is H, Cl or / and F. Rf n0 It is a chain, branched or cyclic alkylene group having 3 to 20 carbon atoms in which some or all of the H groups are replaced by F. The alkylene group may contain one or more ether bonds, and some of the H groups may be replaced by Cl. 0 is an anionic group).

[0248] Y 0The anionic group may be -COOM, -SO2M or -SO3M, or may be -COOM or -SO3M.

[0249] M is H, metal atom, NR 7 4. an imidazolium which may be substituted, a pyridinium which may be substituted, or a phosphonium which may be substituted, R 7 is H or an organic group.

[0250] Examples of the metal atom include alkali metals (Group 1) and alkaline earth metals (Group 2), such as Na, K, or Li.

[0251] R 7 Can be H or C 1-10 The organic group can also be H or C 1-4 The organic group can also be H or C 1-4 of alkyl.

[0252] M can be H, metal atom or NR 7 4, may also be H, alkali metal (Group 1), alkaline earth metal (Group 2) or NR 7 4, and can also be H, Na, K, Li or NH4.

[0253] The above Rf n0 In the above formula (A), more than 50% of the H can be replaced by fluorine.

[0254] As the above general formula (N 0 ) can be exemplified by the following general formula (N 1 ):

[0255] X n0 -(CF2) m1 -Y 0 (N 1 )

[0256] (Where X n0 is H, Cl and F, m1 is an integer from 3 to 15, Y 0 The compound represented by the following general formula (N 2 ):

[0257] R n1 -O-(CF(CF3)CF2O) m2 CFX n1 -Y 0 (N 2 )

[0258] (Where Rf n1 is a perfluoroalkyl group having 1 to 5 carbon atoms, m2 is an integer of 0 to 3, and X n1F or CF3, Y 0 The compound represented by the following general formula (N 3 ):

[0259] R n2 (CH2) m3 -(Rf n3 ) q -Y 0 (N 3 )

[0260] (Where Rf n2 is a partially or completely fluorinated alkyl group having 1 to 13 carbon atoms and which may contain an ether bond and / or a chlorine atom, m3 is an integer of 1 to 3, Rf n3 is a linear or branched perfluoroalkylene group having 1 to 3 carbon atoms, q is 0 or 1, and Y 0 The compound represented by the following general formula (N 4 ):

[0261] R n4 -O-(CY n1 Y n2 ) p CF2-Y 0 (N 4 )

[0262] (Where Rf n4 is a linear or branched partially or completely fluorinated alkyl group having 1 to 12 carbon atoms and may contain an ether bond, n1 and Y n2 The same or different, H or F, p is 0 or 1, Y 0 The compound represented by the above-defined substance); and the general formula (N 5 ):

[0263] [Chemistry 3]

[0264]

[0265] (Where X n2 , X n3 and X n4 Rf may be the same or different and is H, F, or a linear or branched partially or fully fluorinated alkyl group having 1 to 6 carbon atoms which may contain an ether bond. n5 is a linear or branched partially or completely fluorinated alkylene group having 1 to 3 carbon atoms and may contain an ether bond, L is a connecting group, Y 0 is the substance defined above. n2 , X n3 , X n4 and Rf n5The total number of carbon atoms is 18 or less) and the like.

[0266] As the above general formula (N 0 ), more specifically, a perfluorocarboxylic acid (I) represented by the following general formula (I), an ω-H perfluorocarboxylic acid (II) represented by the following general formula (II), a perfluoroether carboxylic acid (III) represented by the following general formula (III), a perfluoroalkyl alkylene carboxylic acid (IV) represented by the following general formula (IV), an alkoxy fluorocarboxylic acid (V) represented by the following general formula (V), a perfluoroalkyl sulfonic acid (VI) represented by the following general formula (VI), an ω-H perfluorosulfonic acid (VII) represented by the following general formula (VII), a perfluoroalkyl alkylene sulfonic acid (VIII) represented by the following general formula (VIII), an alkyl alkylene carboxylic acid (IX) represented by the following general formula (IX), a fluorocarboxylic acid (X) represented by the following general formula (X), an alkoxy fluorosulfonic acid (XI) represented by the following general formula (XI), a compound (XII) represented by the following general formula (XII), a compound (XIII) represented by the following general formula (XIII), and the like.

[0267] The above perfluorocarboxylic acid (I) is represented by the following general formula (I):

[0268] F(CF2) n1 COOM(I)

[0269] (where n1 is an integer from 3 to 14, M is H, a metal atom, NR 7 4. an imidazolium which may be substituted, a pyridinium which may be substituted, or a phosphonium which may be substituted, R 7 is H or an organic group).

[0270] The above-mentioned ω-H perfluorocarboxylic acid (II) is represented by the following general formula (II):

[0271] H(CF2) n2 COOM(II)

[0272] (wherein n2 is an integer of 4 to 15, and M is the substance defined above).

[0273] The above perfluoroether carboxylic acid (III) is represented by the following general formula (III):

[0274] R 1 -O-(CF(CF3)CF2O) n3 CF(CF3)COOM(III)

[0275] (Where Rf 1 is a perfluoroalkyl group having 1 to 5 carbon atoms, n3 is an integer of 0 to 3, and M is the substance defined above).

[0276] The above perfluoroalkyl alkylene carboxylic acid (IV) is represented by the following general formula (IV):

[0277] R 2 (CH2) n4 R 3 COOM(IV)

[0278] (Where Rf 2 is a perfluoroalkyl group having 1 to 5 carbon atoms, Rf 3 is a linear or branched perfluoroalkylene group having 1 to 3 carbon atoms, n4 is an integer of 1 to 3, and M is the substance defined above).

[0279] The above-mentioned alkoxy fluorocarboxylic acid (V) is represented by the following general formula (V):

[0280] R 4 -O-CY 1 Y 2 CF2-COOM(V)

[0281] (Where Rf 4 is a linear or branched partially or completely fluorinated alkyl group having 1 to 12 carbon atoms and which may contain an ether bond and / or a chlorine atom, 1 and Y 2 are the same or different, are H or F, and M is the substance defined above).

[0282] The above perfluoroalkyl sulfonic acid (VI) is represented by the following general formula (VI):

[0283] F(CF2) n5 SO3M(VI)

[0284] (wherein n5 is an integer of 3 to 14, and M is the substance defined above).

[0285] The above-mentioned ω-H perfluorosulfonic acid (VII) is represented by the following general formula (VII):

[0286] H(CF2) n6 SO3M(VII)

[0287] (wherein n6 is an integer of 4 to 14, and M is the substance defined above).

[0288] The above perfluoroalkyl alkylene sulfonic acid (VIII) is represented by the following general formula (VIII):

[0289] R 5 (CH2) n7 SO3M(VIII)

[0290] (Where Rf 5is a perfluoroalkyl group having 1 to 13 carbon atoms, n7 is an integer of 1 to 3, and M is the substance defined above).

[0291] The above alkyl alkylene carboxylic acid (IX) is represented by the following general formula (IX):

[0292] R 6 (CH2) n8 COOM(IX)

[0293] (Where Rf 6 is a linear or branched partially or completely fluorinated alkyl group having 1 to 13 carbon atoms which may contain an ether bond, n8 is an integer of 1 to 3, and M is the substance defined above).

[0294] The above fluorocarboxylic acid (X) is represented by the following general formula (X):

[0295] R 7 -O-Rf 8 -O-CF2-COOM(X)

[0296] (Where Rf 7 is a linear or branched partially or completely fluorinated alkyl group having 1 to 6 carbon atoms and which may contain an ether bond and / or a chlorine atom, Rf 8 is a linear or branched partially or fully fluorinated alkyl group having 1 to 6 carbon atoms, and M is the substance defined above).

[0297] The above alkoxy fluorosulfonic acid (XI) is represented by the following general formula (XI):

[0298] R 9 -O-CY 1 Y 2 CF2-SO3M(XI)

[0299] (Where Rf 9 is a linear or branched alkyl group having 1 to 12 carbon atoms, which may contain an ether bond, and which may contain chlorine, which may be partially or completely fluorinated, 1 and Y 2 are the same or different, are H or F, and M is the substance defined above).

[0300] The above compound (XII) is represented by the following general formula (XII):

[0301] [Chemistry 4]

[0302]

[0303] (Where X 1 , X 2 and X 3Rf may be the same or different and is H, F and a linear or branched partially or fully fluorinated alkyl group having 1 to 6 carbon atoms and may contain an ether bond. 10 is a perfluoroalkylene group having 1 to 3 carbon atoms, L is a connecting group, and Y 0 is an anionic group).

[0304] Y 0 It can be -COOM, -SO2M or -SO3M, or -SO3M or COOM (wherein M is the substance defined above).

[0305] Examples of L include a single bond and a partially or completely fluorinated alkylene group having 1 to 10 carbon atoms which may include an ether bond.

[0306] The above compound (XIII) is represented by the following general formula (XIII):

[0307] R 11 -O-(CF2CF(CF3)O) n9 (CF2O) n10 CF2COOM(XIII)

[0308] (Where Rf 11 is a fluorinated alkyl group having 1 to 5 carbon atoms and containing chlorine, n9 is an integer of 0 to 3, n10 is an integer of 0 to 3, and M is the substance defined above). Examples of compound (XIII) include CF2ClO(CF2CF(CF3)O) n9 (CF2O) n10 CF2COONH4 (mixture with an average molecular weight of 750, wherein n9 and n10 are the numbers defined above).

[0309] As described above, examples of the anionic fluorinated surfactant include carboxylic acid-based surfactants and sulfonic acid-based surfactants.

[0310] The above-mentioned fluorinated surfactant may be a single type of fluorinated surfactant or a mixture containing two or more types of fluorinated surfactants.

[0311] Examples of the fluorinated surfactant include compounds represented by the following formula: The fluorinated surfactant may be a mixture of these compounds.

[0312] F(CF2)7COOM,

[0313] F(CF2)5COOM,

[0314] H(CF2)6COOM,

[0315] H(CF2)7COOM,

[0316] CF3O(CF2)3OCHFCF2COOM,

[0317] C3F7OCF(CF3)CF2OCF(CF3)COOM,

[0318] CF3CF2CF2OCF(CF3)COOM,

[0319] CF3CF2OCF2CF2OCF2COOM,

[0320] C2F5OCF(CF3)CF2OCF(CF3)COOM,

[0321] CF3OCF(CF3)CF2OCF(CF3)COOM,

[0322] CF2ClCF2CF2OCF(CF3)CF2OCF2COOM,

[0323] CF2ClCF2CF2OCF2CF(CF3)OCF2COOM,

[0324] CF2ClCF(CF3)OCF(CF3)CF2OCF2COOM,

[0325] CF2ClCF(CF3)OCF2CF(CF3)OCF2COOM,

[0326] [Chemistry 5]

[0327]

[0328] (In each formula, M is H, metal atom, NR 7 4. An imidazolium which may have a substituent, a pyridinium which may have a substituent, or a phosphonium which may have a substituent. 7 is the group defined above.)

[0329] The fluororesin composition (1) can be produced, for example, by mixing powder of the fluororesin A, particles of the fluororesin B1, a filler, and particles of the fluororesin C as required.

[0330] The particles of fluororesin B1 may be mixed with the powder of fluororesin A in the form of a powder or in the form of an aqueous dispersion. From the perspective of being able to produce a fluororesin composition having better tensile properties, it is preferably mixed with the powder of fluororesin A in the form of an aqueous dispersion.

[0331] The aqueous dispersion containing particles of the fluororesin B1 can be produced by a known method. For example, the dispersion can be produced by emulsion polymerization of monomers required to form the fluororesin B1 in an aqueous medium in the presence of an anionic fluorinated surfactant and a polymerization initiator. In the emulsion polymerization, a chain transfer agent, a buffer, a pH adjuster, a stabilizing aid, a dispersion stabilizer, etc. can be used as needed.

[0332] Those skilled in the art can control the composition and physical properties of the fluororesin B1, the physical properties of the particles, etc. by adjusting the conditions of the emulsion polymerization.

[0333] The aqueous dispersion may contain a hydrocarbon surfactant. The hydrocarbon surfactant preferably does not contain a fluorine atom. The hydrocarbon surfactant may be used in the emulsion polymerization or may be added after the emulsion polymerization.

[0334] As the hydrocarbon-based surfactant, for example, those described in JP-A-2013-542308, JP-A-2013-542309, and JP-A-2013-542310 can be used.

[0335] Hydrocarbon surfactants have a hydrophilic part and a hydrophobic part on the same molecule. They can be cationic, nonionic or anionic.

[0336] Cationic surfactants generally have a positively charged hydrophilic portion such as alkylated ammonium halides such as alkylated ammonium bromides and a hydrophobic portion such as long-chain fatty acids.

[0337] Anionic surfactants generally have a hydrophilic portion such as a carboxylate, sulfonate, or sulfate and a hydrophobic portion which is a long-chain hydrocarbon portion such as an alkyl group.

[0338] Nonionic surfactants generally do not contain charged groups and have a hydrophobic portion that is a long-chain hydrocarbon. The hydrophilic portion of nonionic surfactants contains a water-soluble functional group such as a vinyl ether chain derived from polymerization with ethylene oxide.

[0339] The hydrocarbon-based surfactant is preferably an anionic surfactant or a nonionic surfactant.

[0340] Examples of the anionic hydrocarbon-based surfactant include Versatic (registered trademark) 10 manufactured by Resolution Performance Products and Avanel S series (S-70, S-74, etc.) manufactured by BASF.

[0341] Examples of the anionic hydrocarbon surfactant include RLM 1(wherein, R is a linear or branched alkyl group with or without a substituent having 1 or more carbon atoms, or a cyclic alkyl group with or without a substituent having 3 or more carbon atoms, and when the number of carbon atoms is 3 or more, it may contain a monovalent or divalent heterocyclic ring or form a ring. L is -ArSO3 - 、-SO3 - 、-SO4-、-PO3 - or -COO - , M 1 H, metal atoms, NR 5 4(R 5 may be the same or different, and are H or an organic group having 1 to 10 carbon atoms), an imidazolium with or without a substituent, a pyridinium with or without a substituent, or a phosphonium with or without a substituent. -ArSO3 - It is an anionic surfactant shown by aryl sulfonate.

[0342] Specifically, CH3-(CH2) n -LM 1 (where n is an integer from 6 to 17. L and M 1 Same as above).

[0343] A mixture of substances in which R is an alkyl group having 12 to 16 carbon atoms and L is sulfate or sodium dodecyl sulfate (SDS) can also be used.

[0344] Examples of the anionic hydrocarbon surfactant include: 6 (-LM 1 )2(where R 6 It is a linear or branched alkylene group with or without a substituent having 1 or more carbon atoms, or a cyclic alkylene group with or without a substituent having 3 or more carbon atoms. When the number of carbon atoms is 3 or more, it may contain a monovalent or divalent heterocyclic ring or form a ring. L is -ArSO3 - 、-SO3 - 、-SO4-、-PO3 - or -COO - , M 1 H, metal atoms, NR 5 4(R 5 may be the same or different, and are H or an organic group having 1 to 10 carbon atoms), an imidazolium with or without a substituent, a pyridinium with or without a substituent, or a phosphonium with or without a substituent. -ArSO3 - It is an anionic surfactant shown by aryl sulfonate.

[0345] Examples of the anionic hydrocarbon surfactant include: 7 (-LM 1 )3(where R 7 It is a linear or branched alkylene group with or without a substituent having 1 or more carbon atoms, or a cyclic alkylene group with or without a substituent having 3 or more carbon atoms. When the number of carbon atoms is 3 or more, it may contain a monovalent or divalent heterocycle or form a ring. L is -ArSO3 - 、-SO3 - 、-SO4-、-PO3 - or -COO - , M 1 H, metal atoms, NR 5 4(R 5 may be the same or different, and are H or an organic group having 1 to 10 carbon atoms), an imidazolium with or without a substituent, a pyridinium with or without a substituent, or a phosphonium with or without a substituent. -ArSO3 - It is an anionic surfactant shown by aryl sulfonate.

[0346] Examples of the anionic hydrocarbon-based surfactant include sulfosuccinate surfactant Lankropol (registered trademark) K8300 manufactured by Akzo Nobel Surface Chemistry LLC.

[0347] Examples of the sulfosuccinate hydrocarbon surfactant include diisodecyl sulfosuccinate sodium salt (Emulsogen (registered trademark) SB10 from Clariant), diisotridecyl sulfosuccinate sodium salt (Polirol (registered trademark) TR / LNA from Cesapinia Chemicals), and the like.

[0348] Examples of anionic hydrocarbon surfactants include PolyFox (registered trademark) surfactants from Omnova Solutions, Inc. TM PF-156A, PolyFox TM PF-136A, etc.).

[0349] Examples of the nonionic surfactant include ether-type nonionic surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene alkylphenyl ethers, and polyoxyethylene alkylene alkyl ethers; polyoxyethylene derivatives such as ethylene oxide / propylene oxide block copolymers; ester-type nonionic surfactants such as polyoxyethylene fatty acid esters (polyoxyethylene alkyl esters), sorbitan fatty acid esters (sorbitan alkyl esters), polyoxyethylene sorbitan fatty acid esters (polyoxyethylene sorbitan alkyl esters), polyoxyethylene sorbitol fatty acid esters, and glycerol fatty acid esters (glycerides); amine-based nonionic surfactants such as polyoxyethylene alkylamines and alkyl alkanolamides; and derivatives thereof. Any one of these may be used alone or in combination of two or more.

[0350] The nonionic surfactant may be a non-fluorinated nonionic surfactant.

[0351] Examples of the polyoxyethylene alkyl ethers include polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, and polyoxyethylene behenyl ether.

[0352] Examples of the polyoxyethylene alkylphenyl ether include polyoxyethylene nonylphenyl ether and polyoxyethylene octylphenyl ether.

[0353] Specific examples of the polyoxyethylene fatty acid esters include polyethylene glycol monolaurate, polyethylene glycol monooleate, polyethylene glycol monostearate, and the like.

[0354] Examples of the sorbitan fatty acid ester include sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, and sorbitan monooleate.

[0355] Examples of the polyoxyethylene sorbitan fatty acid ester include polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, and polyoxyethylene sorbitan monostearate.

[0356] Examples of the glyceryl fatty acid ester include glyceryl monomyristic acid, glyceryl monostearate, glyceryl monooleate, and the like.

[0357] Examples of the derivatives include polyoxyethylene alkylamines, polyoxyethylene alkylphenyl-formaldehyde condensates, and polyoxyethylene alkyl ether phosphates.

[0358] The ether type nonionic surfactant and the ester type nonionic surfactant may have an HLB value of 10-18.

[0359] Examples of the nonionic hydrocarbon-based surfactant include Triton (registered trademark) X series (X15, X45, X100, etc.), Tergitol (registered trademark) 15-S series, Tergitol (registered trademark) TMN series (TMN-6, TMN-10, TMN-100, etc.), Tergitol (registered trademark) L series manufactured by Dow Chemical Company, Pluronic (registered trademark) R series (31R1, 17R2, 10R5, 25R4 (m to 22, n to 23)), T-Det series (A138), and Iconol (registered trademark) TDA series (TDA-6, TDA-9, TDA-10) manufactured by BASF, and the like.

[0360] In the compound constituting the above nonionic surfactant, the hydrophobic group may be any of an alkylphenol group, a linear alkyl group and a branched alkyl group, but preferably a compound having no benzene ring, such as a compound having no alkylphenol group in the structure.

[0361] As the above-mentioned nonionic surfactant, a nonionic surfactant having an ether bond (-O-) is preferred, the above-mentioned ether-type nonionic surfactant is more preferred, and polyoxyethylene alkyl ether is further preferred. As the above-mentioned polyoxyethylene alkyl ether, it is preferably composed of a polyoxyethylene alkyl ether structure having an alkyl group with 10 to 20 carbon atoms, and more preferably composed of a polyoxyethylene alkyl ether structure having an alkyl group with 10 to 15 carbon atoms. The alkyl group in the above-mentioned polyoxyethylene alkyl ether structure preferably has a branched structure.

[0362] From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the content of the hydrocarbon surfactant is preferably 12% by mass or less, more preferably 8% by mass or less, further preferably 6% by mass or less, still more preferably 4% by mass or less, particularly preferably 2% by mass or less, and particularly preferably 1% by mass or less, relative to the solid content of the aqueous dispersion. The content of the hydrocarbon surfactant may also be 1 ppm by mass or more, 10 ppm by mass or more, 100 ppm by mass or more, or 500 ppm by mass or more.

[0363] The aqueous dispersion obtained by the above-mentioned emulsion polymerization or the aqueous dispersion containing the above-mentioned hydrocarbon-based surfactant can be contacted with an anion exchange resin or a mixed bed containing an anion exchange resin and a cation exchange resin, and can also be concentrated or processed by the two. By carrying out the above-mentioned treatment, low molecular weight fluorinated compounds can be removed. As the above-mentioned treatment, known treatment can be adopted.

[0364] The powder of fluororesin A can be mixed with the aqueous dispersion of the particles comprising fluororesin B1, and the resulting mixture is precipitated. As the method for precipitating, the method for agglomerating the emulsified particles by freezing or mechanical shearing force can be cited. It is also possible to stir as a precipitating agent while adding inorganic acids such as inorganic salts, hydrochloric acid, sulfuric acid, nitric acid, etc., such as water-soluble organic compounds such as methanol, acetone, potassium nitrate, and ammonium carbonate. The above-mentioned precipitation can also be carried out continuously using a pipeline mixer, etc.

[0365] The fluororesin composition is obtained by drying the above mixture. The wet powder obtained by the above precipitation may be dried.

[0366] The drying method is not particularly limited, and a known method can be used, and for example, the drying can be carried out by vacuum, high frequency, hot air or the like.

[0367] The drying temperature is preferably 50° C. or higher, more preferably 70° C. or higher, further preferably 100° C. or higher, particularly preferably 150° C. or higher, and is preferably 300° C. or lower, more preferably 250° C. or lower.

[0368] The above-mentioned particles of fluororesin C may be mixed with the powder of fluororesin A (and particles of fluororesin B1) in the form of powder or in the form of aqueous dispersion.

[0369] The obtained fluororesin composition may be pulverized by a known method, for example, by using a pulverizer such as a jet mill, a hammer mill, a power mill, a stone mill type pulverizer, or a freeze pulverizer.

[0370] The obtained fluororesin composition can be granulated to obtain a fluororesin composition having a high apparent density and excellent handleability.

[0371] Examples of the granulation method include known methods, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, and a dry solvent granulation method.

[0372] The first fluororesin composition of the present disclosure is also preferably a fluororesin composition (also referred to as a fluororesin composition (2a)) comprising: a fluororesin A which does not exhibit melt fluidity and has a history of being heated to a temperature above its melting point, a fluororesin B2 which does not exhibit melt fluidity and is polymerized by suspension polymerization and does not have a history of being heated to a temperature above its melting point, and a filler, wherein the apparent density is 0.42 g / ml or more.

[0373] The fluororesin composition (2a) contains the fluororesin B2 polymerized by suspension polymerization without a history of heating to a temperature higher than the melting point, and has an apparent density within a specific range. Therefore, despite containing the fluororesin A having a history of heating to a temperature higher than the melting point, the composition has excellent handleability (for example, handleability during transportation and compression molding).

[0374] In addition, the fluororesin composition (2a) has good tensile properties (eg, tensile breaking strength, tensile breaking strain).

[0375] The fluororesin composition (2a) preferably has one or more melting points in a temperature range lower than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0376] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0377] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0378] Having melting points in the above two temperature ranges means that the fluororesin composition comprises fluororesin A which has a history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity, and fluororesin B2 which has no history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity.

[0379] As the fluororesin A and the filler in the fluororesin composition (2a), those described above can be used.

[0380] Fluororesin B2 has no history of being heated to a temperature higher than its melting point.

[0381] The melting point of the fluororesin B2 is preferably 100° C. to 360° C. The melting point is more preferably 140° C. or higher, further preferably 160° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0382] Fluororesin B2 preferably has one or more melting points in the temperature range of 333° C. to 360° C. The temperature range is more preferably 334° C. or higher, further preferably 335° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0383] The melting point being within the above range means that the material does not have a history of being heated to a temperature higher than the melting point.

[0384] In addition to the above-mentioned melting point, the metal may have a melting point in a temperature range lower than 333°C.

[0385] Fluororesin B2 does not exhibit melt fluidity. The melt fluidity is as described above.

[0386] As the fluororesin B2, PTFE is preferred. The PTFE may be high molecular weight PTFE.

[0387] The above-mentioned PTFE (high molecular weight PTFE) as the fluororesin B2 preferably has at least one endothermic peak in the range of 333°C to 347°C in the heat of fusion curve when the temperature is increased at a rate of 10°C / min using a differential scanning calorimeter [DSC], and the heat of fusion at 290°C to 350°C calculated from the above-mentioned heat of fusion curve is 62 mJ / mg or more.

[0388] The standard specific gravity (SSG) of the PTFE as the fluororesin B2 is preferably 2.130 to 2.280. The standard specific gravity is measured by a water displacement method according to ASTM D 792 using a sample molded according to ASTM D 4895 89.

[0389] The "high molecular weight" of PTFE that does not have a history of being heated to a temperature higher than the melting point means that the above-mentioned standard specific gravity is within the above-mentioned range.

[0390] The PTFE as the fluororesin B2 generally has non-melt secondary processability. The non-melt secondary processability is as described above.

[0391] The PTFE as fluororesin B2 may be a homopolymer of TFE or a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0392] Modified PTFE is preferred from the viewpoints of obtaining a fluororesin composition having a higher apparent density and better handleability and a fluororesin composition having better tensile properties.

[0393] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0394] The modifying monomer that can be used for the above-mentioned PTFE as the fluororesin B2 is the same as the modifying monomer exemplified for the PTFE (high molecular weight PTFE) as the fluororesin A.

[0395] The fluororesin B2 is polymerized by suspension polymerization. A fluororesin polymerized by suspension polymerization that does not exhibit melt fluidity is less likely to be fiberized, and thus the apparent density of the fluororesin composition can be increased, thereby improving the handleability.

[0396] The fluororesin B2 which is polymerized by suspension polymerization and does not exhibit melt fluidity preferably satisfies all of the following conditions.

[0397] (i) The proportion of particles having a particle size of 1 μm or less based on image processing using a scanning electron microscope (SEM) is 30% or less.

[0398] (ii) The amount of the anionic fluorinated surfactant measured by liquid chromatography-mass spectrometry (LC / MS / MS) using an extract obtained by Soxhlet extraction with methanol is 1 mass ppm or less.

[0399] The suspension polymerization can be carried out by a known method. For example, by not using anionic fluorinated surfactant or using a limited amount, dispersing the polymerization initiator in an aqueous medium, polymerizing the monomers required to form the fluororesin B2, and directly isolating the granular powder of the fluororesin B2.

[0400] As the fluororesin B2, a powder directly obtained by the above-mentioned suspension polymerization may be used, or a powder obtained by pulverizing and / or granulating the above-mentioned powder may be used.

[0401] The pulverization can be performed by a known method, and can be performed by a pulverization method using a pulverizer such as a hammer mill, a pin mill, a jet mill, or a cutter mill.

[0402] The granulation can be carried out by a known method, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, or a dry solvent granulation method.

[0403] The fluororesin composition (2a) may contain particles of the fluororesin B2. The particles of the fluororesin B2 may be secondary particles of the fluororesin B2.

[0404] The average secondary particle size of the particles of the fluororesin B2 is preferably 1 μm to 700 μm. The average secondary particle size is more preferably 5 μm or more, further preferably 10 μm or more, and even more preferably 20 μm or more. In addition, it is more preferably 500 μm or less, further preferably 150 μm or less, and even more preferably 100 μm or less.

[0405] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0406] The particle size D90 of the fluororesin B2 is preferably 10 μm or more, more preferably 30 μm or more, and even more preferably 50 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, and even more preferably 400 μm or less.

[0407] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0408] The apparent density of the fluororesin composition (2a) is 0.42 g / ml or more. When the apparent density is within the above range, the fluororesin composition (2a) is excellent in handling properties.

[0409] From the viewpoint of better handling properties, the apparent density is preferably 0.45 g / ml or more, more preferably 0.47 g / ml or more. The upper limit is not particularly limited, and may be 1.00 g / ml.

[0410] The above apparent density is measured in accordance with JIS K6891.

[0411] From the viewpoint of further improving the tensile properties, the content of the fluororesin A in the fluororesin composition (2a) is preferably 10 to 90% by mass relative to the fluororesin composition. The content is more preferably 20% by mass or more, further preferably 30% by mass or more, still more preferably 40% by mass or more, particularly preferably 50% by mass or more, and more preferably 85% by mass or less, further preferably 80% by mass or less, still more preferably less than 80% by mass, particularly preferably 75% by mass or less, and particularly preferably 70% by mass or less.

[0412] From the viewpoint of further improving tensile properties, the content of the fluororesin B2 in the fluororesin composition (2a) is preferably 10 to 90% by mass relative to the fluororesin composition. The content is more preferably 15% by mass or more, further preferably 20% by mass or more, still more preferably more than 20% by mass, particularly preferably 25% by mass or more, particularly preferably 30% by mass or more, and more preferably 80% by mass or less, further preferably 70% by mass or less, still more preferably 60% by mass or less, and particularly preferably 50% by mass or less.

[0413] The total amount of the fluororesins A and B2 in the fluororesin composition (2a) is preferably 80% by mass or more, more preferably 85% by mass or more, further preferably 90% by mass or more, still more preferably 95% by mass or more, particularly preferably 98% by mass or more, based on the above-mentioned fluororesin composition.

[0414] The fluororesin composition (2a) preferably comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE, and the amount of the modified monomer units is preferably 1.0% by mass or less relative to all polymerized units. The amount of TFE units is preferably 99.0% by mass or more.

[0415] The lower limit of the content of the modified monomer unit in the fluororesin composition (2a) may be 0% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, still more preferably 0.005% by mass, and particularly preferably 0.010% by mass. The upper limit of the content of the modified monomer unit is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0416] The content of the modified monomer unit can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomer. Alternatively, when the raw material composition is known, the content can be calculated from the raw material composition.

[0417] One preferred embodiment of the fluororesin composition (2a) is that the fluororesin B2 is a homopolymer of TFE, and the content of the fluororesin A is 50% by mass or more and less than 80% by mass relative to the fluororesin composition. In this embodiment, the content of the fluororesin A is more preferably 75% by mass or less, and even more preferably 70% by mass or less relative to the fluororesin composition.

[0418] In another preferred embodiment of the fluororesin composition (2a), the content of the fluororesin A is 50% by mass or more based on the fluororesin composition, and the fluororesin composition has a tensile strength at break of 20 MPa or more.

[0419] Regarding the above tensile strength at break, 35 g of the fluororesin composition was put into a mold, compression molding was performed under a pressure of 30 MPa for 1 minute, the temperature was raised from room temperature to 300°C in 3 hours, then from 300°C to 370°C in 4 hours, and after maintaining at 370°C for 12 hours, the temperature was lowered to 300°C in 5 hours, and then lowered to room temperature in 1 hour. A dumbbell was made by punching the molded body fired in the above steps, and the measurement was performed in accordance with ASTM D1708.

[0420] In this embodiment, the fluororesin B2 is also preferably a homopolymer of TFE.

[0421] The first fluororesin composition of the present disclosure is also preferably a fluororesin composition (also referred to as a fluororesin composition (2b)) comprising: a fluororesin A which does not exhibit melt fluidity and has a history of being heated to a temperature higher than its melting point, a fluororesin B2 which does not exhibit melt fluidity and is polymerized by suspension polymerization and does not have a history of being heated to a temperature higher than its melting point, and a filler comprising a TFE unit and a modified monomer unit based on a modified monomer copolymerizable with TFE.

[0422] The fluororesin composition (2b) has a specific monomer composition and is therefore excellent in handleability (for example, handleability during transportation or compression molding) despite containing the fluororesin A having a history of being heated to a temperature not lower than its melting point.

[0423] In addition, the fluororesin composition (2b) has good tensile properties (eg, tensile breaking strength, tensile breaking strain).

[0424] The fluororesin composition (2b) preferably has one or more melting points in a temperature range lower than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0425] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0426] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0427] Having melting points in the above two temperature ranges means that the fluororesin composition contains fluororesin A which has a history of being heated to a temperature not less than the melting point and does not exhibit melt fluidity, and fluororesin B2 which has no history of being heated to a temperature not less than the melting point and does not exhibit melt fluidity.

[0428] As the fluororesin A and the filler in the fluororesin composition (2b), those described above can be used.

[0429] As the fluororesin B2 in the fluororesin composition (2b), the same fluororesin B2 as that in the fluororesin composition (2a) can be used, preferably a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE (TFE units) and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The above-mentioned fluororesin B2 may consist only of TFE units and modified monomer units.

[0430] Examples of the modified monomer include the monomers described above for the modified PTFE as the fluororesin B2 in the fluororesin composition (2a). The preferred range of the content of the modified monomer unit is also the same as that described for the fluororesin composition (2a).

[0431] The constitution other than the composition of the fluororesin B2 in the fluororesin composition (2b) is the same as that of the fluororesin B2 in the fluororesin composition (2a).

[0432] The fluororesin composition (2b) comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE. The fluororesin composition (2b) may comprise only TFE units and modified monomer units as polymerized units.

[0433] From the perspective of further improving the operability and tensile properties of the fluororesin composition, the content of the modified monomer unit is preferably 1.0% by mass or less relative to all the polymerized units constituting the fluororesin composition. As the lower limit of the content of the modified monomer unit, it is preferably 0.00001% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, further more preferably 0.005% by mass, and particularly preferably 0.010% by mass. As the upper limit of the content of the modified monomer unit, it is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0434] The fluororesin composition (2b) preferably contains 99.0 mass % or more of TFE units based on all polymerized units.

[0435] The content of polymerized units constituting the fluororesin composition (2b) can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the types of monomers. Alternatively, when the raw material composition is known, the content can be determined by calculation from the raw material composition.

[0436] The contents of the fluororesins A and B2 and the total amount of the fluororesins A and B in the fluororesin composition (2b) are the same as those described for the fluororesin composition (2a).

[0437] From the viewpoint of better handling properties, the apparent density of the fluororesin composition (2b) is preferably 0.42 g / ml or more, more preferably 0.45 g / ml or more, and even more preferably 0.47 g / ml or more. The upper limit is not particularly limited and may be 1.00 g / ml.

[0438] The above apparent density is measured in accordance with JIS K6891.

[0439] The form of the fluororesin compositions (2a) and (2b) is not particularly limited, but is preferably a powder.

[0440] In the fluororesin compositions (2a) and (2b), the maximum linear length of the particles of the fluororesin A is preferably smaller than the maximum linear length of the particles of the fluororesin B2. If the maximum linear lengths of the particles of the fluororesins A and B2 are in the above relationship, the apparent density of the fluororesin composition can be increased, and the workability can be further improved. In addition, since there is no need to perform a deformation treatment for increasing the maximum linear length of the particles of the fluororesin A, the manufacturing cost of the fluororesin composition can be reduced.

[0441] The fluororesin compositions (2a) and (2b) preferably satisfy all of the following conditions.

[0442] (i) The proportion of particles having a particle size of 1 μm or less based on image processing using a scanning electron microscope (SEM) is 30% or less.

[0443] (ii) The amount of the anionic fluorinated surfactant measured by liquid chromatography-mass spectrometry (LC / MS / MS) using an extract obtained by Soxhlet extraction with methanol is 1 mass ppm or less.

[0444] The angle of repose of the fluororesin compositions (2a) and (2b) is preferably less than 40°, more preferably less than 38°, and still more preferably less than 35°, from the viewpoint of excellent fluidity and further excellent handleability.

[0445] The above repose angle is the value measured as follows: the total height is 115mm, the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake portion is set so that the height from the bottom of the funnel to the sample falling surface is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the dropped sample is measured with a protractor to obtain the value.

[0446] The average secondary particle size of the fluororesin compositions (2a) and (2b) is preferably 5 to 700 μm. The average secondary particle size is more preferably 10 μm or more, further preferably 20 μm or more, and more preferably 600 μm or less, further preferably 500 μm or less, and particularly preferably 400 μm or less.

[0447] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0448] The D90 of the fluororesin compositions (2a) and (2b) is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, further preferably 400 μm or less.

[0449] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0450] From the viewpoint of further improving the tensile properties, the content (total amount) of the low molecular weight fluorinated compounds in the fluororesin compositions (2a) and (2b) is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the above-mentioned fluororesin composition.

[0451] The content of the low molecular weight fluorine-containing compound is measured by Soxhlet extraction of a sample with methanol and then by liquid chromatography-mass spectrometry (LC / MS / MS).

[0452] Examples of the low molecular weight fluorine-containing compound include the compounds exemplified for the fluorine resin composition (1).

[0453] Fluororesin compositions (2a) and (2b) can be produced, for example, by mixing powder of fluororesin A, particles of fluororesin B2, and a filler. The particles of fluororesin B2 are preferably mixed with powder of fluororesin A in the form of powder. The mixing method is not particularly limited, and a known method can be used. Mixing can also be carried out in a pulverizer.

[0454] From the viewpoint of easily obtaining a fluororesin composition having a higher apparent density and better handleability, the maximum linear length of the particles of the fluororesin A is preferably smaller than the maximum linear length of the particles of the fluororesin B2.

[0455] The obtained fluororesin composition may be pulverized by a known method, for example, by using a pulverizer such as a jet mill, a hammer mill, a power mill, a stone mill type pulverizer, or a freeze pulverizer.

[0456] The obtained fluororesin composition can be granulated to obtain a fluororesin composition having a higher apparent density and better handleability.

[0457] Examples of the granulation method include known methods, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, and a dry solvent granulation method.

[0458] The first fluororesin composition of the present disclosure is also preferably a fluororesin composition (also referred to as a fluororesin composition (3a)) comprising: a fluororesin A which does not exhibit melt fluidity and has a history of being heated to a temperature above its melting point, a fluororesin B3 which does not exhibit melt fluidity and is polymerized by emulsion polymerization and does not have a history of being heated to a temperature above its melting point, and a filler, wherein the apparent density is 0.42 g / ml or more.

[0459] The fluororesin composition (3a) contains the fluororesin B3 polymerized by emulsion polymerization without a history of heating to a temperature higher than the melting point, and has an apparent density within a specific range. Therefore, despite containing the fluororesin A having a history of heating to a temperature higher than the melting point, the composition has excellent handleability (for example, handleability during transportation and compression molding).

[0460] In addition, the fluororesin composition (3a) has good tensile properties (eg, tensile breaking strength, tensile breaking strain).

[0461] The fluororesin composition (3a) preferably has one or more melting points in a temperature range of less than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0462] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0463] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0464] Having melting points in the above two temperature ranges means that the fluororesin composition comprises fluororesin A which has a history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity, and fluororesin B3 which has no history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity.

[0465] As the fluororesin A and the filler in the fluororesin composition (3a), those described above can be used.

[0466] Fluororesin B3 has no history of being heated to a temperature higher than its melting point.

[0467] The melting point of the fluororesin B3 is preferably 100° C. to 360° C. The melting point is more preferably 140° C. or higher, and even more preferably 160° C. or higher, and is more preferably 355° C. or lower, and even more preferably 350° C. or lower.

[0468] Fluororesin B3 preferably has one or more melting points in the temperature range of 333° C. to 360° C. The temperature range is more preferably 334° C. or higher, further preferably 335° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0469] The melting point being within the above range means that the material does not have a history of being heated to a temperature higher than the melting point.

[0470] In addition to the above-mentioned melting point, the metal may have a melting point in a temperature range lower than 333°C.

[0471] Fluororesin B3 does not exhibit melt fluidity. The melt fluidity is as described above.

[0472] As the fluororesin B3, PTFE is preferred. The PTFE may be high molecular weight PTFE.

[0473] The above-mentioned PTFE (high molecular weight PTFE) as the fluororesin B3 preferably has at least one endothermic peak in the range of 333°C to 347°C in the heat of fusion curve when the temperature is increased at a rate of 10°C / min using a differential scanning calorimeter [DSC], and the heat of fusion at 290°C to 350°C calculated from the above-mentioned heat of fusion curve is 62 mJ / mg or more.

[0474] The standard specific gravity (SSG) of the PTFE as the fluororesin B3 is preferably 2.130 to 2.280. The standard specific gravity is measured by a water displacement method according to ASTM D 792 using a sample molded according to ASTM D 4895 89.

[0475] The "high molecular weight" of PTFE that does not have a history of being heated to a temperature higher than the melting point means that the above-mentioned standard specific gravity is within the above-mentioned range.

[0476] The PTFE as the fluororesin B3 generally has non-melt secondary processability. The non-melt secondary processability is as described above.

[0477] The PTFE as the fluororesin B3 may be a homopolymer of TFE or a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0478] Modified PTFE is preferred from the viewpoint of further improving the handling properties and tensile properties of the fluororesin composition.

[0479] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0480] The modifying monomer that can be used for the above-mentioned PTFE as the fluororesin B3 is the same as the modifying monomer exemplified for the PTFE (high molecular weight PTFE) as the fluororesin A.

[0481] Fluororesin B3 is polymerized by emulsion polymerization. Fluororesin B3 which is polymerized by emulsion polymerization and does not exhibit melt fluidity may satisfy any of the following conditions, and preferably all of them.

[0482] (i) The proportion of particles (primary particles) having a particle size of 1 μm or less based on image processing using a scanning electron microscope (SEM) exceeds 50%, preferably exceeds 70%, and more preferably exceeds 90%.

[0483] (ii) The amount of the anionic fluorinated surfactant measured by liquid chromatography-mass spectrometry (LC / MS / MS) using an extract obtained by Soxhlet extraction with methanol is 1 ppb or more.

[0484] The emulsion polymerization can be carried out by a known method. For example, in the presence of anionic fluorinated surfactant and polymerization initiator, emulsion polymerization of monomers required for forming fluororesin B3 is carried out in an aqueous medium to obtain an aqueous dispersion of particles (primary particles) containing fluororesin B3. In the emulsion polymerization, a chain transfer agent, a buffer, a pH adjusting agent, a stabilizing aid, a dispersion stabilizer, etc. can be used as needed.

[0485] The aqueous dispersion may contain a hydrocarbon surfactant. The hydrocarbon surfactant preferably does not contain a fluorine atom. The hydrocarbon surfactant may be used in the emulsion polymerization or may be added after the emulsion polymerization.

[0486] Examples of the hydrocarbon surfactant include the compounds exemplified for the fluororesin composition (1).

[0487] From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the content of the hydrocarbon surfactant is preferably 12% by mass or less, more preferably 8% by mass or less, further preferably 6% by mass or less, still more preferably 4% by mass or less, particularly preferably 2% by mass or less, and particularly preferably 1% by mass or less, relative to the solid content of the aqueous dispersion. The content of the hydrocarbon surfactant may also be 1 ppm by mass or more, 10 ppm by mass or more, 100 ppm by mass or more, or 500 ppm by mass or more.

[0488] The fluororesin B3 can be provided from the above-mentioned aqueous dispersion.

[0489] Alternatively, the aqueous dispersion is precipitated and dried to obtain a powder containing particles of the fluororesin B3. The fluororesin B3 can be provided from the powder.

[0490] Both precipitation and drying can be performed by known methods.

[0491] The fluororesin composition (3a) may contain particles of the fluororesin B3. The particles of the fluororesin B3 may be primary particles or secondary particles of the fluororesin B3.

[0492] From the perspective of further improving the operability of the fluororesin composition, the average secondary particle size of the secondary particles of the fluororesin B3 is preferably 1000 μm or less. The average secondary particle size is more preferably 900 μm or less, further preferably 800 μm or less, and particularly preferably 700 μm or less. In addition, the average secondary particle size is preferably 100 μm or more, more preferably 200 μm or more, further preferably 300 μm or more, and particularly preferably 400 μm or more.

[0493] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0494] From the viewpoint of further improving the handleability of the fluororesin composition, D90 of the particles of the fluororesin B3 is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, and is preferably 2000 μm or less, more preferably 1500 μm or less, further preferably 1200 μm or less.

[0495] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0496] The apparent density of the fluororesin composition (3a) is 0.42 g / ml or more. When the apparent density is within the above range, the fluororesin composition (3a) is excellent in handling properties.

[0497] From the viewpoint of better handling properties, the apparent density is preferably 0.45 g / ml or more, more preferably 0.47 g / ml or more. The upper limit is not particularly limited, and may be 1.00 g / ml.

[0498] The above apparent density is measured in accordance with JIS K6891.

[0499] From the viewpoint of further improving tensile properties, the content of the fluororesin A in the fluororesin composition (3a) is preferably 10 to 90% by mass relative to the above-mentioned fluororesin composition. The above-mentioned content is more preferably 20% by mass or more, further preferably 30% by mass or more, still more preferably 40% by mass or more, particularly preferably 50% by mass or more, and particularly preferably more than 50% by mass, and is more preferably 85% by mass or less, further preferably 80% by mass or less, still more preferably less than 80% by mass, particularly preferably 75% by mass or less, and particularly preferably 70% by mass or less.

[0500] From the viewpoint of further improving tensile properties, the content of the fluororesin B3 in the fluororesin composition (3a) is preferably 10 to 90% by mass relative to the above-mentioned fluororesin composition. The above-mentioned content is more preferably 15% by mass or more, further preferably 20% by mass or more, still more preferably more than 20% by mass, particularly preferably 25% by mass or more, and particularly preferably 30% by mass or more, and is more preferably 80% by mass or less, further preferably 70% by mass or less, still more preferably 60% by mass or less, particularly preferably 50% by mass or less, and particularly preferably less than 50% by mass.

[0501] The total amount of the fluororesins A and B3 in the fluororesin composition (3a) is preferably 80% by mass or more, more preferably 85% by mass or more, further preferably 90% by mass or more, still more preferably 95% by mass or more, particularly preferably 98% by mass or more, based on the above-mentioned fluororesin composition.

[0502] The fluororesin composition (3a) preferably comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE, and the amount of the modified monomer units is preferably 1.0% by mass or less relative to all polymerized units. The amount of TFE units is preferably 99.0% by mass or more.

[0503] The lower limit of the content of the modified monomer unit in the fluororesin composition (3a) may be 0% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, still more preferably 0.005% by mass, and particularly preferably 0.010% by mass. The upper limit of the content of the modified monomer unit is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0504] The content of the modified monomer unit can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomer. Alternatively, when the raw material composition is known, the content can be calculated from the raw material composition.

[0505] The present disclosure is also preferably a fluororesin composition (also referred to as a fluororesin composition (3b)) comprising: a fluororesin A which does not exhibit melt fluidity and has a history of being heated to a temperature above its melting point, a fluororesin B3 which does not exhibit melt fluidity and is polymerized by emulsion polymerization and does not have a history of being heated to a temperature above its melting point, and a filler comprising a TFE unit and a modified monomer unit based on a modified monomer copolymerizable with TFE.

[0506] The fluororesin composition (3b) has a specific monomer composition and is therefore excellent in handleability (for example, handleability during transportation or compression molding) despite containing the fluororesin A having a history of being heated to a temperature not lower than its melting point.

[0507] In addition, the fluororesin composition (3b) has good tensile properties (eg, tensile breaking strength, tensile breaking strain).

[0508] The fluororesin composition (3b) preferably has one or more melting points in a temperature range of less than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0509] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0510] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0511] Having melting points in the above two temperature ranges means that the fluororesin composition comprises fluororesin A which has a history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity, and fluororesin B3 which has no history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity.

[0512] As the fluororesin A in the fluororesin composition (3b), the same fluororesin A as that in the fluororesin composition (3a) can be used.

[0513] As the fluororesin B3 in the fluororesin composition (3b), the same fluororesin B3 as that in the fluororesin composition (3a) can be used, preferably a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE (TFE units) and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The above-mentioned fluororesin B3 may consist only of TFE units and modified monomer units.

[0514] Examples of the modified monomer include the monomers described above for the modified PTFE as the fluororesin B3 in the fluororesin composition (3a). The preferred range of the content of the modified monomer unit is also the same as that described for the fluororesin composition (3a).

[0515] The constitution other than the composition of the fluororesin B3 in the fluororesin composition (3b) is the same as that of the fluororesin B3 in the fluororesin composition (3a).

[0516] The fluororesin composition (3b) comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE. The fluororesin composition (3b) may comprise only TFE units and modified monomer units as polymerized units.

[0517] From the perspective of further improving the operability and tensile properties of the fluororesin composition, the content of the modified monomer unit is preferably 1.0% by mass or less relative to all the polymerized units constituting the fluororesin composition. As the lower limit of the content of the modified monomer unit, it is preferably 0.00001% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, further more preferably 0.005% by mass, and particularly preferably 0.010% by mass. As the upper limit of the content of the modified monomer unit, it is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0518] The fluororesin composition (3b) preferably contains 99.0 mass % or more of TFE units based on all polymerized units.

[0519] The content of polymerized units constituting the fluororesin composition (3b) can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the types of monomers. Alternatively, when the raw material composition is known, the content can be determined by calculation from the raw material composition.

[0520] The contents of the fluororesins A and B3 in the fluororesin composition (3b) and the total amount of the fluororesins A and B3 are the same as those described for the fluororesin composition (3a).

[0521] From the viewpoint of better handleability, the apparent density of the fluororesin composition (3b) is preferably 0.42 g / ml or more, more preferably 0.45 g / ml or more, and even more preferably 0.47 g / ml or more. The upper limit is not particularly limited, and may be 1.00 g / ml.

[0522] The above apparent density is measured in accordance with JIS K6891.

[0523] The form of the fluororesin compositions (3a) and (3b) is not particularly limited, but is preferably a powder.

[0524] The fluororesin compositions (3a) and (3b) may satisfy any one of the following conditions, and preferably all of them.

[0525] (i) The proportion of particles (primary particles) having a particle size of 1 μm or less based on image processing using a scanning electron microscope (SEM) exceeds 50%, preferably exceeds 70%, and more preferably exceeds 90%.

[0526] (ii) The amount of the anionic fluorinated surfactant measured by liquid chromatography-mass spectrometry (LC / MS / MS) using an extract obtained by Soxhlet extraction with methanol is 1 ppb or more.

[0527] The angle of repose of the fluororesin compositions (3a) and (3b) is preferably less than 40°, more preferably less than 38°, and still more preferably less than 35°, from the viewpoint of excellent fluidity and further excellent handleability.

[0528] The above repose angle is the value measured as follows: the total height is 115mm, the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake portion is set so that the height from the bottom of the funnel to the sample falling surface is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the dropped sample is measured with a protractor to obtain the value.

[0529] The average secondary particle size of the fluororesin compositions (3a) and (3b) is preferably 50 to 500 μm, more preferably 70 μm or more, further preferably 100 μm or more, and more preferably 300 μm or less, further preferably 200 μm or less.

[0530] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0531] The D90 of the fluororesin compositions (3a) and (3b) is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, particularly preferably 100 μm or more, and is preferably 800 μm or less, more preferably 600 μm or less, further preferably 500 μm or less.

[0532] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0533] From the viewpoint of further improving the tensile properties, the content (total amount) of the low molecular weight fluorinated compounds in the fluororesin compositions (3a) and (3b) is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the above-mentioned fluororesin composition.

[0534] The content of the low molecular weight fluorine-containing compound is measured by Soxhlet extraction of a sample with methanol and then by liquid chromatography-mass spectrometry (LC / MS / MS).

[0535] Examples of the low molecular weight fluorine-containing compound include the compounds exemplified for the fluorine resin composition (1).

[0536] The fluororesin compositions (3a) and (3b) can be produced, for example, by mixing powder of the fluororesin A, pellets of the fluororesin B3 and a filler.

[0537] The particles of the fluororesin B3 may be mixed with the powder of the fluororesin A in the form of a powder or in the form of an aqueous dispersion. From the perspective of obtaining a fluororesin composition having better handleability and tensile properties, it is preferably mixed with the powder of the fluororesin A in the form of a powder.

[0538] The mixing can be performed using, for example, a crusher equipped with rotary blades. Examples of the crusher equipped with rotary blades include Wonder crusher WC-3 manufactured by Osaka Chemical Co., Ltd.

[0539] When mixing using the above-mentioned pulverizer, the rotation speed of the blade is preferably set to 1500 rpm to 10000 rpm. By making the rotation speed within the above range, the shear force during mixing can be reduced, and the fiberization of the fluororesin B3 can be suppressed, so that a fluororesin composition with high apparent density and excellent operability can be obtained. In the case where the fluororesin B3 is a homopolymer of TFE, the rotation speed is preferably set to 1500 rpm to 2500 rpm.

[0540] In addition, by granulating the mixed fluororesin composition, a fluororesin composition having a high apparent density and excellent handleability can be obtained. The mixing in this embodiment can be performed under the condition that the fluororesin B3 can be easily fiberized.

[0541] Examples of the granulation method include known methods, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, and a dry solvent granulation method.

[0542] The obtained fluororesin composition may be pulverized by a known method, for example, by using a pulverizer such as a jet mill, a hammer mill, a power mill, a stone mill type pulverizer, or a freeze pulverizer.

[0543] The first fluororesin composition of the present disclosure is also preferably a fluororesin composition (also referred to as fluororesin composition (4)) comprising: a fluororesin A which does not exhibit melt fluidity when heated to a temperature higher than its melting point, a fluororesin B4 which does not exhibit melt fluidity when heated to a temperature higher than its melting point, and a filler comprising a tetrafluoroethylene (TFE) unit and a modified monomer unit based on a modified monomer copolymerizable with TFE.

[0544] The fluororesin composition (4) has a specific monomer composition and is therefore excellent in handleability (for example, handleability during transportation and compression molding) despite containing the fluororesin A having a history of being heated to a temperature not lower than its melting point.

[0545] The fluororesin composition (4) is also excellent in tensile properties (eg, tensile breaking strength and tensile breaking strain).

[0546] The fluororesin composition (4) preferably has one or more melting points in a temperature range of less than 333°C, and one or more melting points in a temperature range of 333°C to 360°C.

[0547] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0548] The temperature range of 333°C to 360°C is more preferably 334°C or higher, further preferably 335°C, and more preferably 355°C or lower, further preferably 350°C or lower.

[0549] Having melting points in the above two temperature ranges means that the fluororesin composition includes fluororesin A which has a history of heating to a temperature not lower than the melting point and does not exhibit melt fluidity, and fluororesin B4 which has no history of heating to a temperature not lower than the melting point and does not exhibit melt fluidity.

[0550] As the fluororesin A and the filler in the fluororesin composition (4), those described above can be used.

[0551] Fluororesin B4 has no history of being heated to a temperature higher than its melting point.

[0552] The melting point of the fluororesin B4 is preferably 100° C. to 360° C. The melting point is more preferably 140° C. or higher, and even more preferably 160° C. or higher, and is more preferably 355° C. or lower, and even more preferably 350° C. or lower.

[0553] Fluororesin B4 preferably has one or more melting points in the temperature range of 333° C. to 360° C. The temperature range is more preferably 334° C. or higher, further preferably 335° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0554] The melting point being within the above range means that the material does not have a history of being heated to a temperature higher than the melting point.

[0555] In addition to the above-mentioned melting point, the metal may have a melting point in a temperature range lower than 333°C.

[0556] Fluororesin B4 does not exhibit melt fluidity. The melt fluidity is as described above.

[0557] As the fluororesin B4, PTFE is preferred. The PTFE may be high molecular weight PTFE.

[0558] The above-mentioned PTFE (high molecular weight PTFE) as the fluororesin B4 preferably has at least one endothermic peak in the range of 333°C to 347°C in the heat of fusion curve when the temperature is increased at a rate of 10°C / min using a differential scanning calorimeter [DSC], and the heat of fusion at 290°C to 350°C calculated from the above-mentioned heat of fusion curve is 62 mJ / mg or more.

[0559] The standard specific gravity (SSG) of the PTFE as the fluororesin B4 is preferably 2.130 to 2.280. The standard specific gravity is measured by a water displacement method according to ASTM D 792 using a sample molded according to ASTM D 4895 89.

[0560] The "high molecular weight" of PTFE that does not have a history of being heated to a temperature higher than the melting point means that the above-mentioned standard specific gravity is within the above-mentioned range.

[0561] The PTFE as the fluororesin B4 generally has non-melt secondary processability. The non-melt secondary processability is as described above.

[0562] From the perspective of obtaining a fluororesin composition having a higher apparent density and better operability, and from the perspective of obtaining a fluororesin composition having better tensile properties, the PTFE as the fluororesin B4 is preferably a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0563] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0564] The modifying monomer that can be used for the above-mentioned PTFE as the fluororesin B4 is the same as the modifying monomer exemplified for the PTFE (high molecular weight PTFE) as the fluororesin A.

[0565] Fluororesin B4 can be produced by suspension polymerization or emulsion polymerization.

[0566] The suspension polymerization can be carried out by a known method, for example, by dispersing a polymerization initiator in an aqueous medium without using an anionic fluorinated surfactant or using a limited amount thereof, and polymerizing the monomers required to form the fluororesin B4, thereby directly isolating the granular powder of the fluororesin B4.

[0567] As the fluororesin B4, a powder directly obtained by the above-mentioned suspension polymerization may be used, or a powder obtained by pulverizing and / or granulating the above-mentioned powder may be used.

[0568] The pulverization can be performed by a known method, and can be performed by a pulverization method using a pulverizer such as a hammer mill, a pin mill, a jet mill, or a cutter mill.

[0569] The granulation can be carried out by a known method, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, or a dry solvent granulation method.

[0570] The emulsion polymerization can be carried out by a known method. For example, in the presence of anionic fluorinated surfactant and polymerization initiator, emulsion polymerization of monomers required for forming fluororesin B4 is carried out in an aqueous medium to obtain an aqueous dispersion of particles (primary particles) containing fluororesin B4. In the emulsion polymerization, a chain transfer agent, a buffer, a pH adjusting agent, a stabilizing aid, a dispersion stabilizer, etc. can be used as needed.

[0571] The aqueous dispersion may contain a hydrocarbon surfactant. The hydrocarbon surfactant preferably does not contain a fluorine atom. The hydrocarbon surfactant may be used in the emulsion polymerization or may be added after the emulsion polymerization.

[0572] Examples of the hydrocarbon surfactant include the compounds exemplified for the fluororesin composition (1).

[0573] From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the content of the hydrocarbon surfactant is preferably 12% by mass or less, more preferably 8% by mass or less, further preferably 6% by mass or less, still more preferably 4% by mass or less, particularly preferably 2% by mass or less, and particularly preferably 1% by mass or less, relative to the solid content of the aqueous dispersion. The content of the hydrocarbon surfactant may also be 1 ppm by mass or more, 10 ppm by mass or more, 100 ppm by mass or more, or 500 ppm by mass or more.

[0574] The fluororesin B4 can be provided from the above-mentioned aqueous dispersion.

[0575] Alternatively, the aqueous dispersion is precipitated and dried to obtain a powder containing particles of the fluororesin B4. The fluororesin B4 can be provided from the powder.

[0576] Both precipitation and drying can be performed by known methods.

[0577] The fluororesin composition (4) may contain particles of the fluororesin B4. The particles of the fluororesin B4 may be secondary particles of the fluororesin B4.

[0578] The average secondary particle size of the particles of the fluororesin B4 is preferably 1 μm to 1000 μm. The average secondary particle size is more preferably 5 μm or more, further preferably 10 μm or more, and even more preferably 20 μm or more. In addition, it is more preferably 900 μm or less, further preferably 800 μm or less, and even more preferably 700 μm or less.

[0579] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0580] The particle D90 of the fluororesin B4 is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, and is preferably 2000 μm or less, more preferably 1500 μm or less, further preferably 1200 μm or less.

[0581] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0582] The fluororesin composition (4) comprises TFE units and modified monomer units based on a modifying monomer copolymerizable with TFE. The fluororesin composition (4) may comprise only TFE units and modified monomer units as polymerized units.

[0583] From the perspective of further improving operability and tensile properties, the content of the modified monomer unit is preferably 1.0% by mass or less relative to all polymerized units constituting the fluororesin composition. As the lower limit of the content of the modified monomer unit, it is preferably 0.00001% by mass, more preferably 0.0001% by mass, further preferably 0.001% by mass, further more preferably 0.005% by mass, and particularly preferably 0.010% by mass. As the upper limit of the content of the modified monomer unit, it is preferably 0.90% by mass, more preferably 0.50% by mass, further preferably 0.40% by mass, further more preferably 0.30% by mass, particularly preferably 0.20% by mass, and particularly preferably 0.10% by mass.

[0584] The fluororesin composition (4) preferably contains 99.0 mass % or more of TFE units based on all polymerized units.

[0585] The content of polymerized units constituting the fluororesin composition (4) can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the types of monomers. Alternatively, when the raw material composition is known, the content can be determined by calculation from the raw material composition.

[0586] From the viewpoint of better handling properties, the apparent density of the fluororesin composition (4) is preferably 0.40 g / ml or more, more preferably 0.42 g / ml or more, further preferably 0.45 g / ml or more, particularly preferably 0.47 g / ml or more. The upper limit is not particularly limited and may be 1.00 g / ml.

[0587] The above apparent density is measured in accordance with JIS K6891.

[0588] From the viewpoint of further improving the tensile properties, the content of the fluororesin A in the fluororesin composition (4) is preferably 10 to 90% by mass relative to the fluororesin composition. The content is more preferably 20% by mass or more, further preferably 30% by mass or more, still more preferably 40% by mass or more, particularly preferably 50% by mass or more, and more preferably 85% by mass or less, further preferably 80% by mass or less, still more preferably less than 80% by mass, particularly preferably 75% by mass or less, and particularly preferably 70% by mass or less.

[0589] From the viewpoint of further improving tensile properties, the content of the fluororesin B4 in the fluororesin composition (4) is preferably 10 to 90% by mass relative to the above fluororesin composition. The above content is more preferably 15% by mass or more, further preferably 20% by mass or more, still more preferably more than 20% by mass, particularly preferably 25% by mass or more, particularly preferably 30% by mass or more, and more preferably 80% by mass or less, further preferably 70% by mass or less, still more preferably 60% by mass or less, and particularly preferably 50% by mass or less.

[0590] The total amount of the fluororesins A and B4 in the fluororesin composition (4) is preferably 80% by mass or more, more preferably 85% by mass or more, further preferably 90% by mass or more, still more preferably 95% by mass or more, particularly preferably 98% by mass or more, based on the above-mentioned fluororesin composition.

[0591] The form of the fluororesin composition (4) is not particularly limited, but is preferably a powder.

[0592] In the fluororesin composition (4), the maximum linear length of the particles of the fluororesin A is preferably smaller than the maximum linear length of the particles of the fluororesin B4. If the maximum linear lengths of the particles of the fluororesins A and B4 are in the above relationship, the apparent density of the fluororesin composition can be increased, and the workability can be further improved. In addition, since there is no need to perform a deformation treatment for increasing the maximum linear length of the particles of the fluororesin A, the production cost of the fluororesin composition can be reduced.

[0593] The above embodiment is particularly preferred when the fluororesin B4 is obtained by suspension polymerization.

[0594] The angle of repose of the fluororesin composition (4) is preferably less than 40°, more preferably less than 38°, and still more preferably less than 35°, from the viewpoint of excellent fluidity and further excellent handleability.

[0595] The above repose angle is the value measured as follows: the total height is 115mm, the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake portion is set so that the height from the bottom of the funnel to the sample falling surface is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the dropped sample is measured with a protractor to obtain the value.

[0596] The average secondary particle size of the fluororesin composition (4) is preferably 5 to 700 μm, more preferably 10 μm or more, further preferably 20 μm or more, and more preferably 600 μm or less, further preferably 500 μm or less, particularly preferably 400 μm or less.

[0597] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0598] The D90 of the fluororesin composition (4) is preferably 10 μm or more, more preferably 30 μm or more, further preferably 50 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, further preferably 400 μm or less.

[0599] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0600] From the viewpoint of further improving the tensile properties, the content (total amount) of the low molecular weight fluorinated compounds in the fluororesin composition (4) is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the above-mentioned fluororesin composition.

[0601] The content of the low molecular weight fluorine-containing compound is measured by Soxhlet extraction of a sample with methanol and then by liquid chromatography-mass spectrometry (LC / MS / MS).

[0602] Examples of the low molecular weight fluorine-containing compound include the compounds exemplified for the fluorine resin composition (1).

[0603] The fluororesin composition (4) can be produced, for example, by mixing powder of the fluororesin A, pellets of the fluororesin B4, and a filler.

[0604] When the particles of the fluororesin B4 are obtained by suspension polymerization, they are preferably mixed in the form of powder with the powder of the fluororesin A. The mixing method is not particularly limited, and a known method can be used. The mixing can also be carried out in a pulverizer.

[0605] From the viewpoint of easily obtaining a fluororesin composition having a higher apparent density and better handleability, the maximum linear length of the particles of the fluororesin A is preferably smaller than the maximum linear length of the particles of the fluororesin B4.

[0606] In addition, when the particles of the above-mentioned fluororesin B4 are obtained by emulsion polymerization, they can be mixed with the powder of fluororesin A in the form of a powder, or can be mixed with the powder of fluororesin A in the form of an aqueous dispersion. From the perspective of obtaining a fluororesin composition with better handleability and tensile properties, it is preferred to mix them with the powder of fluororesin A in the form of a powder.

[0607] The mixing can be performed using, for example, a crusher equipped with rotary blades. Examples of the crusher equipped with rotary blades include Wonder crusher WC-3 manufactured by Osaka Chemical Co., Ltd.

[0608] When mixing using the above pulverizer, the blade rotation speed is preferably set to 1500 rpm to 10000 rpm. By setting the rotation speed within the above range, the shear force during mixing can be reduced, and the fiberization of the fluororesin B4 can be suppressed, so that a fluororesin composition with high apparent density and excellent handleability can be obtained.

[0609] In addition, by granulating the mixed fluororesin composition, a fluororesin composition having a high apparent density and excellent handleability can be obtained. The mixing in this embodiment can be performed under the condition that the fluororesin B4 can be easily fiberized.

[0610] Examples of the granulation method include known methods, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, and a dry solvent granulation method.

[0611] The obtained fluororesin composition may be pulverized by a known method, for example, by using a pulverizer such as a jet mill, a hammer mill, a power mill, a stone mill type pulverizer, or a freeze pulverizer.

[0612] The first fluororesin composition of the present disclosure is also preferably a fluororesin composition (also referred to as fluororesin composition (5)) comprising a fluororesin A which does not exhibit melt fluidity and has a history of being heated to a temperature not less than its melting point, a fluororesin B5 which does not have a history of being heated to a temperature not less than its melting point, and a filler, the fluororesin composition comprising microparticles having a primary particle size of 1 μm or less.

[0613] The fluororesin composition (5) contains a fluororesin that has no history of being heated to a temperature higher than its melting point and contains fine particles having a specific particle size. Therefore, despite containing a fluororesin that has a history of being heated to a temperature higher than its melting point, the composition has little coloration and excellent tensile properties.

[0614] The fluororesin composition (5) preferably has one or more melting points in a temperature range lower than 333°C, and one or more melting points in a temperature range of 333°C or higher.

[0615] The temperature range below 333°C is more preferably below 332°C, further preferably below 331°C, and is preferably 100°C or higher, more preferably 140°C or higher, further preferably 160°C or higher.

[0616] The temperature range of 333° C. or higher is more preferably 334° C. or higher, and further preferably 335° C., and is preferably 360° C. or lower, more preferably 355° C. or lower, and further preferably 350° C. or lower.

[0617] Having melting points in the above two temperature ranges means that the fluororesin composition contains fluororesin A (preferably PTFE) which does not exhibit melt fluidity and has a history of being heated to a temperature higher than the melting point, and fluororesin B5 (preferably a fluororesin which does not exhibit melt fluidity, more preferably PTFE) which does not have a history of being heated to a temperature higher than the melting point.

[0618] As the fluororesin A and the filler in the fluororesin composition (5), those described above can be used.

[0619] Fluororesin B5 has no history of being heated to a temperature higher than its melting point.

[0620] The melting point of the fluororesin B5 is preferably 100° C. to 360° C. The melting point is more preferably 140° C. or higher, and even more preferably 160° C. or higher, and is more preferably 355° C. or lower, and even more preferably 350° C. or lower.

[0621] Fluororesin B5 preferably has one or more melting points in the temperature range of 333° C. to 360° C. The temperature range is more preferably 334° C. or higher, further preferably 335° C. or higher, and more preferably 355° C. or lower, further preferably 350° C. or lower.

[0622] The melting point being within the above range means that the fluororesin B5 (preferably a fluororesin that does not exhibit melt fluidity, more preferably PTFE) does not have a history of being heated to a temperature higher than the melting point.

[0623] In addition to the above-mentioned melting point, the metal may have a melting point in a temperature range lower than 333°C.

[0624] Examples of the fluororesin B5 include PTFE, PFA, FEP, ETFE, EFEP, PCTFE, CTFE / TFE copolymer, CTFE / TFE / PAVE copolymer, Et / CTFE copolymer, PVF, PVdF, VdF / TFE copolymer, VdF / HFP copolymer, VdF / TFE / HFP copolymer, VdF / HFP / (meth)acrylic acid copolymer, VdF / CTFE copolymer, VdF / pentafluoropropylene copolymer, VdF / PAVE / TFE copolymer, and low molecular weight PTFE.

[0625] The PTFE as the fluororesin B5 does not exhibit melt fluidity. The PTFE may be a high molecular weight PTFE.

[0626] The above-mentioned PTFE (high molecular weight PTFE) as the fluororesin B5 preferably has at least one endothermic peak in the range of 333°C to 347°C in the heat of fusion curve when the temperature is increased at a rate of 10°C / min using a differential scanning calorimeter [DSC], and the heat of fusion at 290°C to 350°C calculated from the above-mentioned heat of fusion curve is 62 mJ / mg or more.

[0627] The standard specific gravity (SSG) of the PTFE as the fluororesin B5 is preferably 2.130 to 2.280. The standard specific gravity is measured by a water displacement method according to ASTM D 792 using a sample molded according to ASTM D 4895 89.

[0628] The "high molecular weight" of PTFE that does not have a history of being heated to a temperature higher than the melting point means that the above-mentioned standard specific gravity is within the above-mentioned range.

[0629] The PTFE as the fluororesin B5 generally has non-melt secondary processability. The non-melt secondary processability is as described above.

[0630] The PTFE as fluororesin B5 may be a homopolymer of TFE or a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0631] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0632] The modifying monomer that can be used for the above-mentioned PTFE as the fluororesin B5 is the same as the modifying monomer exemplified for the PTFE (high molecular weight PTFE) as the fluororesin A.

[0633] The low molecular weight PTFE as fluororesin B5 exhibits melt fluidity. The melt viscosity (complex viscosity) of the low molecular weight PTFE at 380°C is 1.0×10 1 ~1.0×10 7 The above melt viscosity is preferably 1.0×10 2 More preferably, 1.5×10 3 Pa·s or more, more preferably 7.0×10 3 Pa·s or more, preferably 7.0×10 5 Less than, more preferably 3.0×10 5 Pa·s or less, more preferably 1.0×10 5 Pa·s or less.

[0634] In this specification, "low molecular weight PTFE" means PTFE having the above-mentioned melt viscosity within the above-mentioned range.

[0635] The melt viscosity is measured according to ASTM D 1238 using a flow tester (manufactured by Shimadzu Corporation) and The value was measured by using a die of 100 mm / s and holding a 2 g sample heated in advance at 380°C for 5 minutes at the above temperature under a load of 0.7 MPa.

[0636] The melting point of the low molecular weight PTFE as the fluororesin B5 is preferably 320° C. to 340° C. The melting point is more preferably 324° C. or higher, more preferably 336° C. or lower, further preferably 333° C. or lower, still more preferably 332° C. or lower, particularly preferably 331° C. or lower, and particularly preferably 330° C. or lower.

[0637] The low molecular weight PTFE as fluororesin B5 may be a homopolymer of TFE or a modified PTFE containing 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (modified monomer units). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0638] The content of the modified monomeric unit of the modified PTFE is preferably in the range of 0.00001 mass % to 1.0 mass % relative to all polymerized units. As the lower limit of the content of the modified monomeric unit, it is more preferably 0.0001 mass %, more preferably 0.001 mass %, and then more preferably 0.005 mass %, and especially preferably 0.010 mass %. As the upper limit of the content of the modified monomeric unit, it is preferably 0.90 mass %, more preferably 0.50 mass %, more preferably 0.40 mass %, and then more preferably 0.30 mass %, especially preferably 0.20 mass %, and particularly preferably 0.10 mass %.

[0639] Examples of the modifying monomer that can be used for the low-molecular-weight PTFE of the fluororesin B5 include the monomers described above for PTFE (high-molecular-weight PTFE) which is a fluororesin that does not exhibit melt fluidity.

[0640] The fluororesin B5 may be a fluororesin that does not exhibit melt fluidity or a fluororesin that exhibits melt fluidity.

[0641] As the fluororesin having no melt fluidity, the PTFE (high molecular weight PTFE) is preferable.

[0642] Examples of the fluororesin having melt fluidity include the same ones as those mentioned above for the fluororesin B1.

[0643] The fluororesin B5 is preferably a fluororesin that does not exhibit melt fluidity, and more preferably PTFE (high molecular weight PTFE).

[0644] The fluororesin B5 may be a fluororesin exhibiting melt fluidity, and is preferably at least one selected from the group consisting of PFA, FEP, ETFE, EFEP, PCTFE, CTFE / TFE copolymer, CTFE / TFE / PAVE copolymer, Et / CTFE copolymer, PVF, PVdF, VdF / TFE copolymer, VdF / HFP copolymer, VdF / TFE / HFP copolymer, VdF / HFP / (meth)acrylic acid copolymer, VdF / CTFE copolymer, VdF / pentafluoropropylene copolymer, VdF / PAVE / TFE copolymer and low molecular weight PTFE, more preferably at least one selected from the group consisting of PFA, FEP and low molecular weight PTFE, and further preferably at least one selected from the group consisting of PFA and FEP.

[0645] The fluororesin composition (5) may contain particles of the fluororesin B5.

[0646] The particles of the fluororesin B5 are preferably primary particles of the fluororesin B5. The primary particles preferably do not constitute secondary particles.

[0647] The average primary particle size of the particles of the fluororesin B5 is preferably 1 μm or less. The average primary particle size is more preferably 500 nm or less, further preferably 450 nm or less, even more preferably 400 nm or less, particularly preferably 350 nm or less, and particularly preferably 300 nm or less. In addition, the average primary particle size is preferably 10 nm or more, more preferably 25 nm or more, further preferably 50 nm or more, even more preferably 100 nm or more, and particularly preferably 150 nm or more.

[0648] The above average primary particle size is the average value of the diameters of 100 or more particles randomly selected from an aqueous dispersion adjusted to a solid content concentration of 0.5 mass % dropped onto an aluminum foil, dried at 150° C. for 1 hour to remove water, and observed using a scanning electron microscope (SEM).

[0649] The average primary particle size may be an average value of diameters of 100 or more primary particles randomly selected by observing the fluororesin composition with a scanning electron microscope (SEM).

[0650] In one embodiment of the fluororesin composition (5), the average aspect ratio of the particles of the fluororesin B5 is preferably 2.0 or less, more preferably 1.7 or less, further preferably 1.6 or less, still more preferably 1.5 or less, particularly preferably 1.4 or less, and particularly preferably 1.3 or less. The average aspect ratio may be 1.0 or more.

[0651] The average aspect ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), performing image processing on 100 or more primary particles randomly selected, and averaging the ratio of the major axis to the minor axis.

[0652] In another embodiment of the fluororesin composition (5), the ratio of the particles of the fluororesin B5 having an aspect ratio of 2.5 or more is preferably 0.5% or more, more preferably 1.0% or more, further preferably 1.5% or more, and particularly preferably 2.0% or more relative to the total number of particles of the fluororesin B5. The ratio is preferably 20% or less, more preferably 15% or less, and further preferably 10% or less.

[0653] The above ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), randomly extracting 100 or more primary particles, performing image processing, calculating the aspect ratio of each particle, and determining the ratio to the total number of the extracted particles.

[0654] From the viewpoint of further reducing coloration and further improving tensile properties, the mass ratio of the fluororesin A to the fluororesin B5 (A / B5) ​​is preferably 1 / 99 to 90 / 10.

[0655] The mass ratio A / B5 is more preferably 3 / 97 or more, further preferably 5 / 95 or more, further more preferably 10 / 90 or more, and particularly preferably 15 / 85 or more. In addition, the mass ratio A / B5 is more preferably 85 / 15 or less, further preferably 80 / 20 or less, further more preferably 75 / 25 or less, and particularly preferably 70 / 30 or less.

[0656] The total amount of the fluororesins A and B5 in the fluororesin composition (5) is preferably 80% by mass or more, more preferably 85% by mass or more, further preferably 90% by mass or more, still more preferably 95% by mass or more, particularly preferably 98% by mass or more, based on the above-mentioned fluororesin composition.

[0657] The fluororesin composition (5) contains fine particles having a primary particle size of 1 μm or less.

[0658] The fine particles are particles of the fluororesin constituting the fluororesin composition, and may be particles of at least one selected from the group consisting of fluororesins A and B5, and are preferably particles of fluororesin B5.

[0659] The fine particles may be primary particles, and are preferably primary particles of fluororesin B5.

[0660] The primary particle size of the microparticles is preferably 500 nm or less, more preferably 450 nm or less, further preferably 400 nm or less, further more preferably 350 nm or less, and particularly preferably 300 nm or less. In addition, the primary particle size is preferably 10 nm or more, more preferably 25 nm or more, further preferably 50 nm or more, further more preferably 100 nm or more, and particularly preferably 150 nm or more.

[0661] The primary particle size is an average value of the diameters of 100 or more particles randomly selected from the fluororesin composition by observing the fluororesin composition using a scanning electron microscope (SEM).

[0662] In one embodiment of the fluororesin composition (5), the average aspect ratio of the microparticles is preferably 2.0 or less, more preferably 1.7 or less, further preferably 1.6 or less, still more preferably 1.5 or less, particularly preferably 1.4 or less, and particularly preferably 1.3 or less. The aspect ratio may be 1.0 or more.

[0663] The average aspect ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), performing image processing on 100 or more of the fine particles randomly selected, and averaging the ratio of the major axis to the minor axis.

[0664] In another embodiment of the fluororesin composition (5), the proportion of the above-mentioned fine particles having an aspect ratio of 2.5 or more is preferably 0.5% or more, more preferably 1.0% or more, further preferably 1.5% or more, and particularly preferably 2.0% or more relative to the total number of the above-mentioned fine particles. In addition, the above-mentioned proportion is preferably 20% or less, more preferably 15% or less, and further preferably 10% or less.

[0665] The ratio is determined by observing the fluororesin composition with a scanning electron microscope (SEM), randomly extracting 100 or more of the fine particles, performing image processing, calculating the aspect ratio of each particle, and determining the ratio to the total number of the extracted fine particles.

[0666] The fluororesin composition (5) preferably contains coarse powder having a particle size of 5 μm or more.

[0667] The coarse powder is particles of the fluororesin constituting the fluororesin composition, and may be particles of at least one selected from the group consisting of fluororesins A and B5, and preferably particles of fluororesin A.

[0668] The coarse powder may be secondary particles or secondary particles of the fluororesin A.

[0669] The particle size of the coarse powder is more preferably 10 μm or more, and is preferably 600 μm or less, more preferably 500 μm or less, and further preferably 400 μm or less.

[0670] The particle size of the coarse powder is the particle size detected in the obtained distribution (volume basis) by dry method and vacuum pressure of 20 mH2O using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter.

[0671] In the fluororesin composition (5), the fine particles are preferably attached to the surface of the coarse powder, and the exposed surface of the coarse powder is 60% or less. This further reduces coloration and further improves tensile properties such as tensile strength at break and tensile strain at break.

[0672] The exposed surface is more preferably 55% or less, and further preferably 50% or less.

[0673] The ratio of the exposed surface is calculated by dividing the area of ​​the surface of the coarse powder not covered with the fine particles by the area of ​​the surface of the coarse powder from a 5000-times image of the fluororesin composition observed by a scanning microscope (SEM).

[0674] The average secondary particle size of the fluororesin composition (5) is preferably 5 to 500 μm, more preferably 10 μm or more, further preferably 25 μm or more, and more preferably 450 μm or less, further preferably 400 μm or less.

[0675] The average secondary particle size is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 50% of the cumulative (volume basis) particle size distribution.

[0676] The D90 of the fluororesin composition (5) is preferably 50 μm or more, more preferably 70 μm or more, further preferably 100 μm or more, and is preferably 800 μm or less, more preferably 700 μm or less, further preferably 650 μm or less.

[0677] The D90 is measured using a laser diffraction particle size distribution measuring apparatus (LS13320) manufactured by Bechman Coulter in a dry manner at a vacuum pressure of 20 mH2O, and is equal to the particle size corresponding to 90% of the cumulative (volume basis) particle size distribution.

[0678] From the viewpoint of further reducing coloration and further improving tensile properties, the content of the nonionic surfactant in the fluororesin composition (5) is preferably 1.0% by mass or less, more preferably 0.9% by mass or less, further preferably 0.8% by mass or less, still more preferably 0.7% by mass or less, and particularly preferably 0.6% by mass or less, relative to the above-mentioned fluororesin composition. The lower limit is not particularly limited and may be less than the detection limit or 1000 ppm by mass.

[0679] The content of the nonionic surfactant was measured by subjecting 1 g of the freeze-pulverized fluororesin composition to ultrasonic extraction in 10 mL of methanol at 60°C, in accordance with "Appendix 28 of the method established by the Minister of Health, Labor and Welfare based on the provisions of the Ministry of Labor Notification No. 261 of 2001 on water quality standards".

[0680] The fluororesin composition (5) also preferably contains no nonionic surfactant, and also preferably contains no hydrocarbon surfactant.

[0681] Examples of the nonionic surfactant and hydrocarbon surfactant include the compounds exemplified for the fluororesin composition (1).

[0682] Regarding the fluororesin composition (5), from the viewpoint of further reducing coloration and further improving tensile properties, 1 g of the freeze-pulverized fluororesin composition is subjected to ultrasonic extraction in 10 mL of methanol at 60° C., and the absorbance is measured in accordance with the method determined by the Minister of Health, Labor and Welfare based on the provisions of the Ministry of Labor Notification No. 261 of 2001 on the water quality standard, Appendix Table 28, and the content of the component obtained thereby is preferably 1.0% by mass or less, more preferably 0.9% by mass or less, further preferably 0.8% by mass or less, still more preferably 0.7% by mass or less, and particularly preferably 0.6% by mass or less, based on the fluororesin composition. The lower limit is not particularly limited and may be less than the detection limit or 1000 ppm by mass.

[0683] The fact that the amount of the above components is within the above range means that the above fluororesin composition does not contain a nonionic surfactant, or even if it contains a nonionic surfactant, the content thereof is extremely small.

[0684] Regarding the fluororesin composition (5), from the viewpoint of further reducing coloration and further improving tensile properties, the content (total amount) of the low molecular weight fluorinated compound is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the above-mentioned fluororesin composition.

[0685] The content of the low molecular weight fluorinated compound is measured by liquid chromatography-mass spectrometry (LC / MS / MS) using an extract obtained by Soxhlet extraction of a sample with methanol.

[0686] Examples of the low molecular weight fluorine-containing compound include the compounds exemplified for the fluorine resin composition (1).

[0687] The form of the fluororesin composition (5) is not particularly limited, but is preferably a powder.

[0688] The fluororesin composition (5) can be produced, for example, by the following method for producing a fluororesin composition (hereinafter also referred to as the first production method), which comprises: a step of mixing a powder of a fluororesin A and an aqueous dispersion containing particles of a fluororesin B5 and having a solid content concentration of 70% by mass or less to obtain a mixture (hereinafter also referred to as a mixing step); a step of drying the mixture (hereinafter also referred to as a drying step); and a step of mixing a filler.

[0689] In the first production method, since an aqueous dispersion having a solid content concentration of 70% by mass or less is used, the powder of the fluororesin A and the particles of the fluororesin B5 can be uniformly mixed. As a result, a fluororesin composition having little coloration and excellent tensile properties (e.g., tensile breaking strength and tensile breaking strain) can be produced despite containing a fluororesin having a history of being heated to a temperature above the melting point.

[0690] The content of the particles of the fluororesin B5 is preferably 50% by mass or more, more preferably 60% by mass or more, further preferably 80% by mass or more, even more preferably 90% by mass or more, particularly preferably 95% by mass or more, and most preferably 98% by mass or more, relative to the solid content of the aqueous dispersion.

[0691] The aqueous dispersion in the first production method usually contains an aqueous medium. The aqueous dispersion may be a dispersion in which particles of the fluororesin B5 are dispersed in an aqueous medium.

[0692] The aqueous medium refers to a liquid containing water. The aqueous medium is not particularly limited as long as it contains water, and may contain water and a non-fluorinated organic solvent such as alcohol, ether, ketone, and / or a fluorinated organic solvent having a boiling point of 40° C. or less. In the aqueous medium, water is preferably 90% by mass or more, more preferably 95% by mass or more.

[0693] The solid content concentration of the aqueous dispersion is 70% by mass or less. From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the solid content concentration is preferably 50% by mass or less, preferably 45% by mass or less, more preferably 40% by mass or less, and further preferably 35% by mass or less. In addition, the solid content concentration is preferably 1% by mass or more, more preferably 5% by mass or more, and further preferably 10% by mass or more.

[0694] Regarding the above-mentioned solid content concentration, about 1 g (Xg) of the aqueous dispersion is taken into an aluminum cup with a diameter of 5 cm, and heated at 110°C for 30 minutes to obtain a heating residue (Yg). The obtained heating residue (Yg) is further heated at 300°C for 30 minutes to obtain a heating residue (Zg). The solid content concentration is calculated based on the heating residue (Yg) and the heating residue (Zg) by the formula: P = [Z / X] × 100 (mass %).

[0695] The aqueous dispersion may contain a hydrocarbon-based surfactant. The hydrocarbon-based surfactant preferably does not contain a fluorine atom.

[0696] Examples of the hydrocarbon-based surfactant include those mentioned above.

[0697] From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the content of the hydrocarbon surfactant is preferably 12% by mass or less, more preferably 8% by mass or less, further preferably 6% by mass or less, still more preferably 4% by mass or less, particularly preferably 2% by mass or less, and particularly preferably 1% by mass or less, relative to the solid content of the aqueous dispersion. The content of the hydrocarbon surfactant may also be 1 ppm by mass or more, 10 ppm by mass or more, 100 ppm by mass or more, or 500 ppm by mass or more.

[0698] From the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties, the content of the nonionic surfactant is preferably 12% by mass or less, more preferably 8% by mass or less, further preferably 6% by mass or less, still more preferably 4% by mass or less, particularly preferably 2% by mass or less, and particularly preferably 1% by mass or less, relative to the solid content of the aqueous dispersion. The content of the nonionic surfactant may also be 1 ppm by mass or more, 10 ppm by mass or more, 100 ppm by mass or more, or 500 ppm by mass or more.

[0699] The aqueous dispersion preferably does not contain a nonionic surfactant, and preferably does not contain a hydrocarbon-based surfactant.

[0700] From the viewpoint of being able to produce a fluororesin composition having less coloration and more excellent tensile properties, the content (total amount) of the low molecular weight fluorinated compound in the aqueous dispersion is preferably 1 mass ppm or less, more preferably 500 mass ppb or less, further preferably 100 mass ppb or less, still more preferably 50 mass ppb or less, particularly preferably 25 mass ppb or less, particularly preferably 10 mass ppb or less, particularly more preferably 5 mass ppb or less, particularly particularly preferably 1 mass ppb or less, and most preferably less than 1 mass ppb, relative to the aqueous dispersion.

[0701] The content of the low molecular weight fluorine-containing compound is measured by Soxhlet extraction of a sample with methanol and then by liquid chromatography-mass spectrometry (LC / MS / MS).

[0702] Examples of the low molecular weight fluorine-containing compound include those mentioned above.

[0703] The aqueous dispersion can be produced, for example, by emulsion polymerization of monomers required to form the fluororesin B5 in an aqueous medium in the presence of an anionic surfactant and a polymerization initiator. In the emulsion polymerization, a chain transfer agent, a buffer, a pH adjuster, a stabilizing aid, a dispersion stabilizer, etc. can be used as needed.

[0704] Those skilled in the art can control the composition and physical properties of the fluororesin B5, the physical properties of the particles, etc. by adjusting the conditions of the emulsion polymerization.

[0705] A hydrocarbon-based surfactant may be added to the aqueous dispersion obtained by the emulsion polymerization. Examples of the hydrocarbon-based surfactant include the above-mentioned hydrocarbon-based surfactants.

[0706] The aqueous dispersion obtained by the above-mentioned emulsion polymerization or the aqueous dispersion obtained by adding the above-mentioned hydrocarbon-based surfactant can be contacted with an anion exchange resin or a mixed bed comprising an anion exchange resin and a cation exchange resin, and can also be concentrated or treated by both. By carrying out the above-mentioned treatment, low molecular weight fluorinated compounds can be removed.

[0707] The anion exchange resin and the mixed bed are not particularly limited, and known materials can be used. In addition, a known method can be used for the contact with the anion exchange resin or the mixed bed.

[0708] As the above-mentioned concentration method, a known method can be adopted, and examples thereof include phase separation, centrifugal sedimentation, cloud point concentration, electroconcentration, electrophoresis, filtration treatment using ultrafiltration, filtration treatment using a reverse osmosis membrane (RO membrane), nanofiltration treatment, and the like.

[0709] The aqueous dispersion obtained by the emulsion polymerization (before the addition of the hydrocarbon-based surfactant) may be used in the mixing step, the aqueous dispersion obtained by adding the hydrocarbon-based surfactant may be used in the mixing step, or the aqueous dispersion obtained by contacting with the ion exchange resin or concentrating the aqueous dispersion may be used in the mixing step. When the solid content concentration exceeds 50% by mass, it may be used after dilution.

[0710] From the viewpoint of being able to produce a fluororesin composition with less coloration and better tensile properties, the viscosity of the aqueous dispersion at 25° C. is preferably 100 mPa·s or less, more preferably 50 mPa·s or less, further preferably 40 mPa·s or less, and particularly preferably 30 mPa·s or less. The viscosity may be 0.1 mPa·s or more.

[0711] The viscosity is measured at 25° C. using a B-type rotational viscometer (manufactured by Toki Sangyo Co., Ltd., rotor No. 2) at a rotation speed of 60 rpm and a measurement time of 120 seconds.

[0712] The mixing of the powder of the fluororesin A and the aqueous dispersion is preferably carried out in such a manner that the mass ratio (A / B5) ​​of the powder of the fluororesin A to the particles of the fluororesin B5 is 1 / 99 to 90 / 10, from the perspective of being able to produce a fluororesin composition with less coloration and better tensile properties.

[0713] The mass ratio A / B5 is more preferably 3 / 97 or more, further preferably 5 / 95 or more, further more preferably 10 / 90 or more, and particularly preferably 15 / 85 or more. In addition, the mass ratio A / B5 is more preferably 85 / 15 or less, further preferably 80 / 20 or less, further more preferably 75 / 25 or less, and particularly preferably 70 / 30 or less.

[0714] When the solid content concentration or viscosity of the mixture obtained in the above mixing step is too high, the mixture may be diluted to adjust the solid content concentration or viscosity to the above range.

[0715] The first manufacturing method can include a precipitation step in which the mixture obtained in the above-mentioned mixing step is precipitated. As the method for precipitation, a method for condensing emulsified particles by freezing or mechanical shearing force can be cited. It is also possible to stir as a precipitating agent while adding inorganic acids such as inorganic salts, hydrochloric acid, sulfuric acid, nitric acid, etc. such as water-soluble organic compounds, potassium nitrate, ammonium carbonate, etc., hydrochloric acid, sulfuric acid, nitric acid, etc. The above-mentioned precipitation can also be carried out continuously using a pipeline mixer, etc.

[0716] In the drying step, the mixture obtained in the mixing step is dried to obtain a fluororesin composition. When the first production method includes the precipitation step, the wet powder obtained by precipitation is dried.

[0717] The drying method is not particularly limited, and a known method can be used, and for example, the drying can be carried out by vacuum, high frequency, hot air or the like.

[0718] The drying temperature is preferably 50° C. or higher, more preferably 70° C. or higher, further preferably 100° C. or higher, particularly preferably 150° C. or higher, and is preferably 300° C. or lower, more preferably 250° C. or lower.

[0719] The first production method may include a pulverizing step of pulverizing the fluororesin composition obtained in the drying step. The pulverizing may be performed by a known method, for example, using a pulverizer such as a jet mill, a hammer mill, a power mill, a stone mill, or a freezer pulverizer.

[0720] In the process of mixing the above-mentioned filling material, the above-mentioned filling material can be mixed with the powder of the above-mentioned fluororesin A1, or mixed with the above-mentioned aqueous dispersion, or mixed with the mixture obtained in the mixing process of the powder of the above-mentioned fluororesin A1 and the above-mentioned aqueous dispersion, or mixed with the wet powder obtained in the above-mentioned precipitation process, or mixed with the dry powder obtained in the above-mentioned drying process.

[0721] The fluororesin composition (5) can also be produced by the following method for producing a fluororesin composition (hereinafter also referred to as the second production method), which comprises: a step of mixing a powder of a fluororesin A and an aqueous dispersion containing particles of a fluororesin B5 and not containing a hydrocarbon-based surfactant to obtain a mixture (mixing step); a step of drying the above-mentioned mixture (drying step); and a step of mixing a filler material.

[0722] In the second production method, since an aqueous dispersion containing no hydrocarbon-based surfactant is used, coloration and influence on physical properties caused by residual hydrocarbon-based surfactant can be reduced. As a result, a fluororesin composition with little coloration and excellent tensile properties can be produced despite containing a fluororesin having a history of being heated to a temperature above the melting point.

[0723] The powder of fluororesin A and the particles of fluororesin B5 are as described above in the first production method.

[0724] The aqueous dispersion in the second production method does not contain a hydrocarbon-based surfactant. Examples of the hydrocarbon-based surfactant include the hydrocarbon-based surfactants exemplified in the first production method.

[0725] Regarding the components and physical properties of the aqueous dispersion other than those described above, the same components and physical properties as those in the first production method may be employed.

[0726] A preferred embodiment of the mixing step in the second production method is the same as that described above for the first production method.

[0727] As the drying step in the second production method, the same step as the drying step in the first production method can be adopted.

[0728] In addition, the optional steps and preferred aspects that can be adopted in the second manufacturing method are the same as those in the first manufacturing method.

[0729] The first and second production methods preferably further include a step of granulating the obtained fluororesin composition. In this way, a fluororesin composition having a high apparent density and excellent handleability can be obtained.

[0730] Examples of the granulation method include known methods, such as an underwater granulation method, a warm water granulation method, an emulsion dispersion granulation method, an emulsion warm water granulation method, a solvent-free granulation method, and a dry solvent granulation method.

[0731] Among them, the first fluororesin composition of the present disclosure is preferably the fluororesin composition (1), the fluororesin composition (2a), the fluororesin composition (2b), the fluororesin composition (3a), the fluororesin composition (3b) and the fluororesin composition (4).

[0732] The tensile strength at break of the first fluororesin composition of the present disclosure is preferably 8 MPa or more, more preferably 9 MPa or more, further preferably 10 MPa or more, particularly preferably 13 MPa or more. The upper limit is not particularly limited, and may be, for example, 20 MPa.

[0733] Regarding the above tensile strength at break, 35 g of the above-mentioned fluororesin composition is put into a mold, and compression molding is performed under the conditions of a pressure of 30 MPa and 1 minute. The temperature is raised from room temperature to 300°C in 3 hours, and then from 300°C to 370°C in 4 hours. After maintaining at 370°C for 12 hours, the temperature is lowered to 300°C in 5 hours, and then lowered to room temperature in 1 hour. The dumbbells made by punching the molded body fired by the above process are used for measurement in accordance with ASTM D1708. It should be noted that the above-mentioned tensile strength at break can also be measured using a plunger extrusion molded product by the following method. Using a barrel diameter set to 270°C in the preheating zone and 370°C in the molding zone A vertical plunger extruder with a total length of 1300 mm was used to extrude at a filling length of 70 mm, a pressure of 10 MPa, a pressing time of 20 seconds, and one cycle of 40 seconds to obtain a molded body, which was cut into a thickness of 2.0 mm, a width of 20 mm, and a length of 150 mm to prepare a flat plate, and a dumbbell was prepared by punching the molded product, and the measurement was performed in accordance with ASTM D 1708.

[0734] The tensile strain at break of the first fluororesin composition disclosed herein may be 75% or more, preferably 150% or more, more preferably 200% or more, further preferably 250% or more, still more preferably 300% or more, particularly preferably 360% or more, and particularly preferably 400% or more. The upper limit is not particularly limited, and may be, for example, 600%.

[0735] Regarding the above tensile fracture strain, 35 g of the above-mentioned fluororesin composition is put into a mold, and compression molding is performed under the conditions of a pressure of 30 MPa and 1 minute. The temperature is raised from room temperature to 300°C in 3 hours, and then raised from 300°C to 370°C in 4 hours. After maintaining at 370°C for 12 hours, the temperature is lowered to 300°C in 5 hours, and then lowered to room temperature in 1 hour. The molded body fired by the above process is punched out to make a dumbbell, and the measurement is performed according to ASTM D1708. It should be noted that the above-mentioned tensile fracture strain can also be measured using a plunger extrusion molded product by the following method. Using a barrel diameter set to 270°C in the preheating zone and 370°C in the molding zone A vertical plunger extruder with a total length of 1300 mm was used to extrude at a filling length of 70 mm, a pressure of 10 MPa, a pressing time of 20 seconds, and one cycle of 40 seconds to obtain a molded body, which was cut into a thickness of 2.0 mm, a width of 20 mm, and a length of 150 mm to prepare a flat plate, and a dumbbell was prepared by punching the molded product, and the measurement was performed in accordance with ASTM D 1708.

[0736] The first fluororesin composition disclosed herein can be suitably used as a molding material. The method for molding the fluororesin composition is not particularly limited, and examples thereof include compression molding, plunger extrusion molding, isostatic pressing, etc. Among them, compression molding and plunger extrusion molding are preferred.

[0737] The first fluororesin composition of the present disclosure is preferably a powder for compression molding or a powder for plunger extrusion molding.

[0738] The present disclosure also provides a molded body obtained by compression molding and firing, or plunger extrusion molding, the first fluororesin composition of the present disclosure (hereinafter also referred to as a first molded body of the present disclosure).

[0739] The first molded product of the present disclosure is excellent in tensile properties despite containing a fluororesin having a history of being heated to a temperature not lower than its melting point.

[0740] The compression molding can be performed, for example, by maintaining the pressure at 10 MPa to 50 MPa for 1 minute to 30 hours.

[0741] The calcination can be performed, for example, by heating at a temperature of 350° C. to 380° C. for 0.5 to 50 hours.

[0742] The above plunger extrusion molding can be performed, for example, by using a barrel diameter set to 230°C to 330°C in the preheating zone and 320°C to 400°C in the molding zone. The extrusion is performed using a vertical plunger extruder with a filling length of 70 mm, a pressure of 1 MPa to 50 MPa, a pressurizing time of 5 seconds to 90 seconds, and one cycle of 10 seconds to 120 seconds.

[0743] The present disclosure also provides a fluororesin composition (hereinafter also referred to as the second fluororesin composition of the present disclosure) having one or more endothermic peaks in the range of 320°C to 335°C, wherein when thermally decomposed at 600°C in a nitrogen atmosphere, a residue is generated in an amount of 15% by mass or less based on the fluororesin composition, and the fluororesin composition exhibits electrical conductivity or a thermal conductivity of 0.3 W / m·K or more.

[0744] Since the second fluororesin composition of the present disclosure has the above-mentioned constitution, it is excellent in tensile properties (eg, tensile breaking strength and tensile breaking strain) and handleability (handleability as a powder).

[0745] The second fluororesin composition of the present disclosure also has electrical conductivity or thermal conductivity.

[0746] The second fluororesin composition disclosed herein has one or more endothermic peaks (melting points) in the range of 320°C to 335°C.

[0747] The endothermic peak is preferably 323°C or higher, more preferably 325°C or higher, and is preferably 333°C or lower, more preferably 330°C or lower.

[0748] The fact that the endothermic peak (melting point) is within the above range means that the fluororesin includes a fluororesin that has a history of being heated to a temperature not lower than the melting point and does not exhibit melt fluidity.

[0749] In this specification, the endothermic peak (melting point) of the fluororesin composition is the temperature corresponding to the minimum point in the melting heat curve obtained by differential scanning calorimetry [DSC] at a heating rate of 10°C / min using X-DSC7000 (manufactured by Hitachi High-tech Science Corporation). When there are two or more minimum points in one melting peak, each of them is regarded as the endothermic peak (melting point).

[0750] As the fluororesin having a history of being heated to a temperature not lower than the melting point and not showing melt fluidity, the above-mentioned fluororesin A can be used.

[0751] PTFE is preferred as the fluororesin A. The PTFE may be high molecular weight PTFE.

[0752] The PTFE as fluororesin A may be a homopolymer of TFE or a modified PTFE comprising 99.0% by mass or more of polymerized units based on TFE and 1.0% by mass or less of polymerized units based on a modified monomer (hereinafter also referred to as "modified monomer units"). The modified PTFE may consist only of polymerized units based on TFE and modified monomer units.

[0753] Examples of the modifying monomer include the monomers described above for the modified PTFE as the fluororesin A in the first fluororesin composition of the present disclosure. The preferred range of the content of the modifying monomer unit is also the same as that described for the first fluororesin composition of the present disclosure.

[0754] The preferred ranges of the standard specific gravity (SSG) and melting point of the PTFE as the fluororesin A in the second fluororesin composition of the present disclosure are the same as those described for the first fluororesin composition of the present disclosure.

[0755] The second fluororesin composition of the present disclosure may contain particles of fluororesin A. The particles of fluororesin A may be secondary particles of fluororesin A.

[0756] The preferred ranges of the average secondary particle size and D90 of the particles of the fluororesin A in the second fluororesin composition of the present disclosure are the same as those described for the first fluororesin composition of the present disclosure. The particles of the fluororesin A in the second fluororesin composition of the present disclosure can be obtained by the method described for the first fluororesin composition of the present disclosure.

[0757] The second fluororesin composition of the present disclosure generates a residue in an amount of 15% by mass or less based on the fluororesin composition when thermally decomposed at 600° C. in a nitrogen atmosphere.

[0758] The residue generated by thermal decomposition of the second fluororesin composition of the present disclosure at 600°C in a nitrogen atmosphere is preferably 10% by mass or less, more preferably 8% by mass or less, and may be 1% by mass or more based on the above-mentioned fluororesin composition.

[0759] The residue can be determined, for example, from the weight loss of a TG curve obtained by performing differential thermal gravimetric simultaneous measurement [TG / DTA] at 600° C. in a nitrogen atmosphere at a heating rate of 10° C. / min.

[0760] The second fluororesin composition disclosed herein exhibits electrical conductivity or a thermal conductivity of 0.3 W / m·K or more.

[0761] In this specification, conductivity means that the volume resistivity is 10 5 Ω·cm or less.

[0762] The volume resistivity of the second fluororesin composition disclosed herein is preferably 10 4 Ω·cm or less, more preferably 10 because the conductivity is further improved 3 Ω·cm or less, particularly preferably 10 2 Ω·cm or less, and more preferably 10Ω·cm or less. The lower limit is not particularly limited, and can be, for example, 10 -2 Ω·cm.

[0763] The volume resistivity is measured in accordance with ASTM D991.

[0764] The second fluororesin composition of the present disclosure preferably contains a conductive filler, whereby good conductivity can be imparted to the fluororesin composition.

[0765] As the conductive filler, the conductive filler described above for the first fluororesin composition of the present disclosure can be cited. As the conductive filler, a carbon filler is preferred, and carbon black is more preferred. In the second fluororesin composition of the present disclosure, even if relatively inexpensive and easy-to-handle carbon black is used, good conductivity can be imparted. The carbon black is preferably conductive carbon black, more preferably at least one selected from the group consisting of acetylene black, Ketjen black, channel black, furnace black, lamp black, and thermal black, and further preferably at least one selected from the group consisting of acetylene black, Ketjen black, and furnace black. The preferred range of the oil absorption of carbon black is the same as the range described for the first fluororesin composition of the present disclosure.

[0766] The preferred range of the content of the conductive filler is the same as the range described for the first fluororesin composition of the present disclosure.

[0767] The thermal conductivity of the second fluororesin composition of the present disclosure is preferably 0.4 W / m·K or more, more preferably 0.5 W / m·K or more, further preferably 0.6 W / m·K or more, and still more preferably 0.7 W / m·K or more.

[0768] Regarding the thermal conductivity, the barrel diameter was set to 270°C in the preheating zone and 370°C in the molding zone. A vertical plunger extruder with a total length of 1300 mm was used to extrude at a filling length of 70 mm, a pressure of 10 MPa, a pressing time of 20 seconds, and one cycle of 40 seconds to obtain a molded body, which was cut into a thickness of 2.0 mm, a width of 20 mm, and a length of 20 mm to prepare a flat plate, and measured in accordance with JIS H7903 at a room temperature of 23°C, a heater temperature of 42°C, a cooler temperature of 12°C, and a measuring load of 400N.

[0769] The second fluororesin composition of the present disclosure preferably contains a thermally conductive filler, thereby providing the fluororesin composition with good thermal conductivity.

[0770] Examples of the thermally conductive filler include the thermally conductive fillers described above for the first fluororesin composition of the present disclosure. Boron nitride is preferred as the thermally conductive filler. The second fluororesin composition of the present disclosure can impart good thermal conductivity.

[0771] The preferred range of the content of the thermally conductive filler is the same as the range described for the first fluororesin composition of the present disclosure.

[0772] The second fluororesin composition of the present disclosure may further include at least one fluororesin B selected from the group consisting of a fluororesin that exhibits melt fluidity and a fluororesin that does not exhibit melt fluidity and has no history of being heated to a temperature higher than the melting point. By including the fluororesin B, the tensile properties are improved. As the fluororesin B, the fluororesin B described in the first fluororesin composition of the present disclosure can be used. The preferred ranges of the contents of the fluororesins A and B in the second fluororesin composition of the present disclosure are the same as those described for the first fluororesin composition of the present disclosure.

[0773] The second fluororesin composition of the present disclosure preferably has one or more endothermic peaks (melting points) in a range exceeding 335°C, preferably has one or more endothermic peaks (melting points) at 355°C or lower, and more preferably has one or more endothermic peaks (melting points) at 350°C or lower.

[0774] Having a melting point in the above-mentioned temperature range means that the fluororesin composition further includes a fluororesin having an endothermic peak (melting point) in a range exceeding 335°C, that is, a fluororesin that does not exhibit melt fluidity and has no history of being heated to a temperature higher than the melting point, and / or a fluororesin that does not exhibit melt fluidity and contains a portion that has no history of being heated to a temperature higher than the melting point.

[0775] As the fluororesin that does not exhibit melt fluidity and does not have a history of being heated to a temperature higher than the melting point, the fluororesin that does not exhibit melt fluidity and does not have a history of being heated to a temperature higher than the melting point described as the fluororesin B in the first fluororesin composition of the present disclosure, for example, fluororesins B2 to B4 can be used. The preferred range of the content of the fluororesin that does not exhibit melt fluidity and does not have a history of being heated to a temperature higher than the melting point is the same as the range described for the content of the fluororesin B (or fluororesins B2 to B4) in the first fluororesin composition of the present disclosure.

[0776] As the fluororesin that does not exhibit melt fluidity and that has a portion that has no history of being heated to a temperature not less than the melting point, the fluororesin C described in the first fluororesin composition of the present disclosure can be used. The preferred range of the content of the fluororesin that does not exhibit melt fluidity and that has a portion that has no history of being heated to a temperature not less than the melting point is the same as the range described for the fluororesin C in the first fluororesin composition of the present disclosure.

[0777] From the viewpoint of further improving tensile properties, the content of the fluororesin having an endothermic peak (melting point) in the range exceeding 335° C. in the second fluororesin composition of the present disclosure is preferably 0 to 90% by mass relative to the above fluororesin composition. The above content is more preferably 1% by mass or more, further preferably 10% by mass or more, still more preferably 15% by mass or more, particularly preferably 20% by mass or more, particularly preferably exceeding 20% ​​by mass, particularly more preferably 25% by mass or more, particularly more preferably 30% by mass or more, particularly particularly preferably 40% by mass or more, and more preferably 80% by mass or less, further preferably 75% by mass or less, still more preferably 70% by mass or less, particularly preferably 65% ​​by mass or less, particularly preferably 60% by mass or less, and particularly more preferably 50% by mass or less.

[0778] The second fluororesin composition of the present disclosure does not exhibit melt fluidity.

[0779] The preferred range of MFR of the second fluororesin composition of the present disclosure is the same as the range described for the first fluororesin composition of the present disclosure.

[0780] In addition, when a preform (unfired molded body) obtained by compression molding the second fluororesin composition of the present invention is heated at a temperature above the melting point of the fluororesin composition for more than 1 hour, the reduction rate of the thickness after heating relative to the thickness before heating is less than 20%, or the thickness after heating is increased compared to the thickness before heating, which also means that the fluororesin composition does not show melt fluidity.

[0781] The second fluororesin composition of the present disclosure preferably comprises TFE units and modified monomer units based on a modified monomer copolymerizable with TFE. The above-mentioned fluororesin composition may comprise only TFE units and modified monomer units as polymerized units. The preferred range of the content of the modified monomer is the same as the range described for the first fluororesin composition of the present disclosure.

[0782] The second fluororesin composition of the present disclosure preferably contains 99.0 mass % or more of TFE units based on all polymerized units.

[0783] The content of the polymerized units constituting the second fluororesin composition of the present disclosure can be calculated by appropriately combining NMR, FT-IR, elemental analysis, and fluorescent X-ray analysis according to the type of monomers. Alternatively, when the raw material composition is known, it can be calculated from the raw material composition.

[0784] From the viewpoint of better handling properties, the apparent density of the second fluororesin composition of the present disclosure is preferably 0.40 g / ml or more, more preferably 0.42 g / ml or more, further preferably 0.45 g / ml or more, and particularly preferably 0.47 g / ml or more. The upper limit is not particularly limited and may be 1.00 g / ml.

[0785] The above apparent density is measured in accordance with JIS K6891.

[0786] The angle of repose of the second fluororesin composition of the present disclosure is preferably less than 40°, more preferably less than 38°, and still more preferably less than 35°, from the viewpoint of excellent fluidity and further excellent handleability.

[0787] The above repose angle is the value measured as follows: the total height is 115mm, the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake portion is set so that the height from the bottom of the funnel to the sample falling surface is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the dropped sample is measured with a protractor to obtain the value.

[0788] The average secondary particle size of the second fluororesin composition of the present disclosure is preferably 5 μm to 700 μm. The preferred range of the average secondary particle size in the second fluororesin composition of the present disclosure is the same as that described for the first fluororesin composition of the present disclosure.

[0789] The form of the second fluororesin composition disclosed in the present invention is not particularly limited, but is preferably a powder.

[0790] The tensile strength at break of the second fluororesin composition of the present disclosure is preferably 8 MPa or more, more preferably 9 MPa or more, further preferably 10 MPa or more, particularly preferably 13 MPa or more. The upper limit is not particularly limited, and may be, for example, 20 MPa.

[0791] The tensile strength at break is measured in accordance with ASTM D1708 using a dumbbell produced in the same manner as the first fluororesin composition of the present disclosure.

[0792] The tensile strain at break of the second fluororesin composition disclosed herein may be 75% or more, preferably 150% or more, more preferably 200% or more, further preferably 250% or more, still more preferably 300% or more, particularly preferably 360% or more, and particularly preferably 400% or more. The upper limit is not particularly limited, and may be, for example, 600%.

[0793] The tensile breaking strain is measured in accordance with ASTM D1708 using a dumbbell prepared in the same manner as the first fluororesin composition of the present disclosure.

[0794] The second fluororesin composition disclosed herein can be suitably used as a molding material. There is no particular limitation on the method for molding the fluororesin composition, and examples thereof include compression molding, plunger extrusion molding, isostatic pressing, etc. Among them, compression molding and plunger extrusion molding are preferred, and plunger extrusion molding is more preferred.

[0795] The second fluororesin composition disclosed herein is preferably a powder for compression molding or a powder for plunger extrusion molding, and more preferably a powder for plunger extrusion molding.

[0796] The second fluororesin composition disclosed in the present invention is preferably not for porous use.

[0797] In this specification, the term "porous" means a state in which, when a cross section of a molded body is cut and observed, the area occupied by voids of 10 μm or more per unit area is 20% or more.

[0798] The present disclosure also provides a molded product obtained by subjecting the second fluororesin composition of the present disclosure to plunger extrusion molding (hereinafter also referred to as the second molded product of the present disclosure).

[0799] The second molded product of the present disclosure is excellent in tensile properties despite containing a fluororesin having a history of being heated to a temperature not lower than its melting point.

[0800] As the plunger extrusion molding, the above-mentioned method can be used.

[0801] The tensile strength at break of the first and second molded bodies of the present disclosure is preferably 8 MPa or more, more preferably 9 MPa or more, further preferably 10 MPa or more, and particularly preferably 13 MPa or more. The upper limit is not particularly limited, and may be 20 MPa, for example.

[0802] The tensile strength at break is measured in accordance with ASTM D1708.

[0803] The tensile fracture strain of the first and second molded bodies disclosed herein may be 75% or more, preferably 150% or more, more preferably 200% or more, further preferably 250% or more, still more preferably 300% or more, particularly preferably 360% or more, and particularly preferably 400% or more. The upper limit is not particularly limited, and may be 600%, for example.

[0804] The tensile breaking strain is measured in accordance with ASTM D1708.

[0805] When the purpose is to improve the conductivity, the volume resistivity of the first and second molded bodies of the present disclosure is preferably 10 4 Ω·cm or less, more preferably 10 because the conductivity is further improved 3 Ω·cm or less, particularly preferably 10 2 Ω·cm or less, and more preferably 10Ω·cm or less. The lower limit is not particularly limited, and can be, for example, 10 -2 Ω·cm.

[0806] The volume resistivity is measured in accordance with ASTM D991.

[0807] When the purpose is to prevent static electricity, the volume resistivity of the first and second molded bodies of the present disclosure is preferably 10 5 Ω·cm~10 8 Ω·cm.

[0808] When the purpose is to improve thermal conductivity, the thermal conductivity of the first and second molded bodies of the present disclosure is preferably 0.3 W / m·K or more, and is preferably 0.5 W / m·K or more because the thermal conductivity is further improved. The volume resistivity is measured in accordance with JIS H7903.

[0809] The molded articles obtained from the first and second fluororesin compositions of the present disclosure are preferably not porous.

[0810] The molded articles obtained from the first and second fluororesin compositions disclosed herein can be suitably used for inner lining sheets, gaskets, washers, diaphragm valves, heat-resistant wires, heat-resistant insulating tapes for vehicle motors and generators, mold release sheets, sealing materials, housings, sleeves, bellows, hoses, piston rings, butterfly valves, square grooves, wafer carriers, circuit boards, and the like.

[0811] Although the embodiments have been described above, it should be understood that various modifications may be made to the embodiments and details without departing from the spirit and scope of the claims.

[0812] Example

[0813] Next, the present disclosure will be described in more detail with reference to Examples, but the present disclosure is not limited to these Examples.

[0814] Various physical properties were measured by the following methods.

[0815] (Melting Point)

[0816] Differential scanning calorimetry [DSC] was performed using X-DSC7000 (manufactured by Hitachi High-Tech Science Corporation) at a heating rate of 10°C / min, and the temperature corresponding to the minimum point in the obtained melting heat curve was determined. When there are two or more minimum points in one melting peak, each of them is taken as the melting point.

[0817] When the fluororesin B is 5% by mass or less, X-DSC7000 (manufactured by Hitachi High-Tech Science Corporation) is used to increase the temperature at a heating rate of 10°C / min to 300°C which is lower than the melting point of the fluororesin B. After maintaining at 300°C for 10 minutes, the temperature is increased at a heating rate of 10°C / min to perform differential scanning calorimetry [DSC], and the temperature corresponding to the minimum point in the obtained heat of fusion curve is determined.

[0818] (Residue)

[0819] The weight was determined from the weight loss of the TG curve obtained by simultaneous differential thermal and thermogravimetric measurement at 600°C at a heating rate of 10°C / min in a nitrogen atmosphere using TG / DTA7200 (manufactured by Hitachi High-tech Science Corporation).

[0820] (Monomer composition of fluororesin)

[0821] pass 19 Determined by F-NMR method.

[0822] (Monomer composition of fluororesin composition)

[0823] Determined by calculation from the raw material composition.

[0824] (Secondary particle size of powder)

[0825] The particle size distribution (volume basis) was determined using a laser diffraction particle size distribution measuring device (LS13 320) manufactured by Bechman Coulter in a dry manner and at a vacuum pressure of 20 mH2O. The average secondary particle size was equal to the particle size corresponding to 50% of the cumulative particle size distribution. The particle size corresponding to 10% was taken as D10, and the particle size corresponding to 90% was taken as D90.

[0826] (Average primary particle size)

[0827] An aqueous dispersion adjusted to a solid content concentration of 0.5 mass % was dropped onto an aluminum foil, dried at 150° C. for 1 hour to remove water, and observed using a scanning electron microscope (SEM) to determine the average diameter of 100 or more particles randomly selected.

[0828] (Aspect Ratio)

[0829] An aqueous fluororesin dispersion diluted to a solid content concentration of 0.5 mass % was observed using a scanning electron microscope (SEM), and at least 100 particles randomly selected were imaged and the average aspect ratio was calculated from the average ratio of the major axis to the minor axis.

[0830] Regarding the proportion of particles with an aspect ratio of 2.5 or more, an aqueous fluororesin dispersion diluted to a solid content concentration of 0.5% by mass was observed using a scanning electron microscope (SEM), and image processing was performed on more than 100 randomly selected particles. The aspect ratio of each particle was calculated and determined as a ratio relative to the total number of the particles selected above.

[0831] (Solid content concentration of aqueous dispersion)

[0832] Regarding the solid content concentration (P mass %) in the aqueous dispersion, about 1 g (Xg) of the sample was taken into an aluminum cup with a diameter of 5 cm, and heated at 110°C for 30 minutes to obtain a heating residue (Yg). The obtained heating residue (Yg) was further heated at 300°C for 30 minutes to obtain a heating residue (Zg). The solid content concentration in the aqueous dispersion was calculated by the formula: P = [Z / X] × 100 (mass %).

[0833] (Content of nonionic surfactant in aqueous dispersion)

[0834] Regarding the content of nonionic surfactant relative to PTFE in the aqueous dispersion (N mass %), about 1 g (Xg) of the sample is put into an aluminum cup with a diameter of 5 cm, and heated at 110°C for 30 minutes to obtain a heating residue (Yg). The obtained heating residue (Yg) is further heated at 300°C for 30 minutes to obtain a heating residue (Zg). The heating residue (Yg) and the heating residue (Zg) are calculated according to the formula: N = [(YZ) / Z] × 100 (mass %).

[0835] (Apparent density)

[0836] The measurement was conducted in accordance with JIS K6891.

[0837] (Standard Specific Gravity (SSG))

[0838] The measurement was performed by the water displacement method according to ASTM D792 using a sample molded according to ASTM D4895 89.

[0839] (angle of repose)

[0840] The total height is 115mm and the foot diameter is A funnel with a foot length of 35 mm and an opening of 60° at the intake part is set so that the height from the bottom of the funnel to the bottom where the sample falls is 100 mm. 40 g of sample is dropped from the funnel, and the angle of the lower half of the peak of the falling sample is measured with a protractor as the angle of repose.

[0841] (Maximum straight line length)

[0842] 100 or more secondary particles are observed using an SEM image, and the major diameter of each secondary particle is measured, and the largest major diameter among them is taken as the maximum linear length.

[0843] (MFR)

[0844] In accordance with ASTM D1238, the mass (g / 10 minutes) of the polymer flowing out from a nozzle having an inner diameter of 2.095 mm and a length of 8 mm is measured every 10 minutes using a melt flow indexer at a measurement temperature (e.g., 372° C. in the case of PFA and FEP, and 297° C. in the case of ETFE) and a load (e.g., 5 kg in the case of PFA, FEP and ETFE) determined according to the type of fluororesin.

[0845] (Tensile test)

[0846] In Examples 1 to 6, 35 g of powder is put into a mold, and compression molding is performed at 30 MPa for 1 minute. The temperature is then raised from room temperature to 300°C in 3 hours, and then from 300°C to 370°C in 4 hours. After maintaining at 370°C for 12 hours, the temperature is lowered to 300°C in 5 hours, and then lowered to room temperature in 1 hour. The molded product is fired through this process, and the molded product is punched to prepare dumbbells. A tensile test is performed according to ASTM D1708 to measure the tensile breaking strength and tensile breaking strain. It should be noted that in Examples 7 to 16, when a plunger is used to extrude the molded product, the measurement is performed by the following method. Using a barrel diameter set to 270°C in the preheating zone and 370°C in the molding zone, the molded product is subjected to the following test. A vertical plunger extruder with a total length of 1300 mm was used to extrude at a filling length of 70 mm, a pressure of 10 MPa, a pressurizing time of 20 seconds, and 1 cycle of 40 seconds to obtain a molded body, which was cut into a thickness of 2.0 mm, a width of 20 mm, and a length of 150 mm to prepare a flat plate, and a dumbbell was prepared by punching the molded product. A tensile test was performed in accordance with ASTM D 1708 to measure the tensile breaking strength and tensile breaking strain.

[0847] (Melt fluidity of fluororesin composition)

[0848] When the fluororesin composition (powder) is compression molded and fired under the same conditions as in the above-mentioned tensile test, if the thickness after firing is reduced by 20% or more relative to the thickness before firing, the fluororesin composition is judged to have melt fluidity, and if the reduction rate before and after firing is less than 20%, or the thickness after firing is increased compared to the thickness before firing, it is judged to have no melt fluidity.

[0849] (Volume resistivity)

[0850] In Example 7, the barrel diameter was set at 270°C in the preheating zone and 370°C in the molding zone. A vertical plunger extruder with a total length of 1300 mm was used to extrude at a filling length of 70 mm, a pressure of 10 MPa, a pressing time of 20 seconds, and 1 cycle of 40 seconds to obtain a molded body. The molded body was cut to a thickness of 2.0 mm, a width of 20 mm, and a length of 150 mm to prepare a flat plate. The volume resistivity was measured using a digital ohmmeter R506 (manufactured by Kawaguchi Electric Co., Ltd.) in accordance with ASTM D 991 at a distance of 60 mm between voltage electrodes, a distance of 100 mm between current electrodes, a room temperature of 23° C., and an atmosphere of 50% humidity. It should be noted that in Examples 8 to 14, regarding the volume resistivity, the above-mentioned flat plate was prepared and measured using Lorestar GX MCP-T700 (manufactured by Mitsubishi Chemical Analytech Co., Ltd.) in an atmosphere of 23° C. and 50% humidity in accordance with JIS K 7194.

[0851] (Thermal conductivity)

[0852] The barrel diameter is set to 270℃ in the preheating zone and 370℃ in the forming zone. A vertical plunger extruder with a total length of 1300 mm was used to extrude the molded body at a filling length of 70 mm, a pressure of 10 MPa, a pressing time of 20 seconds, and a cycle of 40 seconds. The molded body was cut to a thickness of 2.0 mm, a width of 20 mm, and a length of 20 mm, and a flat plate was prepared. The thermal conductivity was measured using TCM1001 (manufactured by Rhesca Co., Ltd.) at a room temperature of 23°C, a heater temperature of 42°C, a cooler temperature of 12°C, and a measurement load of 400N in accordance with JIS H7903.

[0853] (Non-porous)

[0854] The cross section of the molded body obtained by plunger extrusion molding the fluororesin composition (powder) under the same conditions as the above thermal conductivity was observed using an SEM image, and when the ratio of voids of 10 μm or more per unit area was 20% or more, it was judged to be porous. When the above ratio was less than 20%, it was judged to be "not porous", and was indicated by "0" in Table 1. Similarly, when the above ratio was 20% or more, it was judged to be "porous", and was indicated by "×" in Table 1.

[0855] Synthesis Example 1 (Synthesis of Perfluoroether Carboxylic Acid Ammonium Salt A)

[0856] After replacing the 1L autoclave with nitrogen, 16.5g of dehydrated tetramethylurea and 220g of diethylene glycol dimethyl ether were added and cooled. 38.5g of carbonyl fluoride was added, and then 100g of hexafluoropropylene oxide was introduced and stirred. After that, 38.5g of carbonyl fluoride and 100g of hexafluoropropylene oxide were added. After that, the same amount of carbonyl fluoride and hexafluoropropylene oxide were further added. After the reaction was completed, the reaction mixture was taken out and separated to obtain the reaction product of the lower layer.

[0857] Add 1000mL of tetraethylene glycol dimethyl ether and CsF (75g) to a 6L autoclave, and replace the autoclave with nitrogen. After that, cool the autoclave, add 2100g of the reaction product obtained above, introduce hexafluoropropylene oxide into the autoclave, and start the reaction. Finally, add 1510g of hexafluoropropylene oxide. Then extract the contents and separate them into the upper layer and the lower layer using a separatory funnel. The upper layer is 1320g, and the lower layer is 3290g. Distill and separate the lower layer.

[0858] Next, add 1000g of pure water to the separated target 1000g and hydrolyze. Afterwards, separate the liquid using a separating funnel to recycle the organic layer (lower floor). Use sulfuric acid water to clean the recovered solution. Further, the obtained solution is subjected to simple distillation and refined. After refining, 500g of the above-obtained simple distillate is added dropwise to an aqueous solution obtained by mixing the obtained compound, 76g of 28% by mass ammonia solution and 600g of pure water. After the addition is completed, 28% by mass ammonia solution is added and the pH is adjusted to 7. It is freeze-dried to thereby obtain perfluoroether carboxylic acid ammonium salt A.

[0859] Production Example 1 (Preparation of Fluororesin Powder A-1)

[0860] 35 g of PTFE molding powder (standard specific gravity (SSG): 2.159, melting point: 345.0° C.) obtained by pulverizing a coarse powder of homopolymerized PTFE obtained by suspension polymerization of only TFE monomer using a pulverizer was used. The mold was compressed and molded at 30 MPa for 1 minute, and fired at 370°C for 3 hours to obtain a molded product. The obtained molded product was cut and crushed by a pulverizer to obtain fluororesin powder A-1. The melting point of fluororesin powder A-1 was 328°C, the average secondary particle size was 23μm, D10 was 8μm, D90 was 48μm, the apparent density was 0.64g / ml, and the maximum straight length was 94μm.

[0861] Production Example 2 (Preparation of Fluororesin Powder A-2)

[0862] The molded product obtained in the same manner as in Production Example 1 was cut and then pulverized by a pulverizer to obtain fluororesin powder A-2. Fluororesin powder A-2 had a melting point of 328°C, an average secondary particle size of 148 μm, D10 of 96 μm, D90 of 212 μm, and an apparent density of 1.03 g / ml.

[0863] Production Example 3 (Preparation of Fluororesin Powder B-1)

[0864] A coarse powder of homopolymerized PTFE obtained by suspension polymerization of only TFE monomer was crushed by a pulverizer to obtain fluororesin powder B-1. Fluororesin powder B-1 had an apparent density of 0.34 g / ml, an average secondary particle size of 24 μm, D90 of 55 μm, a standard specific gravity (SSG) of 2.163, a melting point of 345.0°C, and a maximum straight length of 112 μm.

[0865] Production Example 4 (Preparation of Fluororesin Powder B-2)

[0866] The coarse powder of modified PTFE obtained by suspension polymerization of TFE and perfluoropropyl vinyl ether (PPVE) was crushed by a pulverizer to obtain fluororesin powder B-2. Fluororesin powder B-2 had an apparent density of 0.33 g / ml, an average secondary particle size of 28 μm, D90 of 77 μm, a standard specific gravity (SSG) of 2.168, a melting point of 341.5°C, an amount of PPVE units of 0.09% by mass, and a maximum linear length of 156 μm.

[0867] Production Example 5 (Production of Fluororesin Powder B-3)

[0868] In a SUS autoclave with an internal volume of 6 L and a stirring blade, perfluoroether carboxylic acid ammonium salt A is used to obtain an aqueous dispersion of modified PTFE composed of TFE units and perfluoro(propyl vinyl ether) (PPVE) units by a known emulsion polymerization method, and then precipitated and dried by a known method to obtain fluororesin powder B-3.

[0869] The obtained fluororesin powder B-3 had an apparent density of 0.46 g / ml, an average secondary particle size of 460 μm, a standard specific gravity (SSG) of 2.169, a melting point of 334.6°C, a PPVE unit content of 0.14% by mass, and a maximum straight line length of 1379 μm.

[0870] Production Example 6 (Preparation of Fluororesin Powder B-4)

[0871] In a SUS autoclave with a volume of 6 L and a stirring blade, perfluoroether carboxylic acid ammonium salt A was used to obtain a PFA aqueous dispersion containing PFA particles composed of TFE units and perfluoro(propyl vinyl ether) (PPVE) units by a known emulsion polymerization method. The obtained PFA aqueous dispersion was precipitated to obtain fluororesin powder B-4. The average secondary particle size was 1.5 μm, the MFR was 28 g / 10 min, the melting point was 314°C, the content of PPVE units was 1.4 mol%, and the maximum straight line length was 27 μm.

[0872] Production Example 7 (Preparation of Fluororesin Powder B-6)

[0873] A coarse powder of homopolymerized PTFE obtained by suspension polymerization of only TFE monomer was crushed by a pulverizer to obtain fluororesin powder B-6. Fluororesin powder B-6 had an apparent density of 0.39 g / ml, an average secondary particle size of 31 μm, D90 of 204 μm, a melting point of 343° C., and a maximum straight length of 307 μm.

[0874] The carbon black and boron nitride used in the examples are shown below, respectively.

[0875] Carbon black 1: BET surface area = 225 m 2 / g, DBP oil absorption = 105cc / 100g, average primary particle size = 16nm

[0876] Carbon black 2: BET surface area = 214 m 2 / g, DBP oil absorption = 175cc / 100g, average primary particle size = 37nm

[0877] Boron nitride: BET specific surface area = 5.0 m 2 / g, tap density = 0.3g / cm 3

[0878] Example 1

[0879] 40 g of fluororesin powder A-1, 45 g of fluororesin powder B-2, and 15 g of glass fiber (PFE-001 manufactured by Nitto Bosei Co., Ltd.) were mixed for 60 seconds using Wonder crusher WC-3 at a rotation speed of 6900 rpm to obtain PTFE powder (fluororesin composition). The apparent density of the obtained PTFE powder was 0.45 g / ml, the angle of repose was 34°, and the operability was excellent. In addition, the above-mentioned PTFE powder contained 99.959% by mass of TFE units and 0.041% by mass of PPVE units relative to all polymerized units. The melting point of the above-mentioned PTFE powder was 329° C. and 342° C., the tensile fracture strength was 15 MPa, and the tensile fracture strain was 342%. The characteristics of the obtained PTFE powder are shown in Table 1.

[0880] Example 2

[0881] PTFE powder was obtained in the same manner as in Example 1 using 35 g of fluororesin powder A-1, 40 g of fluororesin powder B-2, 10 g of fluororesin powder B-4, and 15 g of glass fiber (PF E-001 manufactured by Nitto Bosei Co., Ltd.). The apparent density of the obtained PTFE powder was 0.48 g / ml, the angle of repose was 38°, and the operability was excellent. In addition, the above-mentioned PTFE powder contained 99.604% by mass of TFE units and 0.396% by mass of PPVE units relative to the total polymerized units. The melting points of the above-mentioned PTFE powder were 315° C., 329° C., and 342° C., the tensile strength at break was 16 MPa, and the tensile strain at break was 365%. The properties of the obtained PTFE powder are shown in Table 1.

[0882] Example 3

[0883] PTFE powder was obtained in the same manner as in Example 1 using 40 g of fluororesin powder A-1, 35 g of fluororesin powder B-1, 10 g of fluororesin powder B-4, and 15 g of glass fiber (PF E-001 manufactured by Nitto Bosei Co., Ltd.). The apparent density of the obtained PTFE powder was 0.44 g / ml, the angle of repose was 38°, and the operability was excellent. In addition, the above-mentioned PTFE powder contained 99.641% by mass of TFE units and 0.359% by mass of PPVE units relative to the total polymerized units. The melting points of the above-mentioned PTFE powder were 315° C., 329° C., and 345° C., the tensile strength at break was 16 MPa, and the tensile strain at break was 401%. The properties of the obtained PTFE powder are shown in Table 1.

[0884] Example 4

[0885] PTFE powder was obtained in the same manner as in Example 1 using 40 g of fluororesin powder A-1, 40 g of fluororesin powder B-2, 15 g of glass fiber (PFE-001 manufactured by Nitto Bosei Co., Ltd.), and 5 g of graphite (CPB manufactured by Nippon Graphite Industries, Ltd.). The obtained PTFE powder had an apparent density of 0.49 g / ml, an angle of repose of 38°, and excellent operability. In addition, the above-mentioned PTFE powder contained 99.964% by mass of TFE units and 0.036% by mass of PPVE units relative to all polymerized units. The melting point of the above-mentioned PTFE powder was 329° C. and 342° C., a tensile fracture strength of 9 MPa, and a tensile fracture strain of 80%. The properties of the obtained PTFE powder are shown in Table 1.

[0886] Example 5

[0887] PTFE powder was obtained in the same manner as in Example 1 using 40 g of fluororesin powder A-1, 45 g of fluororesin powder B-2, and 15 g of bronze powder (Bro-AT-200 manufactured by Futian Metal Foil Powder Industry Co., Ltd.). The apparent density of the obtained PTFE powder was 0.53 g / ml, the angle of repose was 34°, and the operability was excellent. In addition, the above-mentioned PTFE powder contained 99.959% by mass of TFE units and 0.041% by mass of PPVE units relative to the total polymerized units. The melting point of the above-mentioned PTFE powder was 329° C. and 342° C., the tensile fracture strength was 14 MPa, and the tensile fracture strain was 364%. The properties of the obtained PTFE powder are shown in Table 1.

[0888] Example 6

[0889] 45 g of fluororesin powder A-1, 40 g of fluororesin powder B-3, 15 g of glass fiber (PFE-001 manufactured by Nitto Bosei Co., Ltd.) were used, and the rotation speed was changed to 2900 rpm. PTFE powder was obtained in the same manner as in Example 1. The apparent density of the obtained PTFE powder was 0.43 g / ml, the angle of repose was 35 °, and the operability was excellent. In addition, the above-mentioned PTFE powder contained 99.944 mass % of TFE units and 0.056 mass % of PPVE units relative to all polymerized units. The melting point of the above-mentioned PTFE powder was 329 ° C and 336 ° C, the tensile fracture strength was 11 MPa, and the tensile fracture strain was 283%. The characteristics of the obtained PTFE powder are shown in Table 1.

[0890] Example 7

[0891] PTFE powder was obtained in the same manner as in Example 1 using 65 g of fluororesin powder A-2, 25 g of fluororesin powder B-6 and 10 g of carbon black. The apparent density of the obtained PTFE powder was 0.43 g / ml, the angle of repose was 23°, and the workability was excellent. The melting points of the above PTFE powder were 327°C and 343°C, the tensile strength at break was 11 MPa, the tensile strain at break was 26%, and the volume resistivity was 1.4 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 9.1% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0892] Example 8

[0893] PTFE powder was obtained in the same manner as in Example 1 using 72 g of fluororesin powder A-2, 25 g of fluororesin powder B-6 and 13 g of carbon black. The apparent density of the obtained PTFE powder was 0.54 g / ml, the angle of repose was 21°, and the handling was excellent. The melting points of the above PTFE powder were 327°C and 343°C, the tensile strength at break was 14 MPa, the tensile strain at break was 55%, and the volume resistivity was 8.0 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 5.4% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0894] Example 9

[0895] PTFE powder was obtained in the same manner as in Example 1 using 20 g of fluororesin powder A-2, 70 g of fluororesin powder B-6 and 10 g of carbon black 2. The obtained PTFE powder had an apparent density of 0.48 g / ml, an angle of repose of 20° and excellent operability. The melting points of the above PTFE powder were 327°C and 343°C, a tensile strength of 14 MPa, a tensile strain of 158% and a volume resistivity of 1.6 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 11.9% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0896] Example 10

[0897] PTFE powder was obtained in the same manner as in Example 1 using 40 g of fluororesin powder A-2, 50 g of fluororesin powder B-6 and 10 g of carbon black. The apparent density of the obtained PTFE powder was 0.43 g / ml, the angle of repose was 34°, and the workability was excellent. The melting points of the above PTFE powder were 327°C and 343°C, the tensile strength at break was 10 MPa, the tensile strain at break was 17%, and the volume resistivity was 5.1 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 9.8% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0898] Embodiment 11

[0899] PTFE powder was obtained in the same manner as in Example 1 using 40 g of fluororesin powder A-2, 45 g of fluororesin powder B-6 and 15 g of carbon black 2. The obtained PTFE powder had an apparent density of 0.34 g / ml and an angle of repose of 28°, and excellent operability. The melting points of the above PTFE powder were 327°C and 343°C, a tensile strength of 10 MPa, a tensile strain of 16% and a volume resistivity of 0.6 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 16.8% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0900] Example 12

[0901] PTFE powder was obtained in the same manner as in Example 1 using 70 g of fluororesin powder A-2, 25 g of fluororesin powder B-6 and 25 g of carbon black. The apparent density of the obtained PTFE powder was 0.46 g / ml, the angle of repose was 29°, and the workability was excellent. The melting points of the above PTFE powder were 327°C and 343°C, the tensile strength at break was 17 MPa, the tensile strain at break was 140%, and the volume resistivity was 3.1 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 7.4% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0902] Example 13

[0903] PTFE powder was obtained in the same manner as in Example 1 using 74 g of fluororesin powder A-2, 25 g of fluororesin powder B-6, and 11 g of carbon black. The obtained PTFE powder had an apparent density of 0.60 g / ml, an angle of repose of 22°, and excellent workability. The melting points of the PTFE powder were 327°C and 343°C, a tensile strength of 17 MPa, a tensile strain of 167%, and a volume resistivity of 2.0×10 2 Ω·cm. The residue generated by thermal decomposition at 600°C in a nitrogen atmosphere was 8.1% by mass. Table 1 shows the properties of the obtained PTFE powder.

[0904] Embodiment 14

[0905] PTFE powder was obtained in the same manner as in Example 1 using 69 g of fluororesin powder A-2, 3 g of fluororesin powder B-4, 25 g of fluororesin powder B-6 and 3 g of carbon black 2. The obtained PTFE powder had an apparent density of 0.51 g / ml and an angle of repose of 26°, and excellent operability. In addition, the PTFE powder contained 99.8923% by mass of TFE units and 0.1077% by mass of PPVE units relative to all polymerized units. The melting points of the PTFE powder were 315°C, 327°C and 343°C, the tensile strength at break was 18 MPa, the tensile strain at break was 211%, and the volume resistivity was 9.2 Ω·cm. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 4.8% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0906] Embodiment 15

[0907] 65 g of fluororesin powder A-2, 25 g of fluororesin powder B-6, and 10 g of boron nitride were used to obtain PTFE powder in the same manner as in Example 1. The apparent density of the obtained PTFE powder was 0.56 g / ml, the angle of repose was 30°, and the handling property was excellent. The melting points of the above PTFE powder were 327° C. and 343° C., the tensile strength at break was 10 MPa, the tensile strain at break was 42%, and the thermal conductivity was 0.72 W / m·K. The residue produced by thermal decomposition at 600° C. in a nitrogen atmosphere was 13.9% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0908] Example 16

[0909] PTFE powder was obtained in the same manner as in Example 1 using 72 g of fluororesin powder A-2, 25 g of fluororesin powder B-6 and 3 g of boron nitride. The apparent density of the obtained PTFE powder was 0.72 g / ml, the angle of repose was 31°, and the handling property was excellent. The melting points of the above PTFE powder were 327°C and 343°C, the tensile strength at break was 15 MPa, the tensile strain at break was 154%, and the thermal conductivity was 0.32 W / m·K. The residue produced by thermal decomposition at 600°C in a nitrogen atmosphere was 10.9% by mass. The properties of the obtained PTFE powder are shown in Table 1.

[0910] Comparative Example 1

[0911] 85 g of fluororesin powder A-1 and 15 g of glass fiber (PF E-001 manufactured by Nitto Bosei Co., Ltd.) were used to obtain PTFE powder in the same manner as in Example 1. The apparent density of the obtained PTFE powder was 0.62 g / ml, the angle of repose was 44°, and the operability was poor. In addition, the above-mentioned PTFE powder contained 100% by mass of TFE units relative to all polymerized units. The melting point of the above-mentioned PTFE powder was 329° C., the tensile fracture strength was 6 MPa, and the tensile fracture strain was 71%. The properties of the obtained PTFE powder are shown in Table 1.

[0912] Comparative Example 2

[0913] 85 g of fluororesin powder A-1 and 15 g of graphite (CPB manufactured by Nippon Graphite Industries, Ltd.) were used to obtain PTFE powder in the same manner as in Example 1. The apparent density of the obtained PTFE powder was 0.37 g / ml, the angle of repose was 43 °, and the operability was poor. In addition, the above-mentioned PTFE powder contained 100% by mass of TFE units relative to all polymerized units. The melting point of the above-mentioned PTFE powder was 329 ° C, the tensile fracture strength was 7 MPa, and the tensile fracture strain was 17%. The characteristics of the obtained PTFE powder are shown in Table 1.

[0914] [Table 1]

[0915]

Claims

1. A fluororesin composition that does not exhibit melt fluidity, comprising: A fluororesin A which does not exhibit melt fluidity when heated to a temperature above its melting point; at least one fluororesin B selected from the group consisting of fluororesins that exhibit melt fluidity and fluororesins that do not exhibit melt fluidity and do not have a history of being heated to a temperature higher than a melting point; and Filling material. 2 . The fluororesin composition according to claim 1 , which has one or more melting points in a temperature range of less than 333° C., and one or more melting points in a temperature range of 333° C. to 360° C.

3. The fluororesin composition according to claim 1 or 2, wherein The fluororesin composition comprises a tetrafluoroethylene unit and a modifying monomer unit based on a modifying monomer copolymerizable with tetrafluoroethylene.

4. The fluororesin composition according to claim 3, wherein The amount of the modified monomer unit is 1.0 mass % or less based on the total polymerized units constituting the fluororesin composition.

5. The fluororesin composition according to any one of claims 1 to 4, wherein Fluororesin A is polytetrafluoroethylene.

6. The fluororesin composition according to any one of claims 1 to 5, wherein The fluororesin exhibiting melt fluidity has a melt flow rate of 0.25 g / 10 minutes or more.

7. The fluororesin composition according to any one of claims 1 to 6, wherein The fluororesin exhibiting melt fluidity is a fluororesin having a melting point of 320° C. or less.

8. The fluororesin composition according to any one of claims 1 to 7, wherein The fluororesin B is the fluororesin exhibiting melt fluidity, and the fluororesin composition further comprises a fluororesin C that does not exhibit melt fluidity, and the fluororesin C has a portion that does not have a history of being heated to a temperature higher than a melting point.

9. The fluororesin composition according to any one of claims 1 to 8, which has an apparent density of 0.40 g / ml or more.

10. The fluororesin composition according to any one of claims 1 to 9, which has an angle of repose of less than 40°. 11 . The fluororesin composition according to claim 1 , which has an average secondary particle size of 5 μm to 700 μm.

12. The fluororesin composition according to any one of claims 1 to 11, wherein The maximum linear length of the particles of fluororesin A is smaller than the maximum linear length of the particles of fluororesin B.

13. The fluororesin composition according to any one of claims 1 to 12, wherein The filler material is at least one selected from the group consisting of glass fiber, glass beads, carbon fiber, spherical carbon, carbon black, graphite, silica, alumina, mica, silicon carbide, boron nitride, titanium oxide, bismuth oxide, cobalt oxide, molybdenum disulfide, bronze, gold, silver, copper and nickel.

14. The fluororesin composition according to any one of claims 1 to 13, wherein The filling material is a conductive filler.

15. The fluororesin composition according to claim 14, wherein The conductive filler is carbon black. 16 . The fluororesin composition according to claim 1 , which is in the form of a powder. 17 . The fluororesin composition according to claim 1 , which is a powder for compression molding or a powder for plunger extrusion molding.

18. The fluororesin composition according to any one of claims 1 to 17, which has a tensile strength at break of 8 MPa or more.

19. A molded article obtained by compression molding and firing the fluororesin composition according to any one of claims 1 to 18, or by plunger extrusion molding.

20. A fluororesin composition having one or more endothermic peaks in the range of 320°C to 335°C, wherein: When thermally decomposed at 600° C. in a nitrogen atmosphere, 15% by mass or less of a residue is generated based on the fluororesin composition. The fluororesin composition exhibits electrical conductivity or a thermal conductivity of 0.3 W / m·K or more. 21 . The fluororesin composition according to claim 20 , further comprising one or more endothermic peaks in a range exceeding 335° C. 22 . The fluororesin composition according to claim 20 , further comprising an electrically conductive filler or a thermally conductive filler.

23. The fluororesin composition according to any one of claims 20 to 22, which has a volume resistivity of 10 4 Ω·cm or less.

24. The fluororesin composition according to any one of claims 20 to 23, which has an apparent density of 0.40 g / ml or more.

25. The fluororesin composition according to any one of claims 20 to 24, which has an angle of repose of less than 40°. 26 . The fluororesin composition according to claim 20 , which is a powder for plunger extrusion molding.

27. The fluororesin composition according to any one of claims 20 to 26, which has a tensile strength at break of 8 MPa or more.

28. The fluororesin composition according to any one of claims 1 to 18 and 20 to 27, which is not for porous use.

Citation Information

Cited By

  • Composite sealing diaphragm for diaphragm valve and preparation method of composite sealing diaphragm

    CN121062313A

  • Corrosion-resistant PTFE sealing ring and production process thereof

    CN121182104A

  • Corrosion-resistant PTFE sealing ring and production process thereof

    CN121182104B